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Herpesviruses are ubiquitous in both humans and animals and can cause 
life-threatening disease. The discovery of murine gammaherpesvirus 68 (MHV-68), 
which has many similarities in genome and pathogenesis as the human pathogens 
Epstein-Barr virus and Kaposi’s sarcoma-associated herpesvirus, provides a model 
for further investigation of the pathogenesis of gammaherpesviruses. The M4 gene 
was found to be at the left end region of MHV-68 genome. The presence of the M4 
protein is required during the early establishment of MHV-68 latency. However, the 
function of M4 protein remains unclear. The aim of this project was to investigate the 
function of the M4 protein in vitro and during infection. 
By using an ELISA, the recombinant M4 protein was shown to bind several 
Cxc-chemokines and stop the interaction between Cxcl4 and GAGs. The role of M4 
protein during MHV-68 lytic infection and in the early establishment of latency was 
studied by comparing the pathogenesis of virus which does not express M4 (M4stop) 
and wild type virus (WT). Compared to WT infection, this study found that M4stop 
was decreased in the lungs at day 8 post infection (p.i.). At the same time point, the 
viral loads were higher in M4stop infected spleens, which was accompanied by 
increased expression of the CD4
+
 T cell activation marker PD-1 and the macrophage 
activation marker CD69. However, at day 14 p.i., the M4stop infected spleens had 




 T cells, 
B cells and macrophages. Furthermore, gene expression PCR arrays were used to 
investigate how cellular activation and inflammation were transcriptionally regulated. 
It has been found that the transcription of several genes, which are involved in 
germinal centre development, was lower in the spleens of WT infected mice at day 




of M4stop infection. In addition, the percentage of germinal centre B cells was found 
to be higher in spleens infected with M4stop at day 10 p.i.. However, there was no 
difference in percentages of TFH and plasma cells in the spleens. Finally, in order to 
understand the role of IFN- in control of infection in M4stop infected mice, 
IFN-R
-/-
 mice were infected with M4stop and WT. Although there were differences 
in pathogenesis between WT and M4Stop virus infected IFN-R
-/- 
mice, there was no 
clear evidence that M4 function is involved in inhibiting IFN- pathways. 
In this study, we found M4 can disturb the interaction of chemokine and GAGs and 
might delay virus trafficking to the spleen, which could lead to a reduction of cellular 
activation. M4 may also impair the development of germinal centres at the beginning 
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Herpesviruses are ubiquitous viruses that hosts carry for their life time. More than 
130 herpesviruses have been identified so far. Herpesvirus infections are widely 
established in most vertebrates and in one invertebrate (Davison et al., 2009). The 
natural infection of herpesviruses has host specificity such that most herpesviruses 
infections are restricted to a single species. However, the host can be infected by one 
or more herpesviruses. The herpesvirus infection can induce an asymptomatic or 
mild symptomatic lytic infection. The lytic infection is followed by establishment of 
latent infection in which complete copies of the viral genetic information persist for 
extended periods without continuous production of infectious virus. During infection, 
latency is an ideal strategy used by the herpesvirus to evade the immune attack. 
There are two consequences of latent infection: the first is reactivation or 
reappearance of infectious virus under certain conditions, such as 
immunosuppression; the other aftermath of latent infection is the occasional 
neoplastic alteration of the latently infected cell and the formation of tumors. 
However, the latter only occurs in certain herpesvirus infections. 
1.1.1 Structure 
Herpesviruses are large double stranded DNA viruses, which have a 125-290 nm 
diameter. The virus consists of DNA-containing icosahedral (T=16) shaped 
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nucleocapsid, which is coated in a dense protein layer called the tegument. The 
tegument is surrounded by a lipid bilayer membrane, called the envelope, composed 
of viral proteins and glycoproteins (Flint et al., 2009).  
1.1.2 Classification 
Classification of herpesviridae was initially determined by their structure and 
biological properties, such as host ranges, reproductive cycles, and latency sites. 
Nowadays, molecular characteristics are also considered in classifying of 
herpesviruses. According to this, the herpesviridae are ordered in three subfamilies: 
the Alphaherpesvirinae, the Betaherpesvirinae, and the Gammaherpesvirinae, based 
on the report of the International Committee on Taxonomy of Viruses (ICTV, 
http://www.ictvonline.org). The classifications of common herpesviruses are listed in 
table 1.1. There are eight currently identified human herpesviruses: human herpes 
virus 1-8. The common names of these human herpesviruses are used in this thesis.  
1.1.3 Life cycle 
As mentioned before, herpesviruses have two distinct life cycles: lytic and latent 
replication. The cellular tropisms and mechanisms that support lytic and latent 
infection with different herpesviruses are various (reviewed in Penkert and Kalejta, 
2011) (table 1.2). The life cycle of herpesvirus described below is based on the study 
of herpes simplex virus type 1 (HSV-1). 
 




Table 1.1  Classification of common Herpesviridae and disease associations 
 




Simplexvirus Human herpesvirus 1,2 Herpes simplex 
virus type 1,2  
human Recurrent herpetic 
stomatitis 





Mardivirus Gallid herpesvirus 2, 3 Marek's disease 
virus 




Cytomegalovirus Human herpes virus 5 Human 
cytomegalovirus 
(HCMV) 
human Mononucleosis,  
Muromegalovirus Murid herpesvirus 1 Mouse 
cytomegalovirus 
mouse hepatitis 
Roseolovirus Human herpesvirus 6, 7 Human herpesvirus 
6, 7 










































Saimiriine herpesvirus Herpesvirus saimiri monkey Lymphoproliferative 
disease 




Percavirus Equine herpesvirus 2, 5 Equine herpesvirus 
2, 5  
Horse Respiratory disease 
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1.1.3.1 Lytic replication 
Attachment and entry 
Most herpesvirus virions bind to the cells by exploiting glycosaminoglycans (GAGs), 
usually heparin sulfate or chondroitin sulfate proteoglycans, on the cell surface 
(reviewed in Shukla and Spear, 2001). The reversible binding through HSV-1 
glycoprotein B (gB) and gC manages to concentrate virus on the cell surface thus 
increasing the efficiency of viral entry (Herold et al., 1994; reviewed in Spear and 
Longnecker, 2003).  
The initial entry of herpesvirus, however, interacts with entry receptor molecules on 
the cell surface. During entry, fusion between the viral envelope and the plasma 
membrane of cells requires four glycoproteins, gB, gD, gH and gL (Spear, 1993; 
reviewed in Spear and Longnecker, 2003). Other entry mechanisms have also been 
used to invade certain cellular types in vitro under special conditions. For instance, 
endocytosis is utilized by HSV to enter into Hela and Chinese hamster ovary cell 
lines at low pH conditions (Nicola, McEvoy, and Straus, 2003).   
Gene expression 
The virions are internalized and dismantled, releasing the tegument proteins and the 
nucleocapsids into the cytoplasm after viral entry. The viral nucleocapsids are 
transported along microtubules towards the cell nucleus where viral nucleocapsids 
dock at the nuclear pore, followed by the release of viral DNA into the nucleus 
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(reviewed in Campbell and Hope, 2003; Sodeik, Ebersold, and Helenius, 1997). 
Meanwhile, certain tegument proteins, such as virion protein (VP16), are transported 
to the nucleus as well.  
Within the nucleus, transcription of viral genes takes place using the transcription 
machinery of the host. The transcription of viral genes was examined by Honess and 
Roizman who looked at the synthesis order and rate in infected cells based on the 
study of HSV-1 productive infection. Then these genes were classified into three 
major groups:immediately-early genes (IEGs), early genes (EGs) or late genes (LGs) 
(Honess and Roizman, 1974). IEGs are expressed transiently and rapidly before de 
novo protein synthesis during lytic infection. Unlike other DNA viruses, many 
herpesvirus IEGs are mediated by both viral transactivator proteins and virion 
tegument protein. In the case of HSV-1, VP16 is important in the initiation of the 
lytic programme. VP16 can bind with two host cell factors, DNA-binding 
transcriptional regulator Oct-1 and cell-proliferation regulator HCF-1, to activate 
HSV-1 IEG transcription (reviewed in Wysocka and Herr, 2003). The IEGs and their 
products are involved in viral DNA replication. During transcription, some IE 
mRNAs are spliced and transported to the cytoplasm, then translation of the IE 
mRNAs takes place in the cytoplasm. After that, the IE proteins are transported back 
to the nucleus, where they regulate transcription of IEGs and activate expression of 
the EGs. The early protein is involved in DNA metabolism and replication. The EG 
mRNAs are spliced and transported to the cytoplasm where they are translated. Some  





Table 1.2  Cells that support the different types of herpesvirus infections. 
Adapted from a review of Penkert and Kalejta (2011). 
Family Virus Lytic infection Latency sites 


HSV-1,2 Epithelial and keratinocyte  Neuron 
Varicella-zoster 
virus 
Epithelial, keratinocyte, T cell, sebocyte, 
monocyte, endothelial, Langerhans and 




Cytomegalovirus  Macrophage, dendritic, endothelial, smooth 




stem cell, monocyte 
Human herpesvirus 
6 




T cell  T cell 











Epithelial cell, macrophage, dendritic cell, B 
cell 
B cell, macrophage, 
dendritic cell, epithelial 
cell, plasma cell 
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of the EG proteins are transported to the nucleus, some of them remain in the 
cytoplasm. Viral DNA replication and recombination produces concatemeric DNA, 
which is the template of LGs. Most late mRNAs are transported to the cytoplasm to 
translate without splicing. The proteins encoded by LGs are primarily virion 
structural proteins and proteins for virus assembly and particle egress (Flint et al., 
2009; reviewed in Weir, 2001). 
Assembly and Egress 
The packaging of DNA occurs in the cell nucleus. Newly synthesized viral DNA is 
replicated from concatemeric DNA and packaged into nucleocapsids which are 
transcribed from LGs. The DNA containing nucleocapsids, along with some 
tegument proteins, acquire primary envelopes from the nucleus when the new virions 
bud into perinuclear lumen from the inner nuclear membrane. Then the primary 
envelopes fuse with the outer leaflet of the nuclear membrane and the nucleocapsids 
are released into the cytoplasm, coupling with the loss of the primary envelopes. 
These structures are transported to a late Golgi-endosome compartment or an 
endosome where the tegument proteins and envelope proteins that are encoded by 
LGs are added onto the virions. The enveloped viruses then bud into vesicles 
transported to the plasma membrane and the virus particles are released by 
exocytosis (reviewed in Homa and Brown, 1997; reviewed in Mettenleiter, 2002). 
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1.1.3.2 Latent replication 
Long term latency is a specific feature of herpesvirus infection. The mechanism 
usually involves restrained expression of the viral genome. Therefore, 
immunologically relevant molecules during the course of productive infection are not 
synthesized. Latent infection with HSV-1 occurs in ganglia of neurons in the 
peripheral nervous system. The primary steps of latent infection are similar to 
productive infection, where the DNA of the virion is released into the nucleus. 
However, during latency, the viral genome is transcriptionally silent, and 
latency-associated transcript (LAT) is the only viral gene that is abundantly 
transcribed. LAT RNA is spliced to a significantly smaller subset that either is 
maintained in the nucleus as a stable intron in the form of a lariat or is transported to 
the cytoplasm (Block and Hill, 1997). MicroRNA encoded by the LAT gene inhibits 
apoptosis in the infected cells that contribute to the persistence of HSV-1 in a latent 
form (Gupta et al., 2006). 
1.1.3.3 Reactivation 
In given conditions or stimuli in neuronal physiology induced by trauma, hormonal 
changes or stressful conditions, the reactivation process occurs in the latently 
infected cells as the entire genome is transcribed and replicated as productive 
infection. New progeny virions are produced resulting in recurrent infection. LAT is 
also essential for efficient reactivation of HSV-1 from sensory neurons, as the 
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reactivation is decreased in LAT deletion virus (Perng et al., 1994). Furthermore, 
products of VP16, infected-cell polypeptide 0 (ICP0) and ICP4 are required for the 
HSV-1 reactivation in latently infected trigeminal ganglion tissue culture (Halford et 
al., 2001).  
1.2 Gammaherpesvirinae 
The Gammaherpesvirinae are characterized by variable length of reproductive cycles 
and a lymphocyte-associated infection trend. They are subdivided into four genera: 
lymphocryptovirus (gamma-1 herpesvirus), rhadinovirus (gamma-2 herpesvirus), 
macavirus and percavirus (ICTV, http://www.ictvonline.org). The lymphocrypto- 
viruses include human herpesvirus 4 (also called Epstein-Barr virus (EBV)), 
callitrichine herpesvirus 3, cercopithecine herpesvirus 14, gorilline herpesvirus 1, 
and macacine herpesvirus 4; whereas the rhadinoviruses include saimiriine 
herpesvirus 2 (HVS), human herpesvirus 8 (also called Kaposi's sarcoma-associated 
herpesvirus (KSHV)), ateline herpesvirus 2 and 3, bovine herpesvirus 4 and murid 
herpesvirus 4 (also called murine gammaherpesvirus 68 (MHV-68)). Macavirus and 
percavirus are more recently defined genera. Macaviruses contain ovine herpesvirus 
2, bovine herpesvirus 6, and suid herpesvirus 3-5; whereas percaviruses comprise 
equine herpesvirus 2 and 5, as well as mustelid herpesvirus 1. Host lymphocytes are 
the main location in which viruses establish latent infection. The infection of 
gammaherpesvirus is strongly associated with neoplastic diseases.  
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To date, there are two human gammaherpesviruses (EBV and KSHV) that are able to 
establish a lifelong, persistent infection with few or no clinical symptoms in 
immunocompetent hosts. Nonetheless, the infection can be lethal if the hosts are 
immunosuppressed or immunocompromised, such as chemotherapy drugs or other 
virus infections 
1.2.1 EBV 
EBV is about 172 kilobase (kb) and contains more than 85 genes. EBV was 
discovered in lymphoma cells cultured from Burkitt’s lymphoma in 1964 (Epstein, 
Achong, and Barr, 1964). The infection of EBV can be transmitted through saliva or 
blood (Alfieri et al., 1996; Kieff, 1996; Magel, 2012), hence it is widespread in all 
human populations. In western countries, a high percentage of children and 
adolescents acquire immunity to EBV (Schuster and Kreth, 1992). The primary 
infection is usually accompanied by symptoms like upper respiratory tract infections. 
Infectious mononucleosis (IM), an acute and usually self-limiting 
lymphoproliferative disorder, is characterized by an expansion of EBV-infected 
B-lymphoid blasts and proliferation of activated T-cells. It can be found in 30-50% of 
the primary infected adolescents and adults. Splenomegaly is found in half of these 
people (reviewed in Hanto, 1995). Then the infection remains harmless unless the 
balance of the immunity between the host and EBV has changed. EBV infection 
results in a lifelong infection in the host’s B lymphocytes and has been reported to be 
associated with several human cancers including Hodgkin's lymphoma (HL), 
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Burkitt's lymphoma (BL), nasopharyngeal carcinoma (NPC), and central nervous 
system lymphomas (Washington and Aiyar, 2012).  
1.2.1.1 Entry of EBV and lytic infection 
During a lytic infection, EBV lytically infects oral epithelial cells through saliva. 
Then the virus infects circulating B lymphocytes. Infection can be transferred 
between epithelial cells and B cells (Shannon-Lowe et al., 2006). A successful entry 
of EBV to B cells requires the complicated cooperation of several factors: viral 
envelope glycoprotein 350/220 protein binds to complement receptor CR2, the 
binding of glycoprotein (gp) 42 to human leukocyte antigen (HLA) class II, the 
interaction of gL/gH complex, gB and their receptors, which mediates the fusion 
with the cell membrane, as well as the binding of gB to the membrane directly 
(reviewed in Hutt-Fletcher, 2007). The entry mechanism of EBV to epithelial cells 
requires the B cells transfer infection, but without the binding of gp42 
(Shannon-Lowe and Rowe, 2011).  
During lytic infection, approximately 80 viral proteins are expressed (Kieff, 1996). 
BZLF1 and BRLF1 are the IEGs. Both are required for EGs and LGs expression and 
are essential for viral DNA replication during the lytic programme as they encode 
transcriptional activators that bind to and activate EBV EG promoters 
(Chevallier-Greco et al., 1986; Feederle et al., 2000). Meanwhile they are important 
mediators in the switch from latency to lytic replication (Zalani, Holley-Guthrie, and 
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Kenney, 1996). It has also been found that BZLF1 localizes to chromosomes of some 
cells including epithelial, fibroblast, and B cells during mitosis. As a result, it may 
affect mitotic chromosome architecture, normal cell function and viral replication 
and segregation (Adamson, 2005).  
1.2.1.2 EBV persistent infection 
The latent virus spreads throughout the lymphoid tissues via B cells. Most latently 
infected B cells are attacked and killed by natural killer (NK) cells or CD8
+
 T cells, 
but a small proportion of the persistently infected small non-proliferating memory B 
cells survive in the blood (Babcock et al., 1999; Flint et al., 2009; Rickinson, Lee, 
and Steven, 1996). During latency, EBV gene expression profiles are distinct, which 
are termed Latency type 0, I, II, and III (Washington and Aiyar, 2012).  
The gene expression of EBV which is observed in lymphoblastoid cell lines, 
AIDS-related immunoblastic lymphoma, central nervous system lymphoma and 
post-transplant lymphoma is referred to as Latency III. At least six nuclear antigens 
(EBV nuclear antigen (EBNA)-1, EBNA-2, EBNA-3A, EBNA-3B, EBNA-3C, and 
EBNA-leader protein (LP)), three membrane proteins (latent membrane protein 
(LMP)-1, LMP-2a, LMP-2b), non-coding RNA transcripts (Epstein-Barr 
virus-encoded RNA (EBER)-1, EBER-2, and BamHI A rightward frame (BARF)-0 
and BARF-1) and BamHI H rightward frame (BHRF)-1 can be found in Latency III 
(reviewed in Rowe et al., 2009; Washington and Aiyar, 2012). These proteins and 
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expressed genes are required for immortalization of naïve B cells and are 
anti-apoptotic for B lymphocytes (Washington and Aiyar, 2012). For example, 
BHRF-1 is a B cell lymphoma-2 (Bcl-2) homologue known to be capable of 
protecting B cells from apoptosis (Henderson et al., 1993). Meanwhile, BARF1, as 
well as EBERs can induce the activation and expression of Bcl-2 (Komano et al., 
1999; Wang et al., 2006).  
EBNA-1, LMP-1, LMP-2a, LMP-2b, EBERs and BARTs, which are termed latency 
II, can be found in NPC, EBV-associated gastric carcinomas, T cell lymphomas and 
HL (Washington and Aiyar, 2012). LMP-1 up-regulates anti-apoptotic genes, such as 
Bcl-2 and A20, which interfere with p53-mediated apoptosis (Fries, Miller, and 
Raab-Traub, 1996; Laherty et al., 1992). Additionally, LMP-1 enhances growth and 
differentiation signals by mimicking CD40 signalling in B cells, leading to B-cell 
development, activation and immune responses (Rastelli et al., 2008). 
During Latency I, EBNA-1 is the main EBV encoded protein in the majority of BL 
tumors. Moreover, EBERs and BARTs can also be detected in the tumors. Latency 0 
is observed in infected memory B cells where only the expression of EBNA-1 is 
detectable during cell division.  
Among these four latency patterns, only EBNA-1 can be found in all cells infected 
latently by EBV and EBV associated tumors. The presence of the EBNA-1 disturbs 
several host proteins and pathways that are related to apoptosis (reviewed in Frappier, 
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2012; Washington and Aiyar, 2012).  
1.2.1.3 Reactivation of EBV 
As mentioned in the lytic infection of EBV, the lytic transactivator BRLF1 and 
BZLF1 are essential for the reactivation of EBV. Moreover, the differentiation of 
peripheral memory B cells into plasma cells in the tonsil leads to the reactivation of 
EBV (Sun and Thorley-Lawson, 2007).  
1.2.1.4 EBV associated diseases  
It has been reported that the EBV genome and EBNA-1 are contained in a large 
number of lymphomas. The main EBV associated diseases are listed below.  
BL 
BL, first described by Dr. Dennis Burkitt in 1958, is the most common malignancy 
of children in Africa. BL cells were originally found to arise from germinal centre 
(GC) B cells. The cells express B-cell lymphoma 6 (Bcl-6) and have a high mitotic 
activity (Blum, Lozanski, and Byrd, 2004). Only EBNA-1 protein expression was 
found in EBV-positive BL. In this disease, the overexpression and rearrangement of 
the c-myc oncogene leads to deregulation of c-myc expression, thus inhibiting 
apoptosis (Blum, Lozanski, and Byrd, 2004). In areas of endemic BL, 
lymphomagenesis may be related to immunosuppression of EBV-specific T cell 
immunity and mitogenesis of B cells which are caused by P.falciparum malaria 
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(reviewed in Rowe et al., 2009). Another co-factor for BL is HIV infection, which 
activates the B cell system (reviewed in Rowe et al., 2009). 
IM 
IM is commonly found in adolescents and young adults. The majority of IM cases 
are reported during primary infection with EBV. This disease is characterized by 
lymphadenopathy, splenomegaly, hepatitis, hemolysis and an increase of CD8
+
 T 
cells in the peripheral blood, coupled with an increase in cytokine release, such as 
interleukin (IL)-2, IL-6, interferon-gamma (IFN- and tumour necrosis factor (TNF) 
(Andersson, 1996; reviewed in Luzuriaga and Sullivan, 2010; reviewed in Williams 
and Crawford, 2006). The symptoms last for several weeks, however, fatigue may 
persist for a longer time . 
NPC 
EBV infection is known to be an essential factor for the development of NPC. Other 
co-factors, such as dietary and genetic factors, are important etiological association. 
For example, NPC is more commonly found in certain regions such as southeast 
China, Alaska, and Greenland. According to epidemiology statistics, 95% of NPC 
tumors are EBV associated. NPC was classed in three types dependent on the degree 
of histopathologic differentiation. They are keratinizing squamous cell carcinoma 
(type 1), non-keratinizing carcinoma (type 2), and undifferentiated carcinoma (type 3) 
(reviewed in Raab-Traub, 2002).  




HL is a malignant tumor of the lymphatic system, but also affects the central and 
peripheral nervous systems. EBV genomes and gene products, such as LMP-1 and 
2A, EBNA1, BARTs and EBERs, are detected in the Hodgkin and Reed-Sternberg 
cells, which are derived from crippled, pre-apoptotic GC B cells (Kanzler et al., 
1996). Activation of programmed cell death protein 1 (PD-1)-PD-ligand (PD-L) 
signalling pathway inhibits T-cell effector functions in HL patients (Chemnitz et al., 
2007; Yamamoto et al., 2008). 
1.2.1.5 Immune response to EBV 
Lytic antigens of EBV induce CD8
+
 T cell responses against EBV infected cells 
(Callan et al., 1996). About 1-4% of the total CD8
+ 
T cells are activated by the IE 
and some E antigens during symptomic infection (reviewed in Hislop et al., 2007). 
Moreover, CD8
+
 T cells also help to control EBV during latent infection (reviewed 
in Rickinson, Callan, and Annels, 2000). The increase of CD4
+
 T cells is another key 
factor that contributes to the control of EBV replication because they react to the 
viral antigens and secrete IFN- (Landais et al., 2004). The number of virus-specific 
CD4
+
 T cells reaches to its peak during acute IM, but the number of CD4
+
 T cells 
declines quickly when the lytic and latent antigens are reduced (Amyes et al., 2003). 
Natural immunity is also a vital factor to control EBV infection. The number of NK 
cells is significantly increased after EBV infection and is inversely correlated to the 
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virus load. The mechanism used by NK cells to control EBV is the elimination of 
infected B cells, as well as the secretion of cytokines, like IFN- (Williams et al., 
2005). 
1.2.2  KSHV 
KSHV has a 160 kb DNA genome. The Kaposi sarcoma (KS) was first described by 
Dr. Moritz Kaposi in 1872. However, the etiology of KS was unknown until a 
gammaherpesvirus, KSHV, was connected with this malignant cancer when KS 
biopsies were analysed in 1994 (Chang et al., 1994). KSHV has also been associated 
with two other neoplastic diseases: primary effusion lymphoma (PEL) and 
multicentric Castleman disease (MCD). The infection of KSHV can be found in 
sub-African and some Mediterranean countries, including Israel, Saudi Arabia, Italy 
and Greece.  
1.2.2.1 Lytic infection 
KSHV infection can be found in several cellular types in vivo, such as human B 
lymphocytes, macrophages, endothelial cells and epithelial cells. The IE genes, open 
reading frame (ORF) 45 and ORF50, were found to be transcribed during viral 
reactivation (Zhu, Cusano, and Yuan, 1999). ORF50 is a homologue of the EBV 
replication and transcription activation (RTA), which is the master regulator factor 
and is sufficient to induce KSHV gene expression. Moreover, the binding of ORF45 
or ORF50 to interferon regulatory factor 7 disturbs the immune response as the 
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induction of type I IFN is reduced (Yu, Wang, and Hayward, 2005; Zhu et al., 2002). 
ORF50 can induce the expression of several E and L genes, such as K8, viral IL-6 
(vIL-6) and viral CCL1 (vCCL1) (Sun et al., 1998). Some KSHV lytic genes have 
host/cellular regulation functions, including mitogenic and cell cycle-regulatory, 
anti-apoptotic and immunomodulating. For example, vIL-6 has a similar sequence 
and function to cellular IL-6. vIL-6 can induce cell proliferation and inhibit apoptosis 
and IFN signalling (Aoki et al., 1999; Chatterjee et al., 2002).  
1.2.2.2 Latent infection 
Expression of many KSHV-encoded latent genes, including Kaposin A, viral FLICE 
inhibitory protein (vFLIP), viral cyclin (vCyclin), latency-associated membrane 
protein (LAMP), and latency-associated nuclear antigen (LANA)-1 and -2, can be 
detected in KSHV associated tumors. These genes are indispensable for KSHV 
latency by the manipulation of cellular signalling pathways. For example, LANA-1 
and LANA-2 are highly expressed in all latently infected tumour cells and are found 
to function as inhibitors of the tumor suppressors p53 and Rb, as well as repressors of 
apoptosis (Friborg et al., 1999; Rivas et al., 2001; reviewed in Wen and Damania, 
2010). In addition, vFLIP is also involved in the inhibition of apoptosis (Sarid et al., 
1999; reviewed in Wen and Damania, 2010).  
1.2.2.3 KSHV associated diseases 
KS 
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KS lesions are characterized by poor differentiated and highly proliferating 
spindle-shaped endothelial cells. More than 95% of KS tumor cells contain KSHV 
viral DNA. According to epidemiology and clinical symptoms, KS can be classified 
into four subtypes: classic (sporadic), endemic (African), epidemic (AIDS-associated) 
and iatrogenic (post-transplant). The classic forms of KS are more commonly seen in 
elderly males whose skin has indolent and multiple pigmented sarcomas without 
much involvement with the lymph node and other organs. Endemic KS, which has 
more lymph node involvement, is more common in Eastern and Central Africa. 
AIDS-associated KS which affects internal organs, such as the lymph nodes or lungs, 
leads to a high fatality rate. Iatrogenic KS occurs when patients are under long-term 
immunosuppressive therapy after organ transplantation (reviewed in Wen and 
Damania, 2010).  
MCD 
MCD is an aggressive disease leading to a life-threatening consequence. it is closely 
associated with KS in the case of HIV-related MCD (Soulier et al., 1995). MCD is 
characterized by an overgrowth of B cells, GC expansion and vascular endothelial 
proliferation in the lymph nodes. It has been reported that vIL-6 are expressed in 
naïve B cells and overexpression of IL-6 and are found in MCD disease (Parravinci 
et al., 1997), which may induce the differentiation of KSHV-infected naïve B cells 
into plasmablasts without undergoing GC reaction (Du et al., 2001).  




PEL, also termed body cavity-based lymphoma, was first described in 1989 
(Knowles et al., 1989). It is a rare HIV-associated non-Hodgkin’s lymphoma (NHL). 
The study of clinical cases has found that PEL is always accompanied by EBV 
co-infection (reviewed in Chen, Rahemtullah, and Hochberg, 2007). Molecular 
studies demonstrate that PEL originated from a B cell lineage and may be related to 
Bcl-6 dysregulation (Gaidano et al., 1999) and plasma cells (Jenner et al., 2003). In 
PEL tumor cells, only latent KSHV infection can be detected. 
1.3 Murine gammaherpesvirus 68 
Gammaherpesviruses have clinical influences in both the medical and the veterinary 
medical fields. However, investigation of the pathogenesis of human 
gammaherpesviruses is difficult and limited because of the asymptomatic 
characteristics of the initial EBV and KSHV infection. In addition, the latency 
establishment of EBV and KSHV cannot be directly assessed in humans. Moreover, 
the basic pathogenesis of EBV and KSHV cannot be reproduced in the experimental 
animals. Therefore, it was of great necessity and importance to find an animal model 
to fill these knowledge gaps. The study of MHV-68 was first reported by Blaskovic 
et al from a bank vole (Clethrionomys glareolus) in Slovakia (Blaskovic, 1980). And 
then in 2003, it was found in wood mice (Apodemus sylvaticus) (Blasdell et al., 
2003). Although MHV-68 cannot be found in Mus musculus, including house mice, 
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in nature (Ehlers et al., 2007), it has an ability to infect laboratory mice (Mus 
musculus) through several infectious routes (Sunil-Chandra et al., 1992). The 
pathology of MHV-68 in mice is slightly different from the pathology of KSHV or 
EBV in humans (reviewed in Rickinson, 2001). Nevertheless, the study of MHV-68 
is still significant because of the high similarity of genome and pathobiologies 
between MHV-68 infection of mice and EBV or KSHV infection of humans. Thus 
any MHV-68 infected mouse is a suitable animal model to study the pathogenesis of 
gammaherpesvirus and immune defense from the host. Additionally, MHV-68 
infection associated fibrosis and vasculitis are important models to understand 
clinical pathologies of human diseases. 
1.3.1  Genome 
The MHV-68 genome contains 118237bp of unique sequence flanked by a variable 
number of a 1213bp terminal repeat (TR). The TR may be related to concatemer 
cleavage and assembled capsid packaging. (Efstathiou, Ho, and Minson, 1990; 
Virgin et al., 1997). The genome encodes 73 protein-coding ORFs (figure 1.1a). A 
number of these genes encoded by MHV-68 are closely related to EBV (Efstathiou, 
Ho, and Minson, 1990), while the genome organization of MHV-68 is more similar 
to that of HVS and KSHV (reviewed in Simas and Efstathiou, 1998; Virgin et al., 
1997). Among these ORFs, there are several unique ORFs, termed M1-9, M10 a,b,c 
and M11-14, that have no obvious relationship with known virus or cellular genes 
(reviewed in Barton, Mandal, and Speck, 2011; reviewed in Mistríková and Rajčáni, 




1.3.2 Left end of the genome 
The left end of the MHV-68 genome, comprises M1-M4, 8 vtRNA like structures and 
15 microRNAs, is implicated in lytic infection, latency, reactivation and immune 
evasion in vivo (Evans et al., 2006; Geere et al., 2006; Macrae et al., 2001; Macrae et 
al., 2003; Webb, Smith, and Alcami, 2004), although the function of microRNAs or 
vtRNAs is not known (Zhu et al., 2010). All M1-M4 genes are not required for virus 
replication in vitro (Bridgeman et al., 2001; Clambey, Virgin, and Speck, 2000; 
Evans et al., 2008; Macrae et al., 2003; Townsley, Dutia, and Nash, 2004). However, 
it has been reported that all the genes from the left end are expressed during the 
latency establishment phase (Bowden et al., 1997; Diebel, Smith, and van Dyk, 2010; 
Marques et al., 2003).  
M1 
M1 has sequence similarities to members of the poxvirus serpin family and encodes a 
secreted protein that is homologous to M3 protein. The function of M1 is believed to 
repress reactivation from latency in the spleen (Clambey, Virgin, and Speck, 2000) 




 B cells during chronic infection 
(Krug et al., 2013). Moreover, in the absence of M1, the replication of persistent 
virus or the recrudescence of the virus were found in the lung (Krug et al., 2013). 
The repression function of M1 is opposite to the function of M11 (vBcl-2) and 
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ORF72 (vCyclin) (Gangappa et al., 2002). IM like-disease is a feature of MHV-68 










T cells in vivo and induces V4
+
 TCR signaling in vitro, such as up-regulation of 





 T cells results in the increased expression of IFN- that controls MHV-68 
reactivation without affecting the latent viral loads (Evans et al., 2008).  
M2 
M2 is strictly expressed during latent infection in vitro and in B cells in the spleen 
(Husain et al., 1999; Macrae et al., 2003). It is a target for CD8
+
 T cells, as a CD8
+
 T 
cell epitope was found in this protein (Husain et al., 1999). It has been shown that 
M2 can limit IFN- signaling by down-regulating STAT1/2 levels (Liang et al., 2004) 
and interfere with DNA damage responses (Liang et al., 2006). M2 expression 
induces the Vav1 proteins, which are related to phosphorylation- dependent Rho/RAc 
exchange factors that play critical roles in B-cell activation, proliferation and 
survival, hyperphosphorylation and exchange activity stimulation (Rodrigues et al., 
2006). M2 protein is required for splenic follicle infection and latent infection of GC 
B cells. For example, M2-deficient MHV-68 may reduce the Vav1/Rac1 pathway that 
leads to a decreased latency in the spleen after intranasally infection (Pires de 
Miranda et al., 2008) and the failure of regulation of B cell differentiation (Siegel, 
Herskowitz, and Speck, 2008). Moreover, M2 protein induces the up-regulation of 
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IL-10 that drives B cell proliferation (Siegel, Herskowitz, and Speck, 2008). A recent 
study confirmed that M2 is essential for B cell development during MHV-68 
infection by inducing that differentiation of plasma cells in vitro and in vivo (Liang et 
al., 2009; Siegel, Herskowitz, and Speck, 2008).  
M3 
M3 is a MHV-68 encoded chemokine binding protein. It is transcribed during 
productive infection in the lung and at early stages of latent infection in the spleen 
(Simas et al., 1999). It has been shown that M3 has an ability to bind to C-, CC-, 
CX3C-chemokines and selected CXC-chemokines in vitro (Parry et al., 2000; van 
Berkel et al., 2000). Moreover, it can bind to CCL2, CCL21, CXCL10 and CXCL13 
in vivo (Jensen et al., 2003; Martin et al., 2007; Martin et al., 2006). Study of the 
function of chemokines in the gut during inflammation found that M3 has low 
binding ability to several CXC-chemokines (Shang et al., 2009). The binding of M3 
to chemokines directly interrupts the interaction of chemokines and their receptor as 
M3 interferes with the N-loop of chemokines which is necessary for the binding of 
their G-protein-coupled receptors (Alexander et al., 2002; Webb, Clark-Lewis, and 
Alcami, 2003). Moreover, M3 inhibits the binding of chemokine-GAGs, and thus 
disrupts the pre-formed chemokine gradients that are critical for cellular migration 
(Webb, Smith, and Alcami, 2004). Unexpectedly, no significant deficit of viral titer 
was observed in the lung, MLN or spleen following intranasal M3 deficient virus 
infection of BALB/c mice compared to wild type (WT) virus at acute or latent 
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infection (van Berkel et al., 2002). However, insertion of lacZ to ablate M3 leads to a 
decrease in viral load in the lung and latent virus in the spleen in BALB/C mice in a 
CD8
+
 T cell dependent manner (Bridgeman et al., 2001). However, a study of the 
infection of MHV-68 in its natural host, Apodemus sylvaticus, has found that M3 is 
required for lytic infection because it reduces the inflammation in the lung. 
Furthermore, M3 is also involved in the efficient establishment of latency in the lung 
and spleen (Hughes et al., 2011). The conflicting results about the viral load and 
latency can be explained by different methods to make mutant viruses and infection 
of the different hosts. As a chemokine binding protein, M3 reduced the inflammatory 
response in the brain of the host, by intracerebral inoculation, compared to mice 
infected with M3 non-coding virus (van Berkel et al., 2002). M3 alters CD8
+
 T cell 
subset accumulation in the lung and GC reaction in the wood mice, but the 
mechanism is still unknown (Hughes et al., 2011; Shang et al., 2009). Although the 
alignment comparison between M3 protein and M1 protein showed a high similarity 
between these two proteins (van Berkel et al., 1999), the M1 protein has not been 
shown as a chemokine binding protein.  
The study of M3 not only focuses on MHV-68 immune evasion strategies and host 
responses, but also raises the possibility that M3 protein can be applied to reduce 
autoimmunity and inflammatory diseases in the medical field. For example, intimal 
hyperplasia is inhibited by M3 protein which may due to M3 protein stop the 
recruitment of bone marrow-derived cells in mice (Pyo et al., 2004). A recent study 
 Chapter 1                                                                    Introduction 
27 
 
found that an adenoviral vector encoding M3 protein can control the clinical severity 
of experimental autoimmune encephalomyelitis and reduce inflammation in the 
central nervous system of the mouse (Millward et al., 2010).  
M4 
The transcription of M4 has previously been shown to be expressed with IE kinetics 
during lytic infection in vitro. It encodes a secreted glycoprotein which can be 
detected in cell culture supernatant (Evans et al., 2006). M4 influences the 
establishment of splenic latency at early post infection days following intranasal 
infection by comparison of WT virus infection with M4-deficient-MHV-68 or 
MHV-76 virus infection compared with M4 insertion MHV-76 virus (Evans et al., 
2006; Geere et al., 2006; Townsley, Dutia, and Nash, 2004), but M4 is not required 
for long-term latency in vivo (Evans et al., 2006). In contrast, a latency deficit was 
not found in peritoneal cells after intraperitoneal inoculation (Evans et al., 2006). The 
sequence of M4 protein showed a similarity to M3 protein (Alexander et al., 2002). 
To date, no published data has shown how M4 interacts with the host immune 
system.  
Non-coding RNAs 
The non-coding RNAs, including vtRNAs and microRNAs, play important roles in 
herpesvirus biology (Amen and Griffiths, 2011). These MHV-68 non-coding RNAs 
are encoded under the control of the cellular RNA polymerase III, and are predicted 
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to drive expression of the related microRNAs (Grey, Hook, and Nelson, 2008). The 
exact function of these non-structural RNAs is still undetermined.  
The tRNA-like sequences are transcribed at high levels during lytic and latent 
infections, especially splenic GC (Bowden et al., 1997). vtRNAs are transcripted as 
IEs (Ebrahimi et al., 2003) and packaged within MHV-68 virions (Cliffe, Nash, and 
Dutia, 2009). They are predicted to have cloverleaf like secondary structures. 
Moreover, vtRNAs are found in higher levels in the cytoplasm of infected cells 
(Cliffe, Nash, and Dutia, 2009). The vtRNAs were shown not to be aminoacylated 
(Bowden et al., 1997), hence, they are unable to perform as tRNAs during protein 
synthesis.  
MicroRNAs are post-transcriptional regulators that affect mRNA translation or 
stability in the cytoplasm, sharing hair-pin structures and a silencer function (Pfeffer 
et al., 2005). MHV-68 microRNAs are newly found non-coding RNAs (Pfeffer et al., 
2005). The RNA polymerase III promoters is adjacent to viral tRNA-like sequence 
(Bogerd et al., 2010). Therefore, all the MHV-68 microRNA, except miRNA 11, can 
form co-linear structures with vtRNA, thus forming vtRNA-microRNA-microRNA 
or vtRNA-microRNA structures with unknown function (Grey, Hook, and Nelson, 
2008; Zhu et al., 2010).  
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1.3.3 Mutant viruses 
1.3.3.1 Natural mutants 
Four other murine gammaherpesvirus strains (MHV-60, MHV-72, MHV-76, 
MHV-78) which are similar to MHV-68 were isolated in Slovakia at the same time 
as MHV-68 (Blaskovic, 1980). Some comparative studies of these strains with 
MHV-68 have been made that provide a wider view to understand the pathogenesis 
of EBV and KSHV infection. Among these mutants, MHV-76 and MHV-72 were 
followed with the most interest.  
MHV-76 
In comparison to MHV-68, MHV-76 was isolated from a different murid host, the 
yellow-necked mouse (Apodemus flavicollis). Later studies showed that MHV-76 is a 
naturally occurring deletion mutant of MHV-68 that lacks 9,538bp of the left end of 
the genome including M1-M4, 8 vtRNA like structures and also the microRNAs 
(Macrae et al., 2001). Despite the fact that the kinetics of replication of MHV-76 are 
identical to those of MHV-68 in vitro, there are several prominent alterations in the 
lytic and latent infection in vivo compared to MHV-68 infection. For example, no 
significant splenomegaly can be detected after MHV-76 infection (Macrae et al., 
2001). Nevertheless, MHV-76 maintained long-term latency in the lungs and spleen 
as MHV-68 (Macrae et al., 2001), without tumors or the leukemia-like syndrome 
(Chalupková et al., 2008). The comparison of MHV-76 with MHV-68 infections  






Figure 1.1  Schematic diagram of the genome of MHV-68 and its mutants. (a) MHV-68, (b) 
MHV-76, (c) MHV-72. The red square indicates the left-hand end region of MHV-68, which 
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reveals that the importance of the left end region of MHV-68. Moreover it gives a 
possibility to study the function of the individual genes in this region by making gene 
insertion mutant viruses.  
MHV-72 
MHV-72 was isolated from the same natural host as MHV-68, but is missing M1-M3 
and 8 vtRNA-like genes (Oda et al., 2005). Splenomegaly is not observed after 
infection which is similar to MHV-76. However, unlike MHV-76, multi-organ 
lymphomas are found in the mice during long-term infection (Oda et al., 2005), 
therefore mice infected with MHV-72 are considered as an animal model to study 
tumorigenesis. Moreover, the transmission of MHV-72 is different from other 
isolates as it can infect mammary glands and infect new born mice through the 
mother’s breast milk (Raslova et al., 2001). 
1.3.3.2 Bacterial artificial chromosome (BAC) mutants  
Nowadays, scientists study the function of MHV-68 ORFs by construction of a 
mutant genome with a deletion in its interesting part using a MHV-68 BAC (Adler, 
Messerle, and Koszinowski, 2003; Adler et al., 2000). To generate BAC mutant 
MHV-68, viral DNA and plasmid which contains BAC vector sequences are 
co-transfected into viral permissive cells. The BAC vector-containing viral DNA is 
isolated from infected cells and electroporated into an E. coli strain. Bacterial cells 
containing viral BACs can be selected based upon the antibiotic marker present in 
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the BAC vector. Then the mutated BAC plasmid is transfected into eukaryotic cells 
where recombinant viruses are expressed and new viruses propagate (Adler et al., 
2000). BAC mutant viruses are used widely and by incorporating fluorescent protein 
may be used to identify infected cells in vivo (Adler et al., 2000; Collins and Speck, 
2012; Dutia et al., 2009). 
1.3.4 Virus infection and pathogenesis 
Generally, scientists believe MHV-68 infection is transmitted due to the close 
contact between individuals in the wild. Intranasal and peritoneal inoculations are 
normally used for studying MHV-68 pathogenesis in the laboratory. However, these 
two different infection routes result in different pathogenesis because of the different 
viral reservoirs. The intranasal route of infection is regarded as a mimic of the natural 
route of infection with this virus. Importantly, the pathogenesis of MHV-68 infection 
of mice is similar to that of EBV, with symptoms such as splenomegaly developing 
when using an intranasal inoculation method.  
After intranasal infection, replication of MHV-68 is first found in lung alveolar 
epithelial cells, then the lytic infection is cleared around day 10 p.i., whereas latency 
is found in epithelial cells and B cells during long term latency (Flano et al., 2005; 
Stewart et al., 1998). The infection of B cells requires the pre-infection of epithelial 
cells and macrophages (Frederico et al., 2012). From the lung, the productive viruses 
spread to the lung draining lymph node, the mediastinal lymph node (MLN) and 
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establish latency in B cells, macrophages and dendritic cells (DC) (Nash et al., 2001). 
The migration of B cells from the MLN to the spleen is exploited by MHV-68, 
through B cells, the virus traffick to the spleen at day 3 p.i.. In the spleen, latency is 
mainly established in B lymphocytes (Flano et al., 2000; Sunil-Chandra, Efstathiou, 
and Nash, 1992), although macrophages, splenic dendritic cells (Flano et al., 2000) 
and plasma cells (Collins, Boss, and Speck, 2009) have been shown to harbor the 
latent virus. The infection leads to a massive lymphoproliferation, thus the virus 
expands by a CD4
+
 T cells dependent B lymphocyte proliferation (Stevenson and 
Doherty, 1999). Viral latency reaches peak levels at day 14 p.i. accompanied by a 
CD4
+
 T cell (Usherwood et al., 1996) and cytokine (Lee et al., 2000; Siegel, 
Herskowitz, and Speck, 2008) dependent splenomegaly. Latent infection is 
preferentially associated with GC, as more viral genomes are harbored in GC B cells 
than non-GC B cell populations at early latency (Flano et al., 2002; Willer and Speck, 
2003). Among the infected GC B cells, virus establishes latency mainly in the 
proliferating B cells (Collins and Speck, 2012). However, memory B cells are the 
long-term viral latency reservoir. Memory B cells can first differentiate into 
preplasma memory B cells under certain conditions, then develop into plasmablasts, 
finally becoming plasma cells which promotes viral reactivation (Shapiro-Shelef et 
al., 2003; Willer and Speck, 2003). Relatively high viral frequencies are found in 
memory B cells in the peripheral blood, macrophages, dendritic cells and B cells in 
the spleen and B cells in the lung during long-term latency. Moreover viruses are also 
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harbored in bone marrow, nasopharyngeal- associated lymphoreticular tissue and 
bronchus-associated lymphoid tissue (Flano et al., 2003; Kocks et al., 2009).  
The study of MHV-68 replication is also established in tissue culture, which provides 
a good model to study early stages of gammaherpesvirus infection as well as 
mechanisms controlling viral replication during the lytic cycle. For example, 
MHV-68 can also infect and persist in mouse myeloma cell line NS0 without any 
cytopathic effect (Sunil-Chandra, Efstathiou, and Nash, 1993). 
1.3.5 Immune response to MHV-68 infection 
1.3.5.1 Adaptive immune response 
The function of CD4
+
 T cells in MHV-68 infection is studied in mice with CD4
+
 T 
cell depletion. It has been found that the lack of CD4
+
 T cells does not affect 
Ag-specific CD8
+
 T cells or cytotoxicity (Belz et al., 2003; Stevenson et al., 1998), 
but the clearance of the virus in the lung is delayed (Ehtisham, Sunil-Chandra, and 
Nash, 1993). Moreover, CD4
+
 T cells are an indispensable element for controlling 
MHV-68 latent infection. In transgenic mice lacking CD4
+
 T cells, the virus 
spontaneously reactivated during long-term infection in the lung (Cardin et al., 1996). 
The study of MHC class II-deficient mice showed there was a high titer of virus in 
the lymphoid tissues including spleen, MLN, cervical lymphoid node and bone 
marrow during the long-term infection (Cardin et al., 1996). The increased viral load 
may be due to the suppression of immune responses by IL-10 overexpressed in CD8
+
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T cells in CD4-deficient mice (Molloy, Zhang, and Usherwood, 2011). Another 
function of CD4
+
 T cells is to help the activation of B cells during MHV-68 infection 
(Stevenson and Doherty, 1999).  
Cytotoxic CD8
+
 T cells are mainly charged with controlling viral replication in the 
lytic infection (Ehtisham, Sunil-Chandra, and Nash, 1993). The clearance of latent 
virus in the spleens of the CD8
+
 T cell deficient mice is delayed and leads to dose 
and mouse strain dependent death (Ehtisham, Sunil-Chandra, and Nash, 1993; 
Stevenson et al., 1999). CD8
+
 T cells also have a role in the CD4
+
 T cell and IL-2 
signalling dependent control of virus reactivation in the lung during latent infection 
(Dias et al., 2010; Molloy, Zhang, and Usherwood, 2009). 
B cells not only play an important role for virus transmission and latency 
establishment during MHV-68 infection, but are also essential for regulating 
reactivation from latency and controlling the chronic stage of MHV-68 infection 
(Weck et al., 1999). MHV-68 latency is mainly established in GC B cells, especially 
centroblasts (Collins and Speck, 2012; Flano et al., 2002). The splenic activated B 
cells, which express CD69 on their surface, are the major B cell reservoir for the 
latent virus. It has been said that activated B cells may be related to GC reaction and 
long-lived memory cell differentiation (Flano et al., 2000; Krug et al., 2007).  
1.3.5.2 Innate immune response  
NK cells are known to mount a rapid response to several virus infections by secreting 
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interferons and perforin. Several studies have shown that NK cells play a major role 
in the control of early stages of alpha- or betaherpesvirus infection in humans and 
mice. Additionally, EBV is also controlled by NK cells. On the other hand, NK cells 
are dispensable in controlling the lytic infection, acute latency and long-term latency 
of MHV-68, although the population of NK cells has been found to be increased 
(Cartwright and Watkins, 2004; Thomson et al., 2008).  
Macrophages also take part in the battle against the MHV-68 infection. For instance, 
MHV-68 infection leads to the up-regulation of CC-chemokines in the lung. These 
chemokines induce lymphocyte and macrophage infiltration that control virus 
infection (Sarawar et al., 2002).  
The study of type 1 interferons was based on type 1 interferon receptor deficient 
mice (IFN- R
-/-
). IFN- are important in controlling the lytic and latent phases 
of MHV-68 infection. However, there is splenic atrophy and splenomegaly during 
infection (Dutia et al., 1999). Further evidence for a role of IFN-comes from a 
recent study which has found that a genetically modified IFN-expressing MHV-68 
has the ability to avoid virus reactivation (Aricò et al., 2011). Although the 
cytotoxicity of NK cells is activated by type 1 IFNs, there was no sign that NK cells 
are involved in the virus controlling mechanism. 
IFN- is the only type 2 interferon and it is important for controlling human 
herpesvirus infection. During MHV-68 infection, high levels of IFN- are produced 
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in the lung and lymphoid tissues (Chou et al., 2008; Ganem, 2006). However, the 




 mice revealed that IFN- has no 
effect on the control of MHV-68 at the acute infection stage (Dutia et al., 1997; 




 mice show an increase 
in latently infected cells in the MLN (Sarawar et al., 1997) and spleen accompanied 
by splenic architecture change (Dutia et al., 1997). Furthermore, IFN- is associated 
with T-cell-mediated control of MHV-68 recrudescence in the lung and spleen in B 
cell-deficient mice (Christensen et al., 1999; Sparks-Thissen et al., 2005). IFN- also 
helps to control the reactivation of MHV-68 and viral gene expression in long-term 
infection in a cell type-specific manner (Steed et al., 2007). For example, 
macrophages, but not B cells, are responsive to IFN--mediated suppression of 
MHV-68 reactivation. (Steed et al., 2007). 
1.3.6 Immune evasion 
The MHV-68 genome encodes a number of genes that evolved strategies to allow it 
to persist for the lifetime of an infected animal, despite the presence of a strong 
immune response. Several immune evasion schemes which are important for 
MHV-68 infection are listed below.  
Chemokine receptor homology  
There are three strategies by which herpesvirus impairs the chemokine system: viral 
chemokine ligands, viral G-protein coupled receptors (vGPCRs), and chemokine- 
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binding proteins (Lalani, Barrett, and McFadden, 2000; Murphy, 2001). As 
previously mentioned (section 1.3.2), M3 protein plays an essential role in 
chemokine binding, chemokine gradient disruption and signalling blocking during 
MHV-68 infection. MHV-68 also encodes a vGPCR. The sequence of MHV-68 
vGPCR has significant homology to the GPCRs of mammalian cells, the vGPCR of 
HVS (Nicholas, Cameron, and Honess, 1992), as well as the vGPCR of KSHV 
(Wakeling et al., 2001). The transcription of MHV-68 vGPCR can be examined in 
both lytic and latent infections (Wakeling et al., 2001). The main function of 
MHV-68 vGPCR is to act as a viral CXC-chemokine receptor on the surface of cells 
(Verzijl et al., 2004; Wakeling et al., 2001) and be involved in the replication and 
reactivation of MHV-68 from latency (Lee et al., 2003; Moorman, Virgin, and Speck, 
2003). Moreover, MHV-68 vGPCR induces the activation of nuclear factor kappa-B 
(NFkB) and regulates several other pathways (Verzijl et al., 2004).  
K3  
MHV-68 K3 (mK3) is homologous with KSHV K3 and K5. The expression of mK3 
can be detected during lytic infection in the lung and latent infection in the lymphoid 
tissue (Stevenson et al., 2002). mK3 modulates antigen presentation by degradation 
of MHC class 1 (Stevenson et al., 2000), which is related to the regulation of the 
cellular endoplasmic reticulum-associated degradation pathway (reviewed in Griffin, 
Verweij, and Wiertz, 2010). Moreover, mK3 restricts expression of MHC class I on 
lytically infected DC, thus reducing the priming of the CD8
+
 T cells (Smith et al., 
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2007). Consequently, the deletion of mK3 enhanced the activation of CD8
+
 T cells 
(Stevenson et al., 2002). During latent infection, mK3 appears to inhibit MHC class I 
processing and maintain the number of latently infected spleen cells (Stevenson et al., 
2002). Aside from these, the recruitment of DCs in the MLN is altered in the mice 
infected with mK3-deficient virus at early time points compared with that of WT 
virus infection (Mount et al., 2010).  
Regulator of complement activation (RCA) protein 
The ORF4 of MHV-68 encodes homologs of RCA protein. ORF4 is a late gene 
which is expressed during lytic replication in tissue culture in a cell membrane bound 
form and in a soluble form. The function of RCA protein is to down-regulate both 
classical and alternative pathways of murine complement activation (reviewed in 
Favoreel et al., 2003; Kapadia et al., 1999). Another function of RCA protein is to 
bind glycosaminoglycan (Gillet, Adler, and Stevenson, 2007). Moreover, it is 
essential for MHV-68 DNA synthesis in macrophages (Tarakanova et al., 2010). 
Other than that, RCA protein contributes to efficient infection by activating the 
protein kinase Akt (Steer et al., 2010). 
Research into MHV-68 immune evasion is still ongoing. It has been reported that 
protein production of both ORF36 and ORF54 can inhibit IFN responses (Hwang et 
al., 2009; Leang et al., 2011). Therefore, by using these sophisticated immune 
evasion strategies, MHV-68 manages to escape from the host’s immune recognition. 
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1.4 Chemokines and their receptors 
Chemokines (chemotactic cytokines) are a family of small molecular weight proteins 
(approximately 7-14 kilodaltons (kDa)) that are secreted by cells (CXCL1 and 
CX3CL1 are membrane-bound chemokines (Moser et al., 2004)). Scientists started to 
draw certain attention to these molecules because chemokines promote migration of 
leukocytes, endothelial and epithelial cells. So far, approximately 48 chemokines and 
23 chemokine receptors have been found. Among these, all the chemokine receptors 
have been found in both humans and mice. At least 45 chemokines are involved in 
chemokine network in humans, whereas approximately 38 chemokines have been 
found in mice. Chemokines have versatile functions which are associated with a 
variety of intercellular communication signals, such as cell migration, proliferation, 
differentiation and survival.  
1.4.1 Chemokine classification 
1.4.1.1 Structural classification 
All chemokines share a similar and highly conserved three-dimensional structure 
containing a monomeric fold in the N-terminus, three -strands and an -helix in the 
C-terminus. Furthermore, chemokine molecules have four conserved cysteine 
residues of which the first and third cysteines are connected by a disulfide bond, the 
other two cysteines are connected by another disulfide bond. Based on the 
positioning of the N-terminal two cysteine residues and the number of amino acid 
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between them, chemokines are classified into: CXC-, CC-, C-, and CX3C- 
chemokines (reviewed in Zlotnik and Yoshie, 2000). X denotes the number of 
additional amino acids between the first and second cysteines. In the CC-chemokines, 
the first two cysteines are adjacent, whereas the C-chemokines are different from the 
other three kinds of chemokines, as their first and third cysteines are missing. 
Another chemokine structure, which lacks one of the first two cysteines but retains 
the others (CX-chemokine), has been reported in zebrafish but could not detected in 
mammals (Nomiyama et al., 2008). Human chemokines are designated in capital 
letters, whereas as mouse chemokines are designated in lowercase letters. 
Lymphotactin (XCL1 and XCL2) and CX3CL1 (fractalkine) are the only members so 
far described in C- and CX3C- family, whereas the rest of the chemokines belong to 
CC- and CXC-chemokine families. The function of CXC-chemokines is the 
recruitment of neutrophils, granulocytes and the homing of endothelial cells. 
CXC-chemokines are divided into two sub-families. One has a tri-peptide sequence 
Glu-Leu-Arg which is attached to the first cysteine residue (ELR+CXC-chemokines). 
ELR+CXC- chemokines have an angiogenic function. The ELR+CXC-chemokine 
sub-family includes CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7 and 
CXCL8. In contrast, the CXC-chemokines without the ELR motif 
(ELR-CXC-chemokines) consist of CXCL4, CXCL4L1, CXCL9, CXCL10, and 
CXCL11. The ELR-CXC- chemokines have angiostatic activity. The 
ELR+CXC-chemokines specifically bind to CXCR1 and CXCR2 in humans and 
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only Cxcr2 in mice which are present on endothelial cells, whereas 
ELR-CXC-chemokines act through the chemokine receptors CXCR3, 4 and 5. The 
CC chemokines exert their action on dendritic cells, monocytes, macrophages and 
lymphocytes. However, CC-chemokines cannot attract neutrophils except murine 
neutrophils (Raman et al., 2007).  
1.4.1.2 Functional classification 
Leukocytes contain related chemokine receptors and are attracted and flow from 
lower to higher concentration of chemokines toward the relevant sites (Hoogewerf et 
al., 1997; Proudfoot et al., 2003). This progress is called chemotaxis. Chemokines 
are grouped into the functional sub-families termed homeostatic, inflammatory, or 
dual function chemokines. 
Homeostatic chemokines are constitutively expressed at discrete locations in 
lymphoid and extra-lymphoid tissues. They have the ability to attract subsets of 
lymphocytes and dendritic cells. These chemokines are believed to be important for 
mediation of cellular recruitment at sites of hematopoiesis, initiation of adaptive 
immunity and immune surveillance. In secondary lymphoid organs, lymphocytes are 
attracted to the B cell zone or T cell zone under the control of chemokines. For 
example, both CCL19 and CCL21 induce CCR7-bearing cells, such as T cells, B 
cells and DC cells, to traffick into the T cell zone of secondary lymphoid tissues, then 
these cells promote lymphoid tissue formation (Luther et al., 2002). The homing of 





 T cells into small intestinal epithelium and lamina propria is induced by 
chemokines (Shang et al., 2009). The recruitment of B cells to Peyer’s patches 
depends on several chemokine receptors, such as CCR6, CCR7, CXCR4 and CXCR5, 
and their ligands (Okada et al., 2002).  
Inflammatory chemokines are induced by inflammatory stimuli and play pivotal 
roles in the control of leukocyte recruitment, including granulocytes, monocytes and 
effector T cells. Moreover, inflammatory chemokines regulate basal trafficking of 
resting B cells and T cells. Macrophages and neutrophils are the main cell types 
attracted by inflammatory chemokines and take part in inflammatory conditions, as 
they express various receptors for proinflammatory chemokines, then take part in 
inflammatory conditions. Moreover, the inflammatory function of chemokines was 
studied by the influx of neutrophils, eosinophils, macrophages and dendritic cells in 
the colon which was treated with dextran sulphate sodium. This study has proved 
that chemokines are critical for leukocyte accumulation in the gut during 
inflammation (Shang et al., 2009).  
A number of chemokines which possess both inflammatory and homeostatic 
functions are called dual-function chemokines. CCL11, CCL17, CCL20, CCL22, and 
C-, CX3C- family chemokines belong to dual-function chemokine family (reviewed 
in Zlotnik and Yoshie, 2012). 
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1.4.2 Chemokine receptor 
Chemokine receptors are on cell surfaces, and they have the ability to bind to their 
chemokine ligands with high affinity. Because the receptors have a seven-membrane 
structure and are coupled to GTP-binding proteins, they are also called seven 
transmembrane GPCRs. The signal is delivered into the cells by a flux in 
intracellular Ca
2+
 calcium ions signalling when chemokine receptors interact with 
their chemokine ligands. Under chemokine signalling, cells traffic to desired 
locations. Chemokine receptors are classified as four sub-families according to the 
sub-family of their major ligands. 
Homeostatic and dual-function chemokines bind to restricted receptors. 
Correspondingly, the homeostatic and dual-function chemokine receptors only 
interact with one or two related chemokines. In contrast, some inflammatory 
chemokines do not possess exclusive receptors. Meanwhile, inflammatory 
chemokine receptors have broad chemokine selectivity (reviewed in Zlotnik and 
Yoshie, 2012).  
1.4.3 Chemokine and GAGs 
GAGs are a group of long unbranched polysaccharides consisting of various 
disaccharide repeating units: chondroitin sulfates, dermatan sulfates, heparan sulfate, 
heparin, keratan sulfates, and hyaluronic acid are all belong to GAGs. The binding of 
chemokines to GAGs increases the local chemokine concentration on the 
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extracellular matrices or cell surface, which enhances the chance of recognition of 
chemokines and their GPCRs. Furthermore, the binding is believed to protect 
chemokines against proteolytic degradation (Middleton et al., 2002). It has been 
found that the GAG-chemokine and receptor-chemokine binding sites overlap for 
some chemokines, which indicates GAGs may disrupt cellular recruitment (Lau et al., 
2004).  
1.4.4 Chemokine gradient and cellular migration 
During the inflammatory response, flowing leukocytes roll on the surface of the 
vascular wall. Then, leukocytes move to the relative tissues to aid the immune 
response. The migration of cells involves four steps, including rolling adhesion, 
tethering, diapedesis and migration (figure 1.3), which is reviewed in Rot and von 
Andrian’s paper (2004). To explain this, neutrophils are taken as an example to 
demonstrate the migration of cells during the inflammation. In the first step, the 
circulating speed of neutrophils is slowed down via low-affinity and reversible 
interactions of L- and E-selectin which appear on blood vessel endothelium. Thus, 
neutrophils roll along endothelium. Then integrins LFA-1 and CR3 interact with 
ICAM-1 with a higher affinity than the binding of L- and E-selectin, alongside the 
binding of chemokine receptors and the endothelial cell-surface GAGs binding 
chemokines. As a result, the rolling of the neutrophils is stopped and the neutrophils 
firmly adhere to the endothelium. During the third step, neutrophils cross the 
endothelial wall by the assistance of LFA-1 and CR3, as well as a further adhesive 
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interaction involving an immunoglobulin-related molecule called CD31. 
Consequently, under the mediation of chemokines, neutrophils migrate through the 
tissue to the infection sites. 
1.4.5 Chemokine and cellular differentiation 
Chemokines are directly or indirectly involved in cellular differentiation. For 
example, the differentiation of T helper cell type 1 (Th1)/Th2 depends on several 
chemokines (reviewed in Luther and Cyster, 2001). CCL3-5 can directly stimulate 
CD4
+
 T cells differentiation into the Th1 subtype (reviewed in Luther and Cyster, 
2001; Roughan and Thorley-Lawson, 2009). Moreover, the binding of these 
chemokines and their receptor CCR5 induces IL-12 production in DC and indirectly 
induces Th1 differentiation (Alcami et al., 1998). On the other hand, CCL2 induces 
Th2 differentiation by enhancing IL-4 expression (Luther and Cyster, 2001). 
Moreover, CCL2, CCL7, CCL8 and CCL13 down-regulate the expression of IL-12 
inducing Th2 development (Shukla and Spear, 2001; Spear, 1993). Aside from 
Th1/Th2 differentiation, the study of the function of CXCL4 found that it induces the 
differentiation of monocytes into macrophages (Scheuerer et al., 2000) and dendritic 
cells (Xia and Kao, 2003). 
1.4.6 Chemokine and fibrosis 
Fibrosis is a self-repair process in which excess fibrous connective tissue is formed 
in an organ or tissue. The development of fibrosis may be because of Th2 







Figure 1.2  A diagrammatic sketch of the migration of neutrophils mediated by a chemokine 
gradient. The migration of neutrophils is described by four steps: rolling adhesion, tight 
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inflammatory response contributes to the disruption of the normal tissue structure 
(reviewed in Keane, 2008). For example, CCL17 and CCL22 are associated with a 
Th2 profile and are significantly elevated in bleomycin-induced pulmonary fibrosis 
(Belperio et al., 2004). Moreover, the CC chemokine receptors which are expressed 
on the surface of Th2 T cells are found elevated and related to pulmonary fibrosis 
(reviewed in Keane, 2008). The balance of angiogenic and angiostatic CXC 
chemokine expression is also involved in chronic fibroproliferative disorder in the
lung (reviewed in Strieter, Gomperts, and Keane, 2007). It has also been found that 
interaction of CXCL12 and CXCR4 is important for the trafficking and extravasation 
of fibrocytes into the lung when the pathogenesis of pulmonary fibrosis was studied 
(Phillips et al., 2004). 
1.4.7 Chemokines manipulated by virus 
It has been shown that certain chemokines are produced by tumor cells that are 
important for tumor growth and metastasis, because chemokines recruit 
proinflammatory cells and endothelial cells providing a superior environment for 
tumor growth and progression (reviewed in Raman et al., 2007). The study of KS has 
shown that the expression of CCL2 increased in KS cells in vivo and in vitro (Sciacca 
et al., 1994). Furthermore, EBV has been reported to induce chemokine receptors and 
cytokines during infection. For instance, CCR6, CCR7 and CCR10 are up-regulated 
in EBV infected cells, which may be important for homing these immortalized cells 
to secondary lymphoid tissues (Birkenbach et al., 1993; Nakayama et al., 2002).  
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1.4.8 Viral immune evasion by interrupting chemokine network 
In the coevolution of viruses with the hosts’ immune response, the hosts have 
strengthened their immune system to defend against viruses, meanwhile viruses have 
developed many immune-evasion strategies to limit immune control. The chemokine 
network is indispensable for controlling viral infection. For instance, CCR5 is 
involved in the recruitment of memory CD8
+
 T cells to the lung during influenza 
infection, thus CCR5 leads to control of virus replication (Kohlmeier et al., 2008). 
Interestingly, large DNA viruses, particularly the poxviruses and herpesviruses can 
interrupt the host chemokine network to their advantage. For example, molluscum 
contagiosum virus encodes two chemokine like proteins which interfere with the 
chemotactic response to CXCL12 and CCL3 and block calcium fluxes induced by 
the CC- and CXC- chemokines (Damon, Murphy, and Moss, 1998; Jin et al., 2011). 
Aside from poxviruses, herpesviruses encode a large number of viral chemokines. 
For example, KSHV encodes three CC chemokine like genes (vCCL1, vCCL2 and 
vCCL3). VCCL2 can bind to and antagonize all four chemokine receptor 
sub-families to inhibit the binding and signalling of the leukocytes to their receptors. 
Thus it influences trafficking of leukocytes (Kledal et al., 1997; Luttichau et al., 2001; 
reviewed in Raman et al., 2007).  
The virus subverts the immune system not only by secretion of viral chemokines, but 
also by mimicry of GPCR. The best studied herpesvirus vGPCRs are ORF74 
encoded by KSHV and MHV-68, as well as US28 encoded by HCMV. KSHV 
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ORF74 have been shown to behave as broad-spectrum low-affinity receptor 
(Arvanitakis et al., 1997). KSHV ORF74 can activate oncogenic and angiogenic 
signalling pathways through a large number of G proteins (Bais et al., 1998; Smit et 
al., 2002) and influences the biology of vascular tissues by promoting the expression 
of angiogenic factor (Sadagopan et al., 2009).  
Secretion of chemokine binding protein is another strategy exploited by DNA viruses 
to impair the host immune response. The best example of this is the broad spectrum 
chemokine binding protein M3 that was discussed in section 1.3.2. A newly 
characterized chemokine binding protein from pseudorabies virus only disrupts the 
chemokine-binding domain without affecting the GAG interactions (Viejo-Borbolla 
et al., 2010). Interestingly, Lalani et al (1997) has found that poxvirus chemokine 
binding protein M-T7 protein can bind to C-, CC- and CXC- chemokine, as well as 
rabbit IFN-. In contrast, HSV encoded glycoprotein G can enhance chemokine 
function in vitro and in vivo (Coscoy et al., 2012) 
The main virus-encoded chemokines, chemokine receptors and chemokine binding 
proteins are summarized in Table 1.3. 
1.5 GC and its regulators 
GCs are formed in the B cell follicles of secondary lymphoid tissues during immune 
response to the viral infection. The infection of gammaherpesvirus exploits this 
structure for their benefit to establish long term latency in memory B cell s 





Table 1.3  Main chemokines, chemokine receptors and chemokine binding 
proteins that are encoded by herpesvirus and poxvirus. 
 
     virus 
Gene name 
chemokines vGPCRs vCKBPs 
HSV-1,2   Glycoprotein G 
HCMV UL128, UL146    
and UL147 
UL33, UL78, US27 
and US28 
 
HHV-6 U83 U12 and U51  
EBV  BILF  
KSHV vCCL1, 2 and 3 ORF74  
MHV-68  ORF74 M3 
Myxoma virus 
(MV) 
  M-T7 M-T1 
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(Babcock et al., 1998; Flano et al., 2002). Therefore, the study of GC is an important 
aspect to learn of gammaherpesvirus infection.  
1.5.1 Formation and structure of GC 
B cells which has membrane bound recombination of immunoglobulins (Ig) are 
generated from bone marrow. The naïve B cells aggregate at primary follicles in the 
secondary lymphoid tissue. During the immune response to antigens, foci of rapidly
proliferating B blast cell begin to appear within the primary follicles of peripheral 
organs. Then this structure becomes the secondary follicle, surrounded by a mantle of 
concentrically packed, resting, small B-lymphocytes possessing both 
membrane-bound IgM and IgD, called GC. The differentiation of B cells occurs in 
the GC. First, B blast cells differentiate to centroblasts, which have downregulated 
surface immunoglobulins which undergo affinity maturation generated by somatic 
hypermutation (SHM) and class switch recombination in the dark zone. Thereafter, 
centroblasts develop into smaller and nondividing centrocytes in the light zone, 
where they contact the T follicular helper (TFH) cells and follicular dendritic cells 
(FDCs) (Cyster, 2010). It has been found that most MHV-68 infected GC B cells are 
centroblasts, and only about 20% of GC B cells are centrocytes (Collins and Speck, 
2012). Homeostatic chemokines are requisite for the formation of GC. The migration 
of centroblast and centrocyte is not a one way route, which involves two 
chemokine-receptor pairs, CXCL12-CXCR4 and CXCL13-CXCR5, playing a 
competitive role in homeostatic circulation of B cells. CXCL12 and CXCL13 are 






Figure 1.3  Diagrammatic stretch of GC and the development of B cells. Adapted from Roitt’s 
Essential Immunology 11
th
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constitutively expressed by stromal cells in the follicular region. Centroblasts express 
higher CXCR4 than centrocytes. Meanwhile, CXCL12 was found to be more 
abundant in the dark zone than in the light zone. As a result, the upregulation of 
CXCL12 or CXCR4 drives the positioning of GC B cells to the dark zone (Allen et 
al., 2004). Higher levels of CXCL13 are found in the light zone and CXCR5 is 
expressed on centrocytes. However, CXCR5 is less likely to contribute to the GC
dark zone and light zone polarization as shown by studies of CXCR5 deficient mice 
(Allen et al., 2004). Most centrocytes die from apoptosis without encountering 
antigens which are presented by FDC or without the help of TFH cells. The rest of the 
centrocytes mature and differentiate into memory B cells or immunoblast plasma 
cells (reviewed in Victora and Nussenzweig, 2011) (figure 1.3). The memory B cells 
still maintain the ability to differentiate into plasma cells when they re-encounter 
antigens (Tarlinton, 2006).  
1.5.2 GC reaction and its regulators 
The GC reaction is helper T-cell-dependent and generates antigen-specific humoral 
immune responses in the secondary lymphoid organs. Proliferating B cells, TFH cells 
and the specialized FDCs, which augment the latter stage of the primary immune 
response, are involved in the GC reaction. The function of the FDCs is to trap and 
retain unprocessed antigens through Fc and complement receptors, then present them 
to B cells. FDCs also provide signals to prevent apoptosis of GC B cells and 
stimulate cellular interaction and proliferation (reviewed in Ngo et al., 1999). In 
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addition, FDCs are a major source of CXCL13 in GC light zones, whereas TFH cells 
express CXCR5. The intimate pairing of the GC B cells and TFH cells is also 
apparent at the molecular level, at which both cell types require the transcription 
factors Bcl-6 and interferon regulatory factor 4 (IRF4) and the absence of the B 
lymphocyte-induced maturation protein-1 (Blimp-1). The GC reaction is suppressed 
by follicular regulatory T cells (Treg) (Chung et al., 2011).  
The GC response is regulated by several sophisticated elements. Bcl-6 is reported to 
be a critical regulator for GC B cell phenotype (Basso and Dalla-Favera, 2010; 
reviewed in Victora and Nussenzweig, 2011). The transcription of Bcl-6 in B cells is 
up-regulated during the GC stage which is important for producing high-affinity 
antibodies (reviewed in Victora and Nussenzweig, 2011). The role of Bcl-6 has been 
studied in diffuse large B cell lymphoma. It has been shown that the expression of 
Bcl-6 in GC B cells requires the regulation of IL-21 (Linterman et al., 2010). Bach2 
is another crucial transcriptional regulator that promotes GC formation and antibody 
class switch recombination (CSR) (Muto et al., 2004). Blimp-1 expression reduces 
both Bcl-6 mRNA and protein levels (Shaffer et al., 2002). Moreover, it is vital for B 
cell proliferation and antibody class switching. IRF4 has a dose-dependent function, 
in low concentrations promoting GC formation and CSR; whereas higher 
concentrations repress Bcl-6 and activate Blimp-1 (Klein et al., 2006; Sciammas et 
al., 2006). 
Bcl-6 is also a master regulator of TFH differentiation as it represses the expression of 
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microRNAs that target several key TFH genes products, such as CXCR5 (Yu et al., 
2009). Overexpression of Bcl-6 also regulates PD-1, but represses the master 
regulators like T-bet, RORt and GATA-3 that are requisite for the development of 
other helper T cells (Kusam et al., 2003). TFH cells are the key factor in GC 
formation and are potent inducers of affinity-matured antibody production during 
co-culture with B cells. Therefore, TFH cells are designated as a T helper cell subset. 
After T helper cells are activated by antigens, CXCR5 expressing TFH cells are 
relocated from the T zone into the B cell follicles. However, CXCR5 expression is 
transient and TFH cells cease to exist during extended T cell expansion (Moser and 
Ebert, 2003). TFH cells also express PD-1, which affects the development of TFH cells 
and controls the function of TFH cells, for example the reduced cytokine synthesis 
from TFH is found in the lack of PD-1 signal environment (Good-Jacobson et al., 
2010).  
1.5.3 The differentiation of plasma cells 
There are two types of plasma cell formation that are developed from activated B 
cells. Firstly, extrafollicular B cells that proliferate and terminate differentiation into 
short-lived plasma cells without somatically mutated immunoglobulin genes. These 
cells secrete antibodies and provide a rapid initial response to pathogens. Secondly, 
B cells move into B cell follicles and then proliferate, followed by a GC response. 
This is accompanied by affinity maturation and CSR of immunoglobulin. Afterwards, 
the B cells differentiate into long-lived plasma cells, then migrate to the bone 
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marrow where the subsets live for a long period (reviewed in Allen, Okada, and 
Cyster, 2007; reviewed in Shapiro-Shelef and Calame, 2005). When the B cells 
differentiate to plasma cells, the proliferation of B cells is stopped, the synthesis and 
secretion of Igs are increased. Meanwhile the CXCR4 is up-regulated which results 
in plasma cells leaving the GCs and homing to peripheral tissues (Tokoyoda et al., 
2004). Several regulatory factors affect the differentiation of plasma cells. For 
example, Blimp-1 and Xbp-1 induce plasma cell differentiation, whereas Pax5, Bcl-6 
and Bach2 promote the B cell programme that inhibits the development of plasma 
cells.  
1.6 Project outline 
The role of M4 protein has been examined in vivo by comparing viral latency in the 
spleens following infection with WT and M4stop virus (Evans et al., 2006; Geere et 
al., 2006), but how M4 protein benefits MHV-68 infection has not been fully 
understood from these publications. Therefore, the role of M4 was studied in this 
project. The main methods used in this study were: (1) investigation of the 
chemokine binding ability of M4 by ELISA using recombinant M4 protein; (2) 
comparison of host immune responses by flow cytometry; (3) understand the gene 
expression by PCR arrays and qPCR. The initial objective was to confirm whether 
M4 protein is a chemokine binding protein, and how it influences the interaction of 
chemokine and GAGs. A second objective was to study the effects of M4 protein on 
the activation of lymphocytes. The third aim was to investigate whether M4 protein 
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influence the GC development. The final objective was to assess whether M4 protein 
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2 Materials and Methods 
2.1 Cell Culture techniques 
2.1.1 Cell lines and counting of cells 
Cell lines were maintained in tissue culture plastic flasks (Nunc, UK). Baby hamster 
kidney fibroblast cells (BHK-21 cells) (Usherwood et al., 2005) were cultured at 
37°C with a humidified atmosphere of 5% CO2. Spodoptera frugiperda insect cells 
(Sf9 cells) (Smith and Cherry, 1983) and Trichoplusia ni insect cells (High-Five cells) 
(Granados et al., 1994) were cultured at 27°C and sub-cultured when the flask 
reached 90% confluence.  
For quantification of the cell number, cells were 1 : 1 diluted (50µl of cells were 
mixed with 50µl 0.1% trypan blue (w/v)) or 1 : 9 diluted (10µl of cells were mixed 
with 90µl trypan blue) and the number of un-stained viable cells was counted using a 
haemocytometer under a microscope. The cell number was calculated by following 
calculation: 
Cell number per ml= unstained cell count × the dilution factor × 104 
2.1.2 Monolayer cultures 
BHK-21 cells were maintained in Glasgow Modified Eagle’s Medium (GMEM, 
Invitrogen, UK), supplemented with 2mM L-glutamine (Invitrogen, UK), 100U/ml 
penicillin (Invitrogen, UK), 100µg/ml streptomycin (Invitrogen, UK), 10% (v/v) new 
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born calf serum and 10% (v/v) tryptose phosphate broth (TPB, Invitrogen, UK) 
(complete GMEM). For sub-cultured cells, medium was discarded, and cells were 
washed with 0.02% (w/v) versene, followed by incubating with 10ml of 0.25% (w/v) 
trypsin (Invitrogen, UK) till the cells could be removed from the surface of the flask 
by gently tapping. An equal volume of complete GMEM was utilized to neutralize 
trypsin, and cells with medium were collected in a plastic universal tube and 
centrifuged at 450 × g for 5 minutes. The supernatant was discarded and the cell 
pellet was re-suspended in complete GMEM. 5 × 10
6
 cells were re-seeded into a new 
175cm
2
 tissue culture (TC 175cm
2
) flasks with 35-40 ml of medium. 
Sf9 cells were grown in Sf-900 Ⅱ SFM medium (Invitrogen, UK), supplied with 
100U/ml penicillin, 100U/ml streptomycin and 100µg/ml gentamycin (complete 
Sf-900 Ⅱ SFM medium). To sub-culture the Sf9 cells, 20ml of medium was 
removed from a total 25ml volume medium. The cells were dislodged by gently 
tapping the flask. 1 × 10
7
 cells were re-seeded into a new TC 175cm
2
 flask in 25ml 
of fresh complete Sf-900 Ⅱ SFM medium. 
High-Five cells were grown in EXPRESS-FIVE™ SFM medium (Invitrogen, UK), 
supplemented with 18mM of L-glutamine and 100U/ml penicillin and 100U/ml 
streptomycin (complete EXPRESS-FIVE™ SFM medium). For passaging the cells, 
the monolayer was dislodged by tapping the flask. 9 × 10
6
 cells were re-seeded into a 
fresh TC 175cm
2
 flask with 25ml of complete EXPRESS-FIVE™ SFM medium.  
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2.1.3 Suspension cell cultures 
The Sf9 cells were harvested from monolayer cell culture and then seeded in a 
spinner flask at a density of 10
6 
cells/ml in complete Sf-900 Ⅱ SFM medium, 
incubated at 27°C stirring rate at 75 rpm. An appropriate volume of the medium was 
added to maintain the density of the cells. For suspension culture, High-Five cells 
growth medium contained tissue culture grade heparin (Invitrogen, UK) at 10U/ml. 
2.1.4 Cryopreservation and recovery of cells from liquid nitrogen 
Cells were harvested when in exponential growth phase. BHK-21 cells and insect 
cells were centrifuged for 5 minutes at 450 × g and 200 × g respectively. The cell 
pellet was re-suspended with 10ml freezing media (10% (v/v) dimethylsulphoxide 
(DMSO) and 20% (v/v) fetal calf serum in medium) to allow 1ml per cryovial of 
cells at a density of 2-5 × 10
6
 cells. These vials were then placed in liquid nitrogen 
storage tank for long-term storage. Insect cells were retained in -80°C freezer for 24 
hours before preserved in liquid nitrogen. 
In order to recover the cells, the vials were taken out from liquid nitrogen storage 
tank and defrosted in a 37°C water bath. Insect cells were half defrosted and a few 
droplets of warmed medium were added in the vial in order to equilibrate the osmotic 
pressure slowly. For the BHK-21 cells and High-Five cells, the DMSO was removed 
by centrifugation at 450 × g and 200 × g respectively. Cell pellets were re-suspended 
in 5 ml of warm growth medium and transferred into a TC 25cm
2
 flask for routine 
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culture. For Sf9 cells, the cells which were maintained in freezing medium were 
cultured with 4ml of growth medium in a TC 25cm
2
 flask and incubated at 27°C for 
1 hour to allow the cells attach the flask, and then the medium was replaced by fresh 
complete Sf-900 Ⅱ SFM medium. 
2.2 Virological Methods 
2.2.1 Preparation of virus stock 
2.2.1.1 MHV-68 virus stock 
Stocks of MHV-68 were generated in BHK-21 cells. 1 × 10
7
/ml of cells were 
resuspended in complete GMEM and infected with MHV-68 at a multiplicity of 
infection (MOI) of 0.001. The cells and virus were incubated for 1.5 hours at 37°C 
with shaking and seeded at 2 × 10
6
 cells per flask in TC 175cm
2
 flasks. The infected 
cells were incubated at 37°C for 5-7 days. Then the cells were dislodged by scraping 
or gently tapping the flask and centrifuged in 2000 × g at 4°C for 20min in universal 
tubes. The pellet was resuspended in 5-10ml of sterile phosphate buffered saline 
(SPBS) and homogenized with 20-30 strokes in a chilled Dounce homogenizer. The 
homogenate was transferred to a glass universal and sonicated in an iced water-bath 
for 15 minute. The homogenate was centrifuged in 2000 × g at 4°C for 20 minutes 
and the supernatant was transferred to a clean universal tube. The pellet was 
resuspended in 1ml SPBS, re-homogenised and centrifuged in 2000 × g at 4°C for 
20min. The two supernatants were mixed, aliquoted and stored at -80°C.  
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2.2.1.2 Recombinant Baculovirus stock 
Stock of baculovirus was produced in Sf9 cells. Sf9 cells were infected with 
baculovirus at a MOI=0.1 for 30 minutes at room temperature. Approximately 1.5 × 
10
7
 cells were re-seeded in a TC 175cm
2
 flask with 25ml of medium and incubated 
for 72 hours at 27°C. The baculovirus was harvested by centrifuging the cells with 
medium in 2000 × g for 10min at 4°C. The supernatant was reserved as a virus stock 
covered with tin-foil at 4°C. 
2.2.2 Titration of virus 
2.2.2.1 Titration of MHV-68 




) in 4ml medium in bijoux 
tubes. 200µl of BHK-21 cells at a density of 10
7
 were added to each virus dilution 
and incubated for one hour at 37°C with constant shaking. Each mixture was 
transferred to two 60mm culture plates (Falcon, Becton, Dickinson and Company, 
USA), followed by adding 3ml of complete GMEM on each plate. The infected cells 
were incubated at 37°C supplied with 5% CO2 for 4 days. Uninfected cells were also 
seeded at the same density in the plates as a negative control. After removal of 
medium, cells were fixed in 10% (v/v) neutral buffered formaldehyde (NBF, Leica 
Microsystems, Germany) for 30 minutes. After removing the NBF, 3ml of 0.1% (w/v) 
toluidine blue was added to stain the cells for 5 minutes. Then the dye was removed. 
Virus plaques were counted and virus titre was calculated as plaque forming units 




Titre=number of plaques × dilution/ final volume of virus plus cells added to the 
plate 
2.2.2.2 Titration of baculovirus 
Approximately 10
6
 of Sf9 cells were seeded in duplicate 35mm culture plates with 
2ml complete Sf-900 Ⅱ  SFM medium, incubated at 27°C. The medium was 
removed 1 hour later and the serially diluted virus was added with 200µl medium to 
the plates. Meanwhile, 200µl medium was added to the control plates. The medium 
was discarded after 1 hour incubation and the plates were overlaid with 1ml 1 : 1 
low-melt agarose (3% dissolved in water, steriled, Flowgen MicroSieve, UK) and 
Sf900 Ⅱ SFM medium mixture. The solidified agarose was covered with 2ml of 
medium and the cells were incubated at 27°C for 5 days. After discarding the 
medium, the cells were stained with 2ml of 0.02% neutral red solution (diluted from 
0.1% (w/v) stock and filtered, MP Biomedical, USA) and incubated for another 2 
days at 27°C. The plaques were counted within 1 hour after removing the dye. 
2.3 Recombinant baculovirus expressing system 
2.3.1 Preparation of Bacmid 
0.1M IPTG and X-gal were overlaid on 1.5% Luria-Bertani (LB) agar plates 
containing 50µg/ml kanamycin, 7µg/ml gentamicin, 10µg/ml tetracycline. E.coli 
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containing the M3 bacmid (a gift from Prof. J. Stewart) was streaked on the agar. 
They were cultured at 37°C 12-16 hours and white colonies were picked and grown 
in 10ml LB broth with same concentration of antibiotics. 
Plamid DNA was prepared by QIAprep Spin Miniprep Kit (Qiagen, Germany) 
according manufacturer’s instructions. 1-5 ml overnight cultured E. coli was 
centrifuged at 6000 × g for 3 minutes and pellet was resuspended completely by 
vortexing in 250μl Buffer P1 contained RNase and lyseblue until cell clumps 
disappeared. The mixture was transfer to a microcentrifuge tube, followed by adding 
250μl Buffer P2, and mixed thoroughly by inverting the tube 4-6 times. 350μl Buffer 
N3 was added and mixed immediately and thoroughly by inverting the tube 4-6 times. 
The mixture was centrifuged at 10000 × g for 10 minutes in a table-top 
microcentrifuge. The supernatant was loaded on a QlAprep spin column placed in a 
2ml collection tube, and centrifuged at 6000 × g for 1 minute and the flow-through 
was discarded. The column was washed with 0.5ml Buffer PB and 0.75ml Buffer PE 
respectively by centrifuging at 6000 × g for 1 minute and flow-through was 
discarded. The column was dried by centrifuging for an additional 1 minute and then 
placed in a clean 1.5ml microcentrifuge tube. The plasmid was eluted by 50μl Buffer 
EB (10mM Tris-Cl, pH 8.5) which was added to the centre of the column standing 
for 1 minute and centrifuged the column at 6000 × g for 1 minute. 
The concentration of plasmid DNA of each sample was quantified by using a 
spectrophotometer (NanoDrop 1000, Thermo Scientific, USA). For measurement of 
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the quantity of DNA, 1μl of each sample was evaluated. The concentrations of DNA 
samples were automatically calculated as in ng/μl and A260:A280 ratio was also 
recorded. 
100ng of DNA was amplified by primer pair M3RTPCR For 5’ and M3RTPCR Rev 
3’. Polymerase chain reaction (PCR) was carried out using Invitrogen Taq DNA 
polymerase system (Invitrogen, UK). A typical reaction mixture consisted of 100ng 
of template DNA, PCR reaction buffer (20mM Tris (pH 8.4), 50mM KCl), 100µM of 
each dATP, dCTP, dGTP and dTTP, 50pmol of each primer (MWG-biotech, Germany) 
and 5U of Taq DNA polymerase. The mixture was overlaid with approximately 40µl 
of mineral oil to prevent evaporation. PCR conditions were 1 cycle of 3 minutes at 
95°C, followed by holding at 80°C to add Taq DNA polymerase, followed by 35 
cycles of denaturation at 94°C for 45 seconds, primer annealing at 55°C for 45 
seconds, and extension at 72°C for 1 minute, and finishing with 7 minutes incubation 
at 72°C. The PCR product was analyzed by electrophoresis.  
10μl of each PCR reaction product was mixed with 5µl of the loading dye and 
electrophoresed through a 1.5% (w/v) agarose gel (Seakem® LE Agarose, Lonza, 
Switherland) in 50ml Tris-acetate-EDTA (TAE) buffer. 0.5µg/ml (w/v) ethidium 
bromide (Sigma, UK) was added to the gel whilst molten to allow visualization of 
the DNA fragments. The appropriate volume of 10 × loading buffer (0.25% (w/v) 
orange G, 0.15% (w/v) Ficoll) was added to the DNA samples and 100bp DNA 
ladder (Invitrogen, UK) respectively, which were loaded into the set gel. Samples 
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and DNA ladder were then subjected to electrophoresis at 80 volts in TAE buffer for 
60 minutes. The gel was placed in the documentation gel station (Alpha Innotech, 
Fluor Chem HD2, USA) and exposed under the ultra-violet light. The image was 
captured by the Innotech camera. 
2.3.2 Transfection of baculovirus 
The recombinant bacmid DNA was transfected into Sf9 cells by Effectene® 
Transfection Reagent (Qiagen, Germany). 9 × 10
5
 Sf9 cells were seeded in a 6-well 
plate for 1 hour and then transfected by following the manufacture protocol. 0.4µg 
DNA was dissolved in TE buffer with the DNA-condensation buffer EC, to a total 
volume of 100µl. 3.2µl Enhancer was added and mixed by vortexing for 1 minute. 
The mixture was incubated at room temperature for 2-5 minutes and centrifuged for a 
few seconds to remove the drops from the top of the tube, and then mixed with 10µl 
Effectene Transfection Reagent by pipetting up and down five times. 
Transfection-complex was formed by incubating the mixture for 5-10 minutes at 
room temperature. After that, the Sf9 cells growth medium was replaced by 1.6ml 
fresh medium. 600µl growth medium was mixed with the transfection complexes by 
pipetting up and down twice, and immediately added onto the cells. The mixture and 
medium were mixed by gently swirling. The cells were incubated with transfection 
complexes for three days under normal growth conditions. At that point, the M3 
baculovirus containing medium was collected by centrifugation at 2000 × g for 5 
minutes. To increase the titre of M3 virus, 100µl of the supernatant was added in a 
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new 6-well plate which contained 9 × 10
5
 Sf9 cells and 2ml growth medium each 
well. The cells were sub-cultured for another four generations till the plaques were 
observed easily and supernatant of each culture was harvested as M3 recombinant 
baculovirus.  
2.3.3 Expression and purification of baculovirus recombinant protein 
(M1, M3 and M4) 
500ml of High-Five cells were cultured to a density of 1 × 106/ml in a 1 liter 
spinner flask. 25ml cells were first infected by 1.25 × 109 recombinant M3 or M4 
baculovirus (MOI=2.5 for the whole number of High-Five cells in the spinner flask) 
in 50ml tubes for 30 minutes, then the virus and infected cells were pipetted into a 
spinner flask containing the rest of cells at a spin rate of 60rpm and incubated for 
exactly 72 hours at 27°C. For M1 recombinant baculovirus, the cells were infected at 
MOI of 1. The supernatant was centrifuged at 2000 × g for 10 minutes and pooled. 
Proteases were inhibited by adding Pefabloc SC (Roche, Switzerland) to give a final 
concentration of 1mM. The supernatant was pipetted into snakeskin pleated dialysis 
tubing (Pierce, USA) and dialyzed at 4°C against 5 litres of 20mM Na2HPO4, 
500mM NaCl, 20mM imidazole, pH8.0 (adjusted by 1M NaH2PO4) for at least 4 
hours and the dialysis was repeated twice. The supernatant was aliquoted into BD 
Falcon™ 50ml tubes (Becton, Dickinson and Company, USA) and centrifuged at 
2000 × g for 10 minutes at 4°C. The supernatant was transferred to new BD 
Falcon™ 50ml tubes, followed by adding Pefabloc SC to give a final concentration 
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of 1mM. 1.5ml Ni-sepharose 6 fast flow resin (GE, Germany) was prepared by 
washing with H2O twice and dialysis buffer three times. The resin was equally 
allocated to each tube and mixed with the supernatant. After rotating at 4°C for 2 
hours, the mixture was centrifuged at 200 × g for 5 minutes and the resin was pooled 
and poured into a 10ml Amersham column (GE healthcare, USA). The column was 
attached to a pump giving a fluid speed set to 1ml every 3 minutes. The protein was 
washed by dialysis buffer containing 1mM Pefabloc SC at 4°C overnight. The 
protein fractions were collected in RNA-free non-stick tubes (Ambion, USA) by 
eluting with 10ml of 40mM imidazole buffer, 10ml of 125mM imidazole buffer and 
5ml of 250mM imidazole buffer consecutively. The entire elution buffer contained 
50mM Na2HPO4, 300mM NaCl, 5% glycerol and 1mM Pefabloc SC. Recombinant 
M3 and M4 protein contain a C-terminal penta-histidine (His) tag. The protein was 
stored in 4°C in the dark. 
2.4 Protein techniques 
2.4.1 SDS-PAGE and western blotting 
Proteins were separated by sodium dodecyl sulfate polyacrylamide gel 
electropheresis (SDS-PAGE) followed by western blotting. 20µl of each protein 
fraction was boiled with 5 × loading buffer (20% (v/v) glycerol; 2% (v/v) SDS; 
0.125mM Tris pH 6.8; 0.4% (w/v) bromophenol blue; 5%  (v/v) 2-ME  for 5 
minutes before loading onto the gel (resolving gel: 10% acrylamide/ bisacrylamide; 
 Chapter 2                                                         Materials and Methods 
71 
 
0.375M Tris pH 8.8; 0.1% (v/v) SDS; 0.1% (w/v) ammonium persulphate (AP); 0.01% 
(v/v) Tetramethylethylenediamine (TEMED). Stacking gel: 3.4% (w/v) acrylamide/ 
bisacrylamide; 140mM Tris pH 6.8; 0.1% (w/v) SDS; 0.05% AP; 0.01% (v/v) 
TEMED). One appropriate size of Amersham Hybond-E4 nitrocellulose membrane 
(GE healthcare, USA) was cut and rinsed with distilled H2O. The nitrocellulose 
membrane and 9 pieces of same sized filter paper was soaked in semi-dry transfer 
buffer (25mM Tris base, 150mM glycine, 10% (v/v) methanol) with gentle agitation 
on a platform shaker for 5 minutes. 6 pieces of filter paper was placed on western 
blotting chamber, covered with nitrocellulose membrane, SDS gel, followed by 3 
pieces of filter paper. The protein fractions were transferred to nitrocellulose 
membrane by 0.65mA/cm
2
 for 90 minutes. Non-specific binding was blocked by 
TBS-milk (3g Marvel skimmed milk powder was dissolved in 100ml 1 × TBS (10 × 
TBS buffer, pH7.4, Severn Biotech Ltd.)). The 6 × His-tagged protein was probed 
with the mouse anti penta-His tag antibody (Qiagen, Germany) followed by washing 
with TBS. After that, rabbit anti-mouse IgG biotin (Sigma-Aldrich, USA) was used 
to detect the first antibody. Then, the membrane was washed with TBS-Tween (TBS 
with 4% Tween-20) and TBS only, followed by incubation with 
Streptavidin-Alkaline Phosphatase (Roche, Switzerland). Cxcl4 protein was detected 
with rat anti Cxcl4 (R & D System, UK) followed by biotinylated mouse anti rat 
antibody and Streptavindin-Alkaline Phosphatase. The membrane was washed as 
described for detection of His-tagged protein. At the final step, the membrane was 
 Chapter 2                                                         Materials and Methods 
72 
 
developed by SIGMAFAST BCIP/NBT (Sigma-Aldrich, USA). The dilution of each 
antibody was listed in Appendix I. 
2.4.2 Coomassie staining 
The purification of the protein fractions were determined by Coomassie staining. The 
SDS gel was incubated in Coomassie stain (0.25% (w/v) Coomassie Blue R250 
(Sigma, UK); 40% (v/v) methanol; 7% (v/v) acetic acid) with shaking for at least 1 
hour. After a brief rinse with de-stain (50% (v/v) methanol; 10% (v/v) acetic acid) 
gels were incubated in de-stain until bands were clear. 
2.5 Enzyme-linked immunosorbent assay (ELISA)  
2.5.1 The binding of recombinant protein and chemokines 
ELISAs were performed in 96-well microtiter plates (Thermo, USA). The bottom of 
each well was coated with SPBS diluted Cxcl2, Cxcl5, CXCL8 (20ng each well, 
Pepro Tech, USA) respectively for 16 hours at 4°C. Weakly adherent chemokines 
were washed off three times with washing buffer (TBS, Severn Biotech, UK, 
containing 0.05% (v/v) Tween 20, 0.1% (w/v) bovine serum albumin (BSA)) rinses. 
After washing, the wells were blocked with the blocking buffer (TBS, containing 
0.05% (v/v) Tween 20, 0.1% (w/v) BSA) for 8 hours at 4°C. After washing 3 times 
with washing buffer, the wells were incubated with blocking buffer diluted M4 
protein for 16 hours at 4°C. M3 protein was used as a positive control, and imidazole 
buffer was used as a negative control. Then the solution was removed and the loosely 
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adherent proteins were washed off as before. To detect the bound M3 or M4 protein, 
a primary antibody (Qiagen, Germany) which would bind to 6 × His-tag produced 
in a mouse was diluted in blocking buffer and added to each well for 2 hours at 4°C. 
The plates were repeatedly washed three times with washing buffer. HRP conjugated 
goat anti mouse IgG (AbD Serotec, UK) was used as a secondary antibody that 
diluted in blocking buffer and incubated for additional 1 hour at 4°C in the dark. The 
plates were washed three times with washing buffer to remove the unbound 
secondary antibody. At each step a volume of 100l was added to the well. 
SIGMFAST™ OPD (Sigma-Aldrich, USA) which was used as a substrate at the final 
step was dissolved in 20ml H2O. 200µl of SIGMFAST™ OPD solution was added in 
each well, and the plates were covered with tin-foil paper for 45 minutes. The 
reaction was stopped by addition of 50μl 3M H2SO4 and the absorbance at 492nm 
was measured using ELISA plate reader (Glomax, Promega, USA).   
Alternatively, wells of microtiter plates were coated with SPBS diluted M4 protein 
for 14 hours at 4°C. M3 protein and imidazole were used as positive control and 
negative control respectively. After the protein was bound to the wells, the plates 
were washed three times with washing buffer and blocked with blocking buffer for 8 
hours. After the plates were repeatedly washed for three times, 1ng, 10ng and 20ng 
of blocking buffer diluted Cxcl4 (R & D System, UK) was added and plates were 
incubated for 16 hours at 4°C. The unbound Cxcl4 was removed by washing three 
times with washing buffer. Blocking buffer diluted rat anti-Cxcl4 was used to detect 
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bound Cxcl4 by incubating for 2 hours at 4°C. The plates were repeatedly washed 
with washing buffer as before. Goat anti Rat IgG-HRP (AbD Serotec, UK) was used 
as secondary antibody and incubated for 1 hour at 4°C in the dark. At each step, 
100µl of agent was added. After washing off the unbound enzyme, SIGMFAST™ 
OPD (Sigma-Aldrich, USA) was dissolved in H2O, and 200µl of solution was loaded 
in each well. The plate was covered with tin-foil paper for 45 minutes and the 
reaction was stopped by addition of 50μl 3M H2SO4 and the absorbance at 492nm 
was measured using ELISA plate reader. The dilution of the antibodies was listed in 
Appendix I. 
2.5.2 The binding of M4 and heparin 
Streptavidin coated plates (Thermo scientific, USA) were washed three times with 
washing buffer to rehydrate. Porcine intestinal mucosa biotin conjugated heparin 
(Calbiochem, USA) was added in each well. The plate was shaken constantly for 2 
hours at room temperature and then shaken constantly for 1 hour on a shaker at 4°C. 
After 1 hour the unbound heparin was washed off with washing buffer. M4 was 
diluted with the blocking buffer and incubated with heparin coated plate for 14 hours 
at 4°C.  For this step, 1ng or 20ng Cxcl4 was used as a positive control. After 
incubation, the plate was washed three times with washing buffer as before. Mouse 
anti-penta His antibody was used to detect bound M4 which was diluted in blocking 
buffer and incubated for 1 hour at 4°C. Goat anti mouse IgG HRP was diluted in 
blocking buffer and incubated with constantly shaking at room temperature for 1 
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hour in the dark. The reaction was stopped by addition of 50μl 3M H2SO4 and the 
absorbance at 492nm was measured using ELISA plate reader. As Cxcl4 was used as 
a positive control, rat anti Cxcl4, and HRP conjugated goat anti rat were used to 
detect bound Cxcl4. 
2.5.3 Competitive ELISA 
The binding of heparin-biotin to streptavidin coated plate was described above. The 
unbound biotinylated heparin was washed off, followed by adding blocking buffer 
diluted M4 protein which contained 1 or 10l M4 protein, 14ng Cxcl4 was loaded 
and incubated. At this step, blocking buffer diluted M3 protein which contained 0.1, 
1 or 10l M3 protein and imidazole were used as positive control and negative 
control respectively. After incubation for 14 hours at 4°C, the plate was washed with 
washing buffer. To detect bound Cxcl4, rat anti-Cxcl4 was diluted and incubated for 
2 hours at 4°C. After washing the plate as before, goat anti rat-HRP was diluted in 
blocking buffer and incubated for 1 hour at 4°C. 100µl of diluted agent was added 
for each step. After washing the plate three times, SIGMFAST™ OPD 
(Sigma-Aldrich, USA) was dissolved in H2O, and 200µl of solution was added. The 
plate was covered with tin-foil paper for 45 minutes. The reaction was stopped by 
addition of 50μl 3M H2SO4 and the absorbance at 492nm was measured using ELISA 
plate reader.   
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2.6 Magnetic Cell Sorting (MACS) technique 
2.6.1 Chemokine binding ability assayed by MACS 
Monoclonal anti-6 ×  His antibodies were coupled to paramagnetic µMACS™ 
MicroBeads for specific isolation of His-tagged proteins. The magnetically labeled 
proteins were passed over and retained in µ Columns that provide a strong magnetic 
field when placed in a µMACS separator. After the non-labeled material was washed 
by wash buffer, the magnetically labeled material was eluted by suitable elution 
buffer. The anti-His MACS
TM
 MicroBeads beads kit, column and MACS 
separator were bought from Miltenyi Biotec. M4 protein supernatant was collected 
from small scale M4 baculovirus infection which High-Five cells were infected in 
TC 25cm
2
 flask (MOI=2.5) for 72 hours. 50l of M4 protein supernatant or 50l of 
10 times diluted M4 protein supernatant (5l of M4 protein supernatant containing 
45l imidazole mixture) was mixed with 40l of beads, 250ng of Cxcl4 and 1mm 
Pefabloc in non-stick tubes respectively. To mix them, the tubes were rotated at 
20rpm for 30 minutes at 4°C. During this procedure, the column was prepared by 
standing in the separator and washed with 200l lysis buffer. After 30 minutes, the 
mixture was run through the columns and the flow through was collected. Later on, 
the columns were washed with four times with 200l wash buffer I and 100l wash 
buffer II once as described in the manufacturer’s protocol. In the meantime, the 
elution buffer was prepared by heating at 95°C. To break the binding of anti His-tag 
beads and protein, 20l of elution buffer was added to the columns, and incubated 
 Chapter 2                                                         Materials and Methods 
77 
 
for 5 minutes. Additional 50l of elution buffer was added to the columns, and the 
flow-through was collected in a new non-stick tube. A mixture containing 45l of 
125mM imidazole elution buffer, 5l M3 protein supernatant and same amount of 
Cxcl4 was used as a positive control. A mixture containing 50l 125mM imidazole 
buffer with same amount of Cxcl4 was used as a negative control. The collections 
were loaded in duplicate and separated by Tris-HCL 4-20% precast gel (Biorad, USA) 
followed by western blotting as described before. One of the duplicated samples was 
probed with the mouse anti penta-His tag antibody followed by rabbit anti-mouse 
IgG biotin and Streptavidin-Alkaline Phosphatase. The membrane was developed by 
substrate SIGMAFAST BCIP/NBT (Sigma-Aldrich, USA). The other duplicated 
sample protein was detected by rat anti-Cxcl4, mouse anti rat-biotin and 
streptavidin-alkaline Phosphatase. The colour was generated by adding SIGMAFAST 
BCIP/NBT. 
2.7 Infection and sampling of Mice 
BALB/C mice, Wild type 129Sv mice and IFN-R
-/-
 mice on the 129Sv mice 
background Huang et al.  were purchased from Bantin and Kingman, Hull, 
United Kingdom and bred in house. MacGreen mice (Sasmono et al., 2003) were a 
gift from Prof. David Hume. Age and sex matched mice were anaesthetized with 
isoflurane (Merial Animal Health Ltd.) and intranasally inoculated with 4 × 10
5
 PFU 
of wild-type BAC-derived virus PHA4 (WT virus) or M4 mutant virus M4in2 
(M4stop virus) in 40μl of sterile PBS.  
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At appropriate time point, the mice were sacrificed by CO2 inhalation. Lungs from 
BALB/C, 129Sv and IFN-R
-/-
 mice were removed and kept frozen. Lungs from 
MacGreen mice were infiltrated with 4% paraformaldehyde and immersed in the 
paraformaldehyde. Spleens from 129Sv and IFN-R
-/-
 mice were placed in completed 
RPMI-1640 medium (Invitrogen, UK) supplemented with 2mM L-glutamine, 
100U/ml penicillin, 100ug/ml streptomycin, 10%  fetal calf serum, 2-ME and 
25mM N-2-hydroxyethylpiperazine-N-ethane-sulphonicacid (HEPES) and weighed. 
Pieces of spleen from 129Sv mice were cut from the middle part of each spleen and 
placed in RNAlater®  Soln (Ambion, USA) for PCR array or put into NBF for 
histology analysis. Spleens from MacGreen mice were fixed in 4% 
paraformaldehyde for section cutting.  
In order to prepare cytospin, fresh splenocytes of MacGreen were isolated and red 
blood cells were lysed by adding 1ml H2O, followed by mixing with 9ml SPBS 
immediately. The cells were counted and made to a concentration of 2 × 106 
cells/ml. The slides (Wablemar Knittel, Germany) were prepared by mounting with 
the Shandon filter cards (Thermo Scientific, USA) and the cuvette in the metal 
holder. 500l of PBS was loaded in each cuvette, followed by centrifugation with 
Shandon cytospin 2 (Thermo Scientific, USA) at 1000 rpm for 2 minutes. 200l of 
cells were loaded and centrifuged at 1000 rpm for 5 minutes. The cells were dried at 
room temperature, then fixed in 4% paraformaldehyde for 15 minutes at room 
temperature. After dryness of these cytospins, they were stored in -80°C. 
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2.8 Measure of virus load 
2.8.1 DNA extraction 
Total DNA was isolated from spleen using the DNeasy blood and tissue kit (Qiagen, 
Germany). Up to 25mg of tissue was cut into small pieces, placed in a 1.5ml 
microcentrifuge tube with 180μl Buffer ATL and 20μl proteinase K and was mixed 
by vortexing for 15 seconds. The mixture was incubated at 56°C and vortexed 
occasionally until the tissue was completely lysed. 200μl Buffer AL was added to the 
sample, and mixed thoroughly by vortexing, followed by adding 200μl ethanol (96–
100% (v/v)), and vortexing again. All the mixture was pipetted into the DNeasy Mini 
spin column placed in a 2 ml collection tube. The column was centrifuged at 6000 × 
g for 1 minute. The collection tube with flow-through was replaced with a new 2ml 
collection tube, and 500μl Buffer AW1 was added in the column, and centrifuged for 
1 minute at 6000 × g. The column was put in a new collection tube and 500μl Buffer 
AW2 was added in the column and centrifuged for 3 minutes at 20000 × g to dry the 
DNeasy membrane. The collection tube with flow-through was discarded. A clean 
1.5ml microcentrifuge tube was provided to collect DNA and 200μl Buffer AE was 
pipetted directly onto the DNeasy membrane and incubated at room temperature for 
1 minute, and then centrifuged for 1 min at 6000 × g to elute. The quantity of DNA 
was measured by spectrophotometry. 




Virus genome load was determined by qPCR from 100ng spleen DNA. qPCR was 
performed in 20μl reaction mixture containing PCR reaction buffer (50mM Tris-HCl, 
10mM KCl, 5mM (NH4)2SO4, 20mM MaCl2, pH8.8), 40μM each of dATP, dCTP, 
dGTP and dTTP, 0.7μl intercalating dye SYBR green, 0.15U FastStartTM Taq DNA 
polymerase (Roche) and 50pmol of each primer (ORF 73, ORF73For 
5’-CGTCTGTCTCTCCTACATCTAAACC-3’ and ORF73qPCRRev , 5’-CACCAA 
CACTTCCCTCATCC-3’; or glyceraldehydes-3-phosphate dehydrogenase (GAPDH), 
GAPDHFor 5'-CCCACTCTTCCACCTTCG-3' and GAPDHRev 5'-GGTCCAGGG 
TTTCTTACTCC-3', MWG-Biotech, Germany), and 100ng of DNA by using a 
Corbett Rotorgene (Corbett Research, UK). In all reaction, an initial denaturation 
step was carried out by incubation at 95°C for 10 minutes. 40 cycles of amplification 
were carried out, which consisted of denaturation at 95°C for 15 seconds, annealing 
at 62°C for 20 seconds and extension at 72°C for 20 seconds. Samples were 
quantitated by using a standard curve generated from the serial dilution of plasmid 
DNA containing cloned ORF73 or GAPDH sequence. All products from the 
quantitative PCR were analysed by using a melting curve to confirm specificity and 
the results were normalized against GAPDH. Efficiency of quantitative PCR was ＞ 
95% 
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2.8.3 Measurement of virus load in the lung 
The virus titre in the lung was determined by culturing the lung homogenate with 
BHK-21 cells. The lungs were chopped into small pieces and homogenised in 1ml of 
complete GMEM, followed by another homogenizing with 0.8ml complete GMEM. 
The lung homogenate was kept in -80°C to disrupt cell membranes. The samples 
were thawed and centrifuged at 2000 × g for 5min at 4°C. 4ml serially diluted lung 
supernatants were mixed with 200μl BHK-21 cells at a density of 10
7
 cells/ml in a 
bijoux and incubated for 1 hour with continuously shaking at 37°C. Then the virus 
and cells in each bijou were transferred to two 60mm culture dishes followed by 
adding 3ml complete GMEM and incubated at 37°C with 5% CO2 for 4 days. The 
plaques were counted after being fixed and stained as described for the titration for 
the MHV-68. 
2.9 Infectious centre assay 
Splenocytes were isolated from the spleen casing with a scalpel blade, producing a 
single-cell suspension in 5ml of complete RPMI-1640. The cell suspension was 
transferred to a pre-rinsed 20ml universal tube and centrifuged at 450 × g for 5 
minutes. The supernatant was discarded and the pellet was re-suspended in remaining 
liquid. Erythrocytes were lysed as described before. Cell debris was allowed to settle 
before transfer of the splenocytes suspension to a fresh pre-rinsed universal tube. The 
sample was centrifuged at 450 × g for 5 minutes. The supernatant was discarded and 
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the cell pellet re-suspended in 5ml of complete RPMI-1640. The viable cell count of 







 splenocytes with 10
6
 BHK-21 cells in 60mm tissue culture plates with 5ml 
complete RPMI-1640 medium for 5 days at 37C with 5% CO2. As previously 
described, the cells were fixed and stained and infectious centres were counted when 
the plates were dried. The remaining splenocytes were frozen and thawed 3 times, 






 splenocytes were incubated with 10
6
 BHK-21 
cells in 4ml complete GMEM for 1.5 hours with continuously shaking at 37°C and 
then the cells and medium was transferred to 60mm tissue culture plates, followed by 
adding 3ml of complete GMEM. Plates were fixed and stained after 4 days and 
plaques were counted. 
2.10 Fluorescence activated cell sorting (FCS) 
2.10.1 Cell phenotyping 
The percentages of the splenocytes or percentages of activated splenocytes were 
determined by flow cytometry. 2.5 × 10
5
 fresh splenocytes were labeled directly with 
combinations of the following monoclonal antibodies for 15 minutes at 4°C in the 
dark. CD4
+
 T cells: anti-CD69-FITC (AbD Serotec, UK), anti-CD38-APC 
(Biolegend, USA) and anti-CD4-PE (Invitrogen, UK); CD8
+
 T cells: anti-CD69- 
FITC, anti-CD38-APC and anti-CD8-PE (Invitrogen, UK); B cells: anti-CD69-FITC, 
anti-CD38-APC and anti-CD19-PE; NK cells: anti-CD49-FITC; anti-CD69-FITC, 
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anti-CD38-APC and anti-CD49b-PE (Biolegend, USA), or anti-CD49b-FITC only; 
TFH cells: anti-PD-1-FITC (Biolegend, USA), anti-Cxcr5-APC (Pharmingen BD 
Biosciences, USA) and anti-CD4-PE; plasma cells: anti-CD138-PE (Biolegend, USA) 
and anti-CD19-APC/Cy7 (Biolegend, USA); macrophages and neutrophils: 
anti-CD11b-APC (Miltenyi Biotec), anti-Ly6G-PE (Biolegend, USA), and 
anti-CD69-FITC. After incubation, the cells were washed three times with FACS 
buffer (PBS containing 0.5% BSA and 0.02% sodium azide) and then 400μl FACS 
buffer and 2% NBF mixture (1 : 1) was added. The tubes were preserved in the dark 
at 4°C. The labeled cells were analysed in a FACSCalibur cell sorter (Pharmingen 




 T cells: anti-CD8-PE and biotinylated anti-TCR 
VBD Biosciences, USA was used to label splenocytes for 20 minutes in the dark 
at 4°C, then the cells were washed three times with FACS buffer. The V4 was 
detected by incubating with Streptavidin Alexaflour 647 for 15 minutes in the dark at 
4°C. After that, the cells were washed, fixed and preserved as described before.  
2.10.2 Intracellular IFN- staining 
Spleens were dissected from WT virus or M4stop virus infected 129Sv mice at day 
10, 12 and 14 p.i. and placed in 2ml RPMI containing 10g/ml Brefeldin A (BFA, 
Sigma, UK). The splenocytes were released and erythrocytes were lysed as before. 
Lymphocytes were washed in staining wash buffer (SWB, 1 × PBS, 2% fetal calf 
serum 0.1% NaN3) containing 10g/ml BFA three times to remove the medium. 1 × 
10
6
 cells were stained per sample. FcR receptors were blocked by incubating with an 
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anti CD16/CD32 antibody (Pharmingen BD Biosciences, USA) for 15 minutes at 
4°C, followed by a single wash in SWB + BFA. FITC-labeled CD49b (AbD Serotec, 
UK) was used as NK cell surface marker antibody. It was added and incubated for 20 
minutes at room temperature. The cells were washed in PBS + BFA then fixed in 2% 
NBF. After fixing, the cells were permeabilised in permeabilisation buffer (SWB + 
0.5% saponin (BDH Laboratory Supplies, UK)) for 10 minutes at room temperature. 
IFN- antibody, PE-labeled IFN- (Pharmingen BD Biosciences, USA), was added 
and incubated for 30 minutes on ice, washed in PBS and resuspended in SWB for 
flow cytometry analysis. As a positive control, 1 × 10
6
 cells were incubated in RPMI 
containing 10ng/ml BFA, 50ng/ml phorbol 12-myristate 13-acetate (PMA, Sigma, 
UK) and 500ng/ml ionomycin (Sigma, UK) for 4 hours at 37°C with 5% CO2. 
2.10.3 Detection of B cell proliferation 
Splenocytes were stained with anti-CD19-PE antibody for 15 minutes in the dark at 
4°C. After staining, the cells were washed and fixed with 50l of 1% 
paraformaldehyde for 15 minutes at room temperature in the dark, then washed. 
Permeabilization of cells was performed by adding 50l of 20% Tween-20 (diluted 
in SPBS (v/v)) for 10 minutes at room temperature in the dark. After washing, the 
cells were stained with rabbit poly-clonal anti-ki67 antibody (Abcam, UK) for 15 
minutes in the dark at 4°C. Then the cells were washed for three times. Biotinylated 
goat anti rabbit IgG (H+L) (Vector Laboratories, USA) was used to stain the cells for 
15 minutes in the dark at 4°C. The cells were washed for three times and were 
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stained with streptavindin Alexa Flour®  647 conjugated antibody (Invitrogen, UK) 
for 15 minutes in the dark at 4°C. Then the cells were washed and preserved as 
described before. 
2.10.4 Isotype control and analysis 
PE (Biolegend, USA), FITC (BD Pharmingen, USA or eBiosience, USA), APC 
(Biolegend, USA) isotype controls were used at the same concentration as each 
antibody. The concentrations of antibodies were listed in Appendix I. Flow cytometry 
was performed on a DakoCytomation using CyAn
Tm
 ADP with Summit
TM
 software 
(Dako, Danmark). For each sample, a minimum of 50000 events were counted. 
Further analysis was carried out using FCS express V3 (De Novo Software, USA) 
2.11 RNA extraction and manipulation 
2.11.1 RNA extraction from spleen  
RNeasy Mini Kit (Qiagen, UK) was used for extraction of RNA. Spleens were 
dissected and preserved in RNAlater RNA Stabilization Reagent immediately to 
avoid RNA degradation. The samples were stored at -20°C until use. The tissues 
were removed from RNAlater using forceps. Approximately 30mg of spleen was cut 
on a clean surface and placed in an RNA free eppendorf tube. The tissue was 
completely homogenised in 600l Buffer RLT containing ME using a mini pestle 
followed by centrifugation for 2 minutes at full speed in a QIAshredder spin column 
(Qiagen, UK) placed in a 2ml collection tube. The lysate was centrifuged again for 
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three minutes at full speed and the supernatant was transferred to a new 
microcentrifuge tube carefully. 600l of 70% ethanol was added to the supernatant 
and mixed immediately by pipetting. 600l of the sample including any precipitate 
was transferred to an RNeasy spin column placed in a 2ml collection tube and 
centrifuged for 15 seconds at 8000 × g to bind the total RNA to the column 
membrane. The remaining sample was centrifuged in the same RNeasy spin column. 
The flow-through after each centrifugation was discarded. At this point, DNA was 
removed by an on-column DNase digestion with the RNase-Free DNase Set (Qiagen, 
UK). 350l of buffer RW1 was added to the RNeasy spin column, and centrifuged 
for 15 seconds at 8000 × g. After discarding the flow-through, 80l of DNase 1 
mixture (10l DNase 1 stock solution + 70l Buffer RDD) was added to the RNeasy 
spin column membrane. The column was incubated for 15 minutes at 20-30°C 
followed by adding 350l Buffer RW1 and centrifuged for 15 seconds at 8000 × g. 
The flow-through was discarded. The column was washed twice with 500l of 
Buffer RPE at 8000 × g for 15 seconds and 2 minutes separately. To remove any 
Buffer RPE, the column was placed in a new 2 ml collection tube and centrifuged at 
full speed for 2 minutes. The column was placed in a new 1.5ml collection tube. 
RNA was eluted from the column by centrifugation at 10000 × g for 1 minute with 
30l of RNase-free water. RNA was stored at -80°C. 
The RNA integrity was checked by gel electrophoresis and quantified by 
spectrophotometry and Agilent RNA 6000 Nano Assay. 
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2.12 Gene expression analysis by RT2 first strand kit 
2.12.1 Reverse Transcription of RNA 
Genomic DNA Elimination Mixture (Qiagen, Germany) was made by mixing 0.8mg 
total RNA, 2l 5 × g DNA Elimination Buffer (Qiagen, Germany) in an RNase free 
tube, and made up to 10l by adding nuclease-free H2O. The contents were gently 
mixed by a pipettor followed by centrifugation. After centrifugation, the mixture was 
incubated at 42°C for 5 minutes, and then was chilled on ice immediately for at least 
one minute. The RT cocktail was prepared by mixing 4l 5 × RT Buffer 3, 1l 
Primer & External Control Mix, 2l RT Enzyme Mix and 3l H2O. This RT cocktail 
was added to each 10l Genomic DNA Elimination Mixture and was mixed gently 
with a pipettor. The mixture was incubated at 42°C for exactly 15 minutes and the 
reaction was stopped by immediately putting in 95°C condition for 5 minutes. The 
20l of cDNA synthesis reaction mixture was mixed well with 91l of H2O.  
2.12.2  PCR Array 
PAMM-12 PCR Array rings (Qiagen, Germany) were used to determine the 
expression levels of chemokines and their receptors. The genes containing in the 
PCR Array were listed in Appendix II. The PCR Array ring was carefully removed 
from its sealed bag and fitted into the Rotor-Disc 100 loading block using the tab at 
position A1 and the tube guide holes. 20l of the RT
2
 SYBR®  Green qPCR 
mastermix was dispensed into each well of the PCR Array wheel by the PCR robot 
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(Qiagen, Germany). The Rotor-Gene Q 100 PCR Array was carefully sealed with the 
Rotor-Disc heat sealing film using the Rotor-Disc heat sealer. The excessive sealing 
film was removed when the film was cooled down. The Rotor-Gene Q 100 PCR 
Array was inserted into Rotor-Disc 100 rotor and locked by the Rotor-Disc 100 
locking ring followed by inserting into Rotor-Gene Q real-time PCR machine. In all 
reaction, an initial denaturation step was carried out by incubation at 95°C for 10 
minutes. 40 cycles of amplification were carried out, which consisted of denaturation 
at 95°C for 10 seconds, annealing at 60°C for 30 seconds. 
The data of each run was maintained in Rotor-gene software  
2.13 Histology analysis  
2.13.1 Production of paraformaldehyde 
4g of paraformaldehyde (Sigma, UK) was dissolved in 50ml distilled deionized H2O 
and then 1ml of 1M NaOH solution was added. The mixture was stirred gently on a 
heating block (about 65°C) in the fume hood. After the paraformaldehyde was totally 
dissolved, 10ml of 10 × PBS was added and allowed the mixture to cool to room 
temperature. The pH of the mixture was adjusted to 7.4 using HCl. The solution was 
filtered through a 0.25m membrane filter to remove any particulate matter. The 
paraformaldehyde was allocated in 30ml universal, and stored at -20°C until use.  
Repeated cycles of freeze-thawing were avoided.  
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2.13.2 Preparation of frozen section of Macgreen mice  
The spleens of MacGreen mice were preserved into 4% paraformaldehyde for 2 
hours on the ice in the dark. The tissues were washed with PBS and dropped into 18% 
sucrose solution (18g sucrose (Thermo Fisher Scientific, USA) in 100ml PBS). After 
keeping for 6-8 hours at 4°C in the dark, the samples were transferred to 30% 
sucrose solution overnight. On the next day, the tissues were washed followed by 
embedding in OCT compound (Sakura Finetek, USA) in each plastic mould. The 
sample was frozen by dipping the plastic mould in liquid nitrogen using long forceps. 
When the sample was completely frozen, it was taken out from liquid nitrogen and 
pushed out from the plastic mode. The tissue was labeled and ready for sectioning. 
The remained tissue was preserved on dry ice or in -80°C freezer. 
2.13.3  Immunostaining 
2.13.3.1 Detection of binding ability of M4 protein to splenocytes 
20l of recombinant M4 protein was incubated on MacGreen splenocyte cytospin 
over night at 4°C in the dark. Then slides were washed twice with PBS containing 4% 
Tween-20 at room temperature in the dark for 10 minutes. The His-tagged M4 
protein was detected by incubation with mouse anti His-tag antibody, biotinylated 
rabbit anti mouse antibody and Alexa Fluor®  568 (Invitrogen, UK). To-Pro® -3 was 
used to stain the cell nucleus for 5 minutes. The slides were washed between each 
step as described. Then the slides were mounted and covered with cover slides 
(VWR international, USA). The fluorescent was observed by a confocal microscope. 
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2.13.4 Data analysis 
Statistics: The results were investigated by the Mann-Whitney test at the 5% level. 
PCR Array results: The RT
2
 Profiler PCR Array results were analysed through 
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3 In vitro characterization of M4 protein 
3.1 Introduction  
MHV-68 contains the ORF M4 encoding a glycoprotein known as M4 protein. The 
transcripts can be detected during the lytic and latent establishment phase in vivo and 
the protein can be detected in the medium of infected cell cultures in vitro (Evans et 
al., 2006; Marques et al., 2003; Townsley, Dutia, and Nash, 2004). The M4 protein 
may have a role in down-regulating the immune response, leading to an increase in 
viral latency during a MHV-68 early latent infection in the spleen (Evans et al., 2006; 
Geere et al., 2006). However, the roles of the M4 protein of MHV-68 during 
infection are not yet fully understood. It was therefore of interest to further 
characterize the importance of the left end of the MHV-68 genome in pathogenesis 
by specifically investigating the role of the M4 protein in vitro and during infection.  
The M4 protein has been shown to share a considerably close amino acid sequence 
similarity to the M3 protein. From the in silico analysis, it is indicated that M4 might 
share folding features with M3 (Alexander et al., 2002), suggesting M4 may have a 
similar function to M3. Large DNA viruses, such as herpesvirus and poxvirus, 
encode chemokine binding proteins to evade immune responses. The chemokine 
binding proteins have the potential to disrupt or alter chemokine signalling (reviewed 
in Webb and Alcami, 2005). M3 has an ability to bind to CC-, CXC-, C-, and 
CX3X-chemokines, thus blocking the interaction of these chemokines with their 
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receptors in vitro (Parry et al., 2000; van Berkel et al., 2000). However, M3 binds to 
CXC-chemokines at a lower activity as compared to the other three chemokine 
families (Alcami, 2003). It has also been reported that M3 blocks certain CC- and 
CXC- chemokines in vivo, which interrupts leukocyte trafficking (Jensen et al., 2003; 
Martin et al., 2006).  
A few experiments have been carried out in our lab using recombinant M4 protein to 
investigate the function of the M4 protein in vitro. The recombinant M4 protein was 
expressed using the baculovirus expression vector system (BEVS), because the 
expression of inserted foreign genes in this BEVS is facilitated by the powerful 
polyhedron promoter, and proteins are subsequently folded, modified, sorted and 
assembled correctly (Hara et al., 1986; Hitchman, Possee, and King, 2009). Although 
the recombinant M4 protein can also be produced by engineered Escherichia coli, the 
M4 protein proved difficult to produce in a soluble form even when expressed at 
various temperatures (Y. Ligertwood personal communication) (Mackay et al., 1997). 
Because poor solubility of a protein affects any high resolution structural studies and 
biochemical characterization of protein, BEVS is a better method of producing the 
M4 protein. Moreover, BEVS was also used to produce the M3 protein for studies of 
its chemokine binding function in vitro (Parry et al., 2000; van Berkel et al., 2000). 
The results of a cytokine and chemokine protein array showed that Cxcl4 levels were 
increased in the spleens of mice infected with M4stop virus compared to the WT 
virus infection, despite the transcription of Cxcl4 in spleens being the same following 
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M4stop and WT virus infections (Y Ligertwood personal communication). Therefore, 
we hypothesized that Cxcl4 in the WT virus infected spleens may be neutralized by 
the M4 protein. CXCL4 is involved in the migration of activated T lymphocytes 
which is mediated by CXCR3 (Mueller et al., 2008) and it has been shown to be 
involved in the control of a HIV-1 infection by interacting with gp120 which is 
essential for virus attachment and entry (Auerbach et al., 2012). Therefore, the 
neutralization of Cxcl4 in the spleen may be one of the immune evasion strategies 
used by MHV-68 during infection. In addition, Cxcl4, Cxcl9 and Ccl9-Ccl10 have 
been found to bind to the M4 protein in vitro (Y Ligertwood personal 
communication). Whether M4 has the ability to bind more chemokines is one of our 
interests and the results are shown in this chapter. 
The interaction of chemokine binding proteins and their ligands may come about in 
two distinct ways. First, the chemokine binding protein may block the binding of 
chemokines to their receptors，thus inhibiting chemokine-induced chemotaxis. For 
example, vCCI protein binds to a large number of CC-chemokines, blocking the 
binding sites of receptor to reduce inflammation (Alcami et al., 1998; Beck et al., 
2001; Dabbagh et al., 2000). Second, the binding of chemokines to GAGs may be 
blocked by a chemokine binding protein, therefore disturbing the local levels of 
chemokines. However, this binding mechanism is reversible. For example, the 
binding of A41 to chemokines was blocked by the overwhelming presence of 
sulphated GAGs (Bahar et al., 2008). Moreover, some chemokine binding proteins 
 Chapter 3                                      In vitro characterization of M4 protein 
95 
 
also interact with GAGs. For example, M-T1 binds to GAGs; whereas the M3 
protein and M-T7 do not bind to GAGs (Lalani et al., 1997; van Berkel et al., 2002; 
Webb, Smith, and Alcami, 2004). It has been reported that ORF M4 contains a 
heparin sulphate-binding domain (Ebrahimi et al., 2003), but the binding ability of 
M4 to heparin has not been determined. Therefore, whether the M4 protein can bind 
to GAGs and whether the M4 protein inhibits the binding of chemokine to GAGs 
were the questions that we wanted to understand in this study. 
M4 may interact with the cell membrane via proteoglycan heparan sulphate, since it 
has a heparin sulphate-binding domain (Ebrahimi et al., 2003). Additionally, a 
previous study of M4 has shown that the M4 protein has the ability to bind a small 
quantity of mouse splenocytes, which have been shown not to be T or B lymphocytes 
(Y Ligertwood personal communication). It has been reported that some chemokine 
binding proteins can bind to cell surfaces. For example, M-T1 can remain on the cell 
surface as it simultaneously binds chemokines and GAGs (van Berkel et al., 2002). 
M4 protein may bind to cell surfaces to interrupt chemokine signalling. Therefore, 
we further explored the cell population which M4 protein may bind to. 
In this chapter, we mainly focused on the function of the M4 protein in vitro. 
Moreover, we also wished to provide evidence of how M4 protein influences the 
chemokine network. 




3.2.1  The preparation of recombinant M3 and M4 protein 
To study the function of M4 protein in vitro, a M4 recombinant baculovirus strain 
was constructed in our lab that expressed the M4 ORF and was confirmed to be M4 
protein by protein mass spectrometry. A recombinant M4 protein which has a 
penta-His residues at its C terminal was secreted into the supernatant of an insect cell 
culture and purified by metal-affinity chromatography following standard protocols 
as described in Materials and Methods. Because it is known that M3 binds to human 
CXCL8, but not murine Cxcl1, Cxcl2 and Cxcl5 (Parry et al., 2000), M3 was 
selected to be used in my experiment as a positive (with CXCL8) and negative (with 
Cxcl2 and Cxcl5) control. M3 recombinant baculovirus was made from a baculovirus 
plasmid (a generous gift from Prof J.P Stewart) which contains the M3 gene under 
the control of a baculovirus promoter. The M3 coding sequence is preceded by an 
insect secretory signal which enables secretion into the medium and has a C terminal 
penta-His tag. Both M3 and M4 protein fractions were eluted from the affinity 
column with buffer containing 40mm, 125mm and 250mm imidazole. The fractions 
were characterized by SDS-PAGE and proteins were detected using an 
anti-Penta-His antibody (figure 3.1). From a western blot it can be seen that the 
concentration of M3 protein is much higher than for the M4 protein. The size of M3 
is 44 kDa in the supernatant of cell culture, whereas the predicted size of M4 is 45 
kDa (Evans et al., 2006; van Berkel et al., 1999). However, the observed molecular  











Figure 3.1  Western blotting detection of M3 and M4 proteins. Insect cells were infected with 
M3 or M4 baculovirus. The protein fractions were purified by metal affinity chromatography. 
20l of M3 or M4 protein fractions were loaded on a 10% SDS-polyacrylamide gel. Lane 1-3 
are are M3 protein fractions, and lane 4 and 5 are different M4 protein fractions. The protein 
fractions were transferred to nitrocellulose membrane by western blotting. These His-tagged 
proteins were detected by mouse anti-His antibody, biotinylated rabbit anti mouse antibody, 
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weight of M4 protein (60 kDa) may result from it being glycosylated, which may 
also interfere with the expression of M4 protein. The higher molecular size of M3 
(55 kDa) was probably the result of protein aggregation, because the M3 protein is 
not glycosylated (van Berkel et al., 1999). M1 protein was also considered as a 
negative control since it has not been shown to bind to chemokines (Seet and 
McFadden, 2002). M1 baculovirus is available to infect insect cells and encode M1 
protein in our lab. Unfortunately, the level of the M1 protein was low. Additionally, 
the M1 protein was degraded rapidly before further experiments could be carried out. 
Meanwhile, M4 protein was also difficult to produce at high concentration and 
maintain in a stable form. To characterize the binding ability of M4 protein, the 
binding of M3 protein and CXCL8 was used as a positive control; whereas the 
binding of imidazole elution buffer or M3 to Cxcl2 or Cxcl5 were used for negative 
controls. 
3.2.2 Binding ability of M4 protein with chemokines 
The binding of M4 protein to chemokines, which was mentioned in section 3.1, 
indicates that the M4 protein may be another chemokine binding protein secreted by 
MHV-68 infected cells. The results were confirmed by an ELISA carried out by 
coating chemokines onto plates. To reduce non-specific binding, the plates were 
blocked after coating. Because the concentration of M3 protein was much higher 
than M4 protein, 1l or 10l of M3 protein were used as controls, whereas 1l, 10l 
or 30l of M4 protein were used in the ELISA. The absorbance values of 1l and 
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10l of M3 proteins with chemokines were the same (about 3.2). However, the 
background absorbance values of M3 protein (without coating with chemokines) was 
2.22 for 1l of M3 protein, 3.16 (the photometric measuring range of the ELISA 
reader is 0-5.0 OD, and the linear dynamic range of the ELISA reader is 0-4.0 OD)  
for 10l of M3 protein which was much higher than the absorbance value of M4 
protein (0.84), indicating that the M3 protein may have a higher binding ability to the 
plate compared to the M4 protein and/or the concentration of 1l of M3 was much 
higher than 10l of M4 protein. The concentration of M3 and M4 proteins had not 
been quantified before the experiment; they were only predicted from the western 
blot result (figure 3.1). The ELISA results were corrected by subtracting background 
and are shown in figure 3.2. Unexpectedly, both M3 and M4 bound to murine Cxcl2, 
Cxcl5 and human CXCL8, but with various binding ability, as the binding ability of 
M4 to murine Cxcl2/Cxcl5 was higher than human CXCL8 which the M3 protein 
can bind with a high ability. In addition, the binding ability of the M3 protein to 
Cxcl2/Cxcl5 was weaker compared to CXCL8, which may explain why Cxcl2/Cxcl5 
cannot replace M3 bound 
125
I-CXCL8 in the cross-link assay (Parry et al., 2000).  
To reduce the high background of M3 and M4 proteins, the plates were coated either 
with 2l of M3 protein or 30l of M4 protein. Murine Cxcl4 was used in this 
experiment since it has been shown to bind to the M4 protein and the antibodies 
which can detect the existence of Cxcl4 had been optimized in the lab. The 
non-specific binding of Cxcl4 was 0.233 which was lower than the background seen 







      
 
Figure 3.2  The chemokine binding ability of M4 was assayed by ELISA. The sandwich 
ELISA was performed by using recombinant M4. The wells were coated with or without Cxcl2, 
Cxcl5 and CXCL8. M3 protein was used as a positive and negative control. The M3/M4 
protein was detected by anti penta-His antibody. The graph showed the absorbance value 
\above the protein non-specific binding background. The    represents the binding of M4 
protein and Cxcl2, the    represnets the binding of M4 protein and Cxcl5, the    represents 
the binding of M4 protein and CXCL8. The    represents the binding of M3 protein and Cxcl2, 
the     represents the binding of M3 protein and Cxcl5, the    represents the binding of M3 
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from M3 and M4 protein. The results are plotted in figure 3.3, which show both M4 
and M3 protein can bind to Cxcl4. However, the binding ability of M4 was far less 
than for the M3 protein, possibly because the concentration of the M4 protein was 
lower than the M3 protein even though we diluted the latter before use.  
The chemokine binding ability of the M4 protein was further investigated by using 
MACS
TM 
Technology. The reagent, methods and equipments were described in 
Material and Methods. Cxcl4 was chosen for this experiment because it has been 
shown that there was a reduction in the spleen after a MHV-68 infection and it has 
been found to bind the M4 protein in an ELISA. The other reason for selecting Cxcl4 
was because it can also be used for a competitive ELISA which will be described 
later in this chapter. The MACs
TM
 beads have a high affinity for His-tagged proteins 
and will select the His-tagged M3 and M4 proteins in the supernatant of M3 or M4 
baculovirus infected cell cultures. The supernatants were incubated with anti-His 
MACs beads, with or without Cxcl4 as described in Material and Methods. Eluted 
material was equally divided into two groups and both of them (20l each) were 
loaded on a precast gradient gel followed by western blotting. Then the membrane 
was divided into two parts to detect either using the His-tagged proteins or the 
presence of Cxcl4. The M3 protein and imidazole containing elution buffer were 
used as a positive and negative control respectively. In order to detect the 
non-specific binding of Cxcl4 to the beads, Cxcl4 was incubated with MACs
TM
 
beads without M4 protein, then eluted and examined. Similar to the M3 protein  










Figure 3.3  The chemokine binding ability of M4 was detected by ELISA. A sandwich ELISA 
was performed by coating recombinant M4 in the wells. M3 protein was used as a positive 
control and 125mM imidazole protein elution buffer was used as a negative control. The 
Cxcl4 which bound to proteins was detected by anti Cxcl4 antibody. The background 
absorbance value observed when no protein was coated onto the plate was deducted from 
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(figure 3.4, lane 1 and 4), Cxcl4 (about 10kDa) was found in the eluted M4 protein 
sample (figure 3.4, lane 2 and 5); whereas Cxcl4 was not found in the samples 
without M4 protein, indicating Cxcl4 does not bind the beads (figure 3.4, lane 3 and 
6). The bound Cxcl4 in the M4 protein sample was less than in the M3 protein 
sample, which may be because the concentration of the M3 protein used in this 
experiment was higher than the M4 protein, as the band of the M3 protein was more 
intense than that of the M4 protein. Although we understand this, the concentration 
of M3 and M4 proteins contained in the supernatant of cell culture has to be 
measured. However, the concentration of the proteins could not be measured before 
MACs
TM
, because M4 protein degrades and the protein quantification experiments 
take time to perform. 
3.2.3  Quantitation of the M3 and M4 protein. 
The binding of M3 and M4 protein to chemokines appears to be dose-dependent. We 
predicted the concentration of 20l of M3 is 10-50 folds higher than the same 
volume of M4 protein from the western blot (figure 3.1). As the ELISA showed the 
absorbance value of 1l of M3 protein with Cxcl2/Cxcl5 was lower than 10l of M4 
protein with Cxcl2/Cxcl5, it is possibly that the M4 protein binds to Cxcl2/Cxcl5 
with a higher ability than M3 protein. Therefore, it was necessary to quantify the 
concentration of these proteins. In order to find out the concentration, the 
quantification of M3 and M4 was carried out by comparing band strengths with 2.5l 
of a 6 x His-tagged protein ladder where the amount of each protein band was known  









                           Anti 6 × His-tag     Anti Cxcl4 
                       
Figure 3.4  The chemokine binding ability of M4 was detected by MACS
®
 Technology. 
Supernatant from M3 or M4 baculovirus infected cells was incubated with anti-His MACs 
beads in the presence of Cxcl4. Cxcl4 was also incubated with beads alone. After washing, 
20l of each eluted material was loaded on the gradient precast gel in duplicate, and the gel 
was run at the same time. Lane 1, 2, 3 were used to detect his-tagged protein by mouse 
anti-his antibody. Lane 4, 5, 6 were used to identify Cxcl4 by rat anti Cxcl4 antibody. Lane 1 
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(figure 3.5). The M3 protein was serially diluted in imidazole containing elution 
buffer and the most diluted M3 protein sample contained 0.375l M3 protein (figure 
3.5, lane 1-5). Meanwhile, 20l of neat M4 protein was loaded on the same gel 
(figure 3.5, lane 6). Then the density of the M3 protein (lower band) and M4 protein 
was analysed by ImageJ and compared to a 50 kDa marker band which is 50ng per 
2.5l. The marker was set to be 100%, thus the 20l of M4 protein contained about 
493% (246ng) and 0.375l of M3 protein was about 1032% (516ng). Therefore, the 
concentration of 1l of M3 protein was about 11 times that of 10l of M4 protein. 
Therefore, it may explain the reason that 1l or 2l of M3 protein bound more 
chemokine than 10 l or 30 l of M4 protein in the ELISA assay. In order to compare 
the binding affinities between the M3 and M4 proteins, it would be better to dilute 
the M3 protein down to the same concentration as the M4 protein. Unfortunately, due 
to time constraints, and the poor stability of M4, this experiment has not been 
performed. 
3.2.4 M4 protein cannot bind to GAGs 
Some chemokine binding proteins also binds GAGs through the GAGs binding 
domain (van Berkel et al., 2002). It has been predicted that the M4 protein also 
contains this binding domain (Ebrahimi et al., 2003), therefore, it may have an ability 
to bind GAGs. In order to examine the binding ability of M4 protein to GAGs, an 
ELISA was performed using the M4 protein and heparin-biotin (a kind of highly 
sulfated GAGs and widely used as a GAGs substitute) as described in material and 
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Figure 3.5  The quantity of M3 and M4 protein was measured by His-tagged protein ladder. 
Serially diluted M3 protein was loaded on lane 1-5, and the most diluted sample (lane 5) 
contained 0.375l of M3 protein. The quantity of M4 protein was checked on lane 6 which 
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methods. For this experiment Cxcl4 was used as a positive control, because it is 
widely known that Cxcl4 has a high activity for binding with heparin (Mayo et al., 
1995). Binding of M4 protein to GAGs could not be detected (data not shown), while 
the binding of the parallel positive control was successful (figure 3.6).  
3.2.5 Competitive character of M4 protein 
It has been reported that chemokine binding proteins, such as the M3 protein 
(Alexander-Brett and Fremont, 2007; Webb, Smith, and Alcami, 2004) and 
alphaherpesvirus gG (Bryant et al., 2003) inhibit the binding of chemokines to both 
chemokine receptors and GAGs. The binding activity of M3 protein to chemokines 
was stronger than the binding of chemokines to GAGs, because the M3 protein can 
displace chemokines from the pre-established chemokine-GAGs complex (Webb and 
Alcami, 2005). We have shown that the M4 protein has the ability to bind 
chemokines, and it would be interesting to investigate the ability of the M4 protein to 
inhibit binding of chemokine to GAGs.  
To investigate whether the M4 protein inhibits the binding of chemokines and GAGs, 
heparin-biotin, Cxcl4 and the M4 protein were used in a competitive ELISA as 
described in Materials and Methods. The M3 protein was used as a positive control 
and imidazole containing elution buffer was used as a negative control in this 
experiment. The heparin-bound Cxcl4 was detected by rat anti Cxcl4 antibody and 
results are plotted in figure 3.7, which showed increasing the amount of M4 protein  








Figure 3.6  ELISA for detecting Cxcl4’s GAGs binding ability. Heparin-biotin was used as a 
highly sulfated GAGs. A streptavidin plate was used to bind heparin-biotin onto the plate. After 














   
 
Figure 3.7  The ability of M4 protein to prevent binding of chemokine to GAGs was 
investigated by competitive ELISA. Diluted M4/M3/imidazole and Cxcl4 mixture was 
incubated in heparin coated wells overnight. The Cxcl4 which bound to the heparin was 
detected by anti-Cxcl4 antibody after washing. The purple square is imidazole negative 
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led to a decrease in the heparin-bound Cxcl4, indicating the binding of Cxcl4 and 
heparin was interrupted by the M4 protein. As expected, the M3 protein largely 
reduced the binding of Cxcl4 to GAGs. Since we have shown that M4 protein does 
not bind GAGs, we can exclude the possibilities that (1) M4 protein blocks the 
binding site of GAGs for Cxcl4 and (2) M4 has different binding domains which can 
bind GAGs and Cxcl4 at the same time. 
3.2.6 M4 protein binds to splenocytes 
Some studies have found that the M4 protein can interact with a small population of 
splenocytes, which have been shown to be neither T cells nor B cells (Y. Ligertwood 
personal communication). Since M4 cannot bind GAGs, other mechanisms such as 
binding with the cell-membrane receptor or cell-membrane bound chemokines may 
be involved in. Cxcl2 and Cxcl5 are the ligands of Cxcr2, which is expressed on 
neutrophils and macrophages. As we showed M4 protein binds to Cxcl2 and Cxcl5, it 
is possible that the binding of Cxcl2/Cxcl5 to Cxcr2 mediates the binding of M4 
protein to neutrophils and macrophages. Moreover, considering the size of the 
splenocytes to which the M4 protein binds, macrophages were thought to be the most 
likely cell population. Therefore, in order to investigate whether the M4 protein binds 
to macrophages or neutrophils, immunostaining was carried out using MacGreen 
mice which have enhanced green fluorescent protein (EGFP) expressed in 
macrophages and granulocytes (Sasmono et al., 2007; Sasmono et al., 2003). The 
spleens were harvested from uninfected MacGreen mice and the splenocytes were 
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prepared for cytospins. The M4 protein was incubated with the monolayer of 
splenocytes on a slide overnight then detected by rabbit anti M4 antibody. Imidazole 
containing elution buffer was used as a negative control. The results showed M4 can 
bind with a small population of cells, but they are not macrophages or granulocytes 
(figure 3.8). The cellular type to which the M4 protein binds still needs to be further 
investigated.  
3.3 Discussion 
This study confirmed that the M4 protein is a chemokine binding protein and 
further investigated the function of the M4 protein in vitro. We utilized recombinant 
M4 protein tagged with a C-terminal penta-His, made by a baculovirus expression 
system to study the function of M4. It showed that recombinant M4 protein has the 
ability to bind murine Cxcl2, Cxcl4, Cxcl5 and human CXCL8 with different binding 
affinities. Apparently, the binding activity of the M4 protein to human CXCL8 is 
much lower than the other two chemokines which the M3 protein binds poorly (Parry 
et al., 2000). Moreover, the binding activity of the M4 protein to CXC-chemokines is 
higher than with the M3 protein. A similar situation is found with M-T1 and 
M-T7,which are both secreted from the poxvirus myxoma and have different 
chemokine binding affinities (Graham et al., 1997; Lalani et al., 1997) and the 
binding sites of these two chemokine binding proteins are different (van Berkel et al., 
2000). Therefore, it is not astonishing to find two chemokine binding proteins 
encoded from the same virus. The crystal structure of M3 protein showed that the  








Figure 3.8   Staining for binding of M4 with splenocytes. Cytospins were made with 
splenocytes from uninfected MacGreen mice which have EGFP in the macrophages (bright 
green) and granulocytes. Orange arrows in A and B indicates macrophages, and yellow 
arrows in A and B indicate granulocytes. After incubation with M4 protein (B, D, F) or elution 
buffer control (A, C, E) the bound protein was detected by rabbit anti M4 antibody, a second 
biotinylated antibody and Alexa Fluor®  568 (C and D). E and F show the overlaid picture of 
the fluorescent and shape and location of the cells seen through white light. White arrows 
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dimerization of M3 generates a binding site for chemokines (Alexander et al., 2002), 
indicating that M4 may need a specific structure to maintain its function. Therefore, 
the experiments which were performed in vitro were limited, because at lower 
concentrations the M4 may lose the structure which benefits the binding of 
chemokines.  
Moreover, we found that M4 can inhibit the binding of chemokine to GAGs, 
indicating that the M4 protein may influence the chemokine gradient which is 
established by GAG molecules on the surface of endothelial cells, thus reducing the 
chance of recruiting leukocytes to the inflammation sites. As we know, murine Cxcl2, 
Cxcl5 and human CXCL8 all have the same receptor, CXCR2, which is expressed on 
neutrophils and macrophages and is related to inflammation. Therefore, the decrease 
in latent virus load in the spleen during a M4stop virus infection at day 14 p.i. (Evans 
et al., 2006; Geere et al., 2006) may be because of the increase of leukocytes at the 
infected sites where the virus was cleared by phagocytosis and degranulation. The 
percentages of leukocytes have been described in the experiments in the later 
chapters of this thesis. There are several chemokine binding proteins involved in 
inhibiting the binding of chemokines and their receptors (Webb and Alcami, 2005). 
A recent study found some chemokine binding proteins can enhance chemotaxis 
(Coscoy et al., 2012). It would be interesting to know the function of M4 protein 
during chemotaxis. 
This study also revealed that the M4 protein does not have a binding ability for 
 Chapter 3                                      In vitro characterization of M4 protein 
114 
 
GAGs, which excluded the possibility that the M4 protein and Cxcl4 bind to the 
same site on GAGs so that the M4 protein can inhibit the binding of Cxcl4 to GAGs. 
It also excludes another possibility that M4 can bind with GAGs and Cxcl4 at the 
same time. This characteristic is like the M3 protein and vCCI (Parry et al., 2000; 
Webb and Alcami, 2005), but not like M-T1 which is the only known chemokine 
binding protein which can bind GAGs at the same time (van Berkel et al., 2002). 
M-T7 and heparin can both bind the C-terminal of CXCL8, whereas M-T7 utilized 
the N-terminal of CXCL8 to stop it binding with its receptor (Lalani et al., 1997). In 
addition, the M3 protein exploited the same binding domain (N-terminal) of CXCL8 
(Webb, Clark-Lewis, and Alcami, 2003) as M-T7. But we cannot rule out the 
possibility that M4 protein binds to Cxcl4 through the same residues as the 
chemokine-GAG binding site presumably located within the lysine-rich, C-terminal 
region of the chemokine (Stuckey, Charles, and Edwards, 1992; Ziporen et al., 1998). 
Therefore, it would be interesting to know the binding domain of M4 protein to 
chemokines. 
Interestingly, binding with chemokine and blockage of the chemokine-GAGs 
interaction seems not to be the only function of M4 protein, it may have other 
unknown functions, such as interacting with cells directly. At beginning, we 
hypothesised M4 may bind to neutrophils or macrophages. After examination, we 
found the cells were not neutrophils or even not granulocytes by staining the 
MacGreen mice splenocytes with bound M4 protein. As a chemokine binding protein, 
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M4 protein may have an ability to bind to cell membrane-bound chemokine, such as 
CX3CL1. However, the binding ability of M4 protein to CX3CL1 has not been 
determined. Moreover, it has been reported that vaccinia virus secreted viral IFN-α/β 
receptor can bind to both infected or uninfected cells (Alcamı́, Symons, and Smith, 
2000). Therefore it may possibly be that M4 protein binds to a certain cell surface to 
mimic the chemokine receptor, competitively attracts chemokines and stops the 
cellular signal transduction which is induced by chemokines.  
The experiments described in this chapter point to some roles for the M4 protein in 
vitro. The binding ability of M4 is somewhat different from the M3 protein, which 
indicates that M4 appears to be complementary to the M3 protein. The decrease of 
Cxcl4 in the spleen of WT virus infection can be explained by the chemokine 
binding of the M4 protein, but we do not know the reason for this. In addition, we 
found that the M4 protein can break the gradient of chemokines by inhibiting the 
binding of chemokine-GAGs. This might reduce inflammation and provide a better 
environment for viral lytic and latent infections. Therefore, the inflammation 
following infection was investigated in vivo in the next chapter. The binding of M4 
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4 M4 affects the viral lytic and latent infections 
4.1  Introduction  
M4 is an IEG transcribed immediately after infection and independently of de novo 
protein synthesis in vitro (Ebrahimi et al., 2003; Townsley, Dutia, and Nash, 2004). 
The transcription of M4 can be detected in the lung and spleen during the lytic and 
acute-phases of latent infection up to day 14 p.i. (Marques et al., 2003; Townsley, 
Dutia, and Nash, 2004). Following infection with M4 expressing MHV-76 mutant 
virus (MHV-76inM4), there is an increase in viral load in the lungs and a higher level 
of viral DNA load in the spleens during early time points compared to MHV-76 
infection (Townsley, Dutia, and Nash, 2004). To study the function of M4 protein 
further, a recombinant M4 non-coding (M4stop) virus was generated in our lab using 
BAC techniques with the insertion of three stop codons in the ORF (Geere et al., 
2006). In M4stop virus, ORF M3, which is adjacent to ORF M4, is not disrupted as 
verified by real-time reverse transcription PCR (Geere et al., 2006). Moreover, the 
M4stop virus should have fully functional vtRNAs and miRNAs as they are not 
affected by the modification. Therefore, the pathogenic changes caused by M4stop 
virus are due to the lack of M4 protein. The same kinetics of replication have been 
reported among M4stop, WT and revertant viruses in vitro (Geere et al., 2006). 
Moreover, there is little difference in viral loads in the lungs of BALB/C mice 
following M4stop and WT virus infection at days 1, 3, 5, 7 and 10 p.i. (Geere et al., 
2006). However, Evans et al (2006) find that M4stop virus decreased significantly in 
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the lung compared to WT virus infection at day 9 p.i.. (Evans et al., 2006). The 
conflicting results may be because the latter chose a different time point and/or a 
different mouse strain, since the immune response is different between strains. 
However, in both studies, the latency of viruses in the spleen is similar at day 10 p.i.. 
Thereafter, a rapid decline of the latent M4stop virus is detected in the spleen around 
day 14 p.i. as compared to WT virus infection (Evans et al., 2006; Geere et al., 2006). 
During long term latency, there is no difference in the viral DNA loads in the spleen 
or the number of splenic cells that have a reactivation ability between the two viral 
infections (Evans et al., 2006).  
MHV-68 latent infection in the spleen is associated with splenomegaly (Usherwood 
et al., 1996). It has been reported that splenic lymphocytosis depends on the presence 
of an intact left end of the unique region of the MHV-68 genome (Chalupková et al., 
2008; Macrae et al., 2001). M4 does not appear to be required for splenic 
lymphocytosis (Geere et al., 2006; Townsley, Dutia, and Nash, 2004). However, 
Evans et al (2006) have found that there is less splenomegaly in C57Bl/6 mice 
following infection with M4 mutant virus at a different time point. The relative 
proportions of splenic cell populations following M4stop virus infection has not been 
examined in these studies.  
It has been demonstrated that the expression of chemokine binding protein M3 
during MHV-68 infection in the central nervous system interferes with the trafficking 
of lymphocytes and macrophages (Jensen et al., 2003; van Berkel et al., 2002). In 
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Chapter 3, we showed that M4 protein binds to several neutrophil-, macrophage-, and 
T cell-trafficking associated chemokines, and M4 protein can prevent the formation 
of chemokine gradients. Therefore, M4 may influence the migration of neutrophils, 
macrophages and T cells from lymphatics to the spleen. It has been found that 
macrophages and B cells harbor MHV-68 in a latent form (Flano et al., 2000), 
therefore, the proliferation of B cells and macrophages would affect the viral burden. 
In this study, in order to understand whether splenomegaly was caused by the same 
cell populations and whether the decrease in the M4stop viral latency was due to a 
change in B cell and macrophage populations, the percentages of lymphocytes, 
macrophages and neutrophils were evaluated by flow cytometry during the early 
latency of M4stop and WT virus. MacGreen mice are c-fms transgenic mice, which 
express EGFP in macrophages and granulocytes of all tissues, although the EGFP is 
expressed in relatively lower levels in granulocytes compared to macrophages 
(Sasmono et al., 2003). In this chapter, MacGreen mice were used to examine the 
locations of macrophages and granulocytes in the spleens following M4stop and WT 
virus infections.  
It has been reported that chemokines play an important role in T cell activation in 
vitro (Bacon et al., 1995; Taub et al., 1996). Chemokines and their receptors increase 
the basal motility of lymphocytes, increasing the chance for lymphocytes to 
encounter antigen presenting cells, such as dendritic cells. In addition, the interaction 
of dendritic cells with CD4
+
 T cells or natural killer T (NKT) cells results in the 
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release of chemokines from dendritic cells which enhances the recruitment of CD8
+
 
T cells (Kurts et al., 2011). The activated lymphocytes are capable of responding to 
antigens and producing large quantities of cytokines or antibodies to control the 
infection. Moreover, the absence of CCL5 reduces the cytotoxicity of CD8
+
 T cells 
and compromises cytokine production, leading to a higher viral load in chronic 
lymphocytic choriomeningitis virus infection (Douek et al., 2011). The activation of 
T-, B- and NK-lymphocytes, which are induced by M4stop virus infection during the 
early phase of latency, remains to be investigated. As M4 protein has the ability to 
bind chemokines, we hypothesized that the presence of M4 may reduce lymphocyte 
activation, resulting in increased WT viral latency in the spleen. Therefore, the 




 T cells, B cells, NK cells and macrophages in 
the spleens following WT and M4stop virus infections were examined and compared. 
The aims of this study were to (1) determine whether M4 affects MHV-68 infection 
in the lung; (2) examine whether M4 alters the proliferation or migration of 
splenocytes in the spleen; and (3) understand the mechanisms that control M4stop 
virus infection in the spleen. 
4.2 Results 
4.2.1 Acute viral infection in the lung 
After intranasal MHV-68 infection, virus replicates in the alveolar epithelium and 
induces an inflammatory infiltrate in the lung. Afterwards, the virus is cleared around 
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day 10 p.i. by a T cell dependent mechanism (Cardin et al., 1996; Ehtisham, 
Sunil-Chandra, and Nash, 1993). The presence of chemokine binding protein M3 in 
the lung of wood mice supports lytic infection in the lung (Hughes et al., 2011). 
Since M4 was shown to possess the ability to bind to CXC-chemokines in Chapter 3 
and the expression of M4 protein is detectable during acute infection (Marques et al., 
2003; Townsley, Dutia, and Nash, 2004), it could possibly influence the host immune 
response in the lung. To investigate the function of M4 in the acute infection, age- 
and sex- matched BALB/c or 129Sv mice were intranasally infected with 4 × 10
5
 
PFU of either WT or M4stop virus. All experiments used three or four mice per 
group.  
4.2.1.1 Viral loads in the Lung  
The role of M4 during the lytic infection in the lung has been examined by Evans et 
al (2006) and Geere et al (2006). The results were not comparable possibly because 
of the different mouse strains, various time points, and distinct infection dose. Hence, 
the viral loads in the lungs following M4stop and WT virus infections were 
examined in this study during the lytic stage of the infections. To compare the viral 
replication kinetics in the lung, lungs were harvested at (1) days 7 and 10 p.i.; (2) day 
8 p.i. after M4stop and WT virus infections and homogenised. The diluted lung 
homogenate was co-cultured with BHK-21 cells as described in Materials and 
Methods. The plaques were counted and the results are plotted in figure 4.1. At day 7 
p.i., the viral loads in lungs of mice infected with M4stop were indistinguishable 
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from those infected with WT virus (figure 4.1a). However, the viral loads of M4stop 
virus infected mice decreased at day 8 p.i. as compared to WT infection (figure 4.1b). 
By day 10 p.i., the infected mice had so little virus in the lungs that they were below 
the detection limit of the plaque assay (figure 4.1a). The results of days 7 and 10 p.i. 
were consistent with Geere et al (2006)’s finding, which showed that WT and 
M4stop virus had similar replication kinetics in the lungs of BALB/c mice. It 
indicated that during lytic infection in the lung, by day 7 p.i., M4 is completely 
dispensable for MHV-68 replication. The results of day 8 p.i. were more close to the 
finding of Evans et al (2006) that the loss of M4 protein caused a more rapid 
clearance of virus during the late lytic phase of the infection in the lung. However, 
this time point was only examined once in this study. It would therefore be necessary 
to repeat this experiment to confirm the result, however due to time constraints, this 
was not possible. 
4.2.1.2 Inflammation of the lung following infection 
The decrease in M4stop viral loads may be related to overwhelming host 
inflammation, since M4 protein was shown to bind macrophage- and 
neutrophil-migration chemokines in the Chapter 3 and the lack of M4 protein may 
trigger an increase of neutrophils and macrophages. Therefore, more neutrophils and 
macrophages may be found in the BAL of the mice infected with M4stop compared 
to WT. To determine whether M4 protein altered inflammation of the lung, BAL 
samples were taken and sampled at day 3, 7 and 10 p.i. from BALB/c mice, which 
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Figure 4.1  Viral loads in the lungs of M4stop or WT-inoculated mice. 129Sv mice were 
intranasally infected with 4 × 10
5
 PFU of either WT or M4stop. Lungs were harvested at days 
7 and 10 p.i. (a) or day 8 p.i. (b). The amount of virus is quantitated by plaque assay on 
BHK-21 monolayers. The black bars donate the median; dotted line represents the limit of 
detection of the assay; D represents day. Each symbol denotes an individual animal. Groups 
that have mean values that vary significantly (p<0.05) by Mann-Whitney test are indicated by 
*. 
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were infected with either M4stop or WT virus. The BAL was fixed on the slides  
and examined by hematoxylin and eosin (HE) staining. Similar inflammation was 
detected in the lungs of BALB/c mice infected with either M4stop or WT virus at 
defined time points (data not shown). Unfortunately, we did not have the BAL 
samples at day 8 p.i. when the viral loads were significantly different. Moreover, it 
would be more accurate to determine the percentage of the neutrophils and 
macrophages in the BAL by flow cytometry. 
4.2.2 Latent infection in the mediastinal lymph nodes 
MHV-68 spreads to the lung draining lymph nodes, MLNs, then establishes latency 
in B cells, macrophages and dendritic cells in the MLNs (Nash et al., 2001). The 
latent virus can be detected from day 6 p.i. and is maintained until late time points 
(Cardin et al., 1996).  
Cellular activation in the MLNs reflects the host immune response to the initial 
seeding of virus and viral latency. CD69 is an early activation marker, which is 
transiently expressed on activated lymphocytes. It can, therefore, indicate the 
activation and/or differentiation of T cells and the activation of NK cells (Hara et al., 
1986; Lanier et al., 1988; Testi, Phillips, and Lanier, 1989). An increased expression 
of CD69 is found on B cells in the draining lymph nodes and spleens, which was 
dependent on the presence of CD4
+
 T cells (Stevenson and Doherty, 1999). To assess 




 T cells, B 
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cells and NK cells in the MLNs, MLNs were harvested at days 3 and 7 p.i.. The size 
of MLNs at day 7 p.i. was greater than at day 3 p.i., which may be due to the 
proliferation of lymphocytes (data not shown). The cells from MLNs were directly 
double-stained with fluorescent conjugated anti-CD69 and anti-CD4, anti-CD8, 
anti-CD19 (CD19 is a B-cell-specific marker whose expression is detectable as early 
as the pro-B-cell stage and subsequently in all further stages of B-cell development 
until the plasma cell stage), or anti-CD49b (pan-NK cells antibody) antibodies and 





 T cells, B cells and NK cells in the MLNs between M4stop and WT virus 
infection groups at each time point (figure 4.2). An increase in the percentages of 
CD4
+ 
T cells was found at day 7 p.i. compared to the result of day 3 p.i. (figure 4.2a) 
that may be because the number of CD4
+
 T cells in the MLNs was increased 
following infection with MHV-68 (Christensen and Doherty, 1999). However, 
because the total cell number in MLNs was not determined in this experiment, the 




 T cells, B cells and NK cells between the 
two viral infections was unclear. The activation percentage is assessed by the 




 T cells and B cells and the percentage 





 T cells and B cells were comparable in the MLN between M4stop and WT 




 T-cells and 
B-cells was significantly decreased in the MLNs at day 7 p.i. when compared to day  





Figure 4.2  Percentages of lymphocytes in the MLNs of M4stop or WT virus infected mice. 
BALB/c mice were infected with 4×10
5





 T cells, CD19
+
 B cells and CD49
+
 NK cells in mediastinal lymph 
node were determined by flow cytometry at days 3 and 7 p.i. (a) CD4
+
 T cells (b) CD8
+
 T cells 













 T cells and B lymphocytes in the total 
population of each cellular subset. BALB/C mice were infected with 4×10
5
 PFU of WT or 
M4stop intranasally. The percentages of activated CD4
+
 T cells, CD8
+
 T cells and CD19 B 
cells in mediastinal lymph node were identified by surface marker CD69
+
 using flow cytometry 
at days 3 and 7 p.i. (a) CD4
+
 T cells (b) CD8
+
 T cells (c) B cells. The black bar shows the 
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3p.i..The percentages of CD69
+
 B cells were consistent with Stevenson et al (1999)’s 
report. The decrease in the percentages of activated lymphocytes may be due to high 
proliferation of the lymphocytes or may be because of decreased cellular activation 
following the decrease in viral loads in the MLNs. Moreover, it would be quite 
interesting to know the percentages of these lymphocytes, the level of cellular 
activation and the viral loads in the MLNs during the M4stop and WT infections at 
day 8 p.i., when the increased WT viral loads were found in the lungs. However, the 
difference in the viral loads in the lung at day 8 p.i. was obtained from my last 
experiment, and no further study has been done. 
4.2.3 The role of M4 during the early phase of the latent infection in 
the spleen 
As no clear difference in host immune response was detected in the MLNs of mice 
infected with either M4stop or WT virus at the indicated time points, it was unlikely 
that M4stop infection was controlled by activated T cells. Therefore, the study of M4 
protein was moved to the next infection stage, the early latent phase of infection in 
the spleen. M4 protein is also essential for the establishment of the acute latency, 
because it has been shown that the latency of M4stop in the spleens is comparable to 
the WT at day 10 p.i., then decreased suddenly by day 14 p.i. (Evans et al., 2006; 
Geere et al., 2006). The functions of M4 during early latency were examined in this 
study. 
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To assess the role of M4 in the early latent infection, age- and sex- matched 129Sv 
were intranasally infected with 4 x 105 PFU of WT or M4stop virus. Mice were 
sacrificed at (1) days 7, 10, 14 and 17 p.i.; (2) days 10, 12 and 14 p.i.; and (3) days 8, 
10, 12 and 14 p.i.. Three or four mice were used in each group. Because it would be 
interesting to understand the change of host immune response after infection, a 
negative control group, which was inoculated with same amount of PBS, was used 
and named mock in this study. Only the 129Sv strain was used in this experiment, 
because IFN-R
-/-
 129Sv mice were allocated to use in other experiments in the 
future, thus results from IFN-R
-/-
 mice could be compared with the results of 129Sv 
infection. 
4.2.3.1 Viral DNA loads in the spleens 
The viral loads in the spleens of the mice infected with M4stop and WT virus were 
examined by Geere et al (2006) from day 10 p.i.. The reduction of the M4stop viral 
load was found in the spleens around day 14 p.i. (Evans et al., 2006; Geere et al., 
2006). In my study, viral loads were also determined to correlate with the results of 
cellular percentages and cellular activation. The viral loads were quantified by 
examining the amount of viral DNA by qPCR. Then, the results were normalized to 
GAPDH realtime PCR results. The results from all three experiments were combined 
and are shown in figure 4.4.  
The virus loads were consistent with Geere et al (2006)’s results that a significant  









Figure 4.4  Viral DNA loads in the spleen. The results were combined from three different 
experiments. Viral DNA of WT and M4stop obtained from latently infected splenocytes, 
analysed by Realtime PCR at (1) days 7, 10, 14 and 17 p.i. and (2) days 8, 10, 12 and 14 p.i. 
and normalized to GAPDH. The genomic load in the spleens of MHV-68 infected animals was 
measured by quantitative PCR of the ORF73 gene. Each symbol represents a mouse. The 
black bar shows the median of two to twelve mouse replicates, and D denotes day. Groups 
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decrease (p<0.0001) of viral loads was found in the spleens infected with M4stop  
virus at day 14 p.i. compared to that of WT virus infection. That aside, a significantly 
increased (p<0.05) viral load was found in the M4stop-infected spleens at day 8 p.i. 
at the first time.  
4.2.3.2 Infectious centre of the infected splenic cells 
In previous reports the number of infectious centres of WT-infected splenic cells is 
significantly higher than M4stop virus infection when examined at days 14 and 16 p.i. 
(Evans et al., 2006; Geere et al., 2006). Because the kinetics of viral pathogenesis 
may be different between mouse strains, splenic cells, which are able to reactivate 
MHV-68, were examined by infectious centre assay and compared between viral 
infections. 129Sv mice were sacrificed at days 7, 10, 14 and 17 p.i.. The spleens were 
harvested and the latent virus in the spleens was determined as described in Materials 
and Methods. The results are plotted in figure 4.5, which shows a significant 
decrease in number of infectious centres of M4stop in the spleens of 129Sv mice at 
days 14 and 17 p.i. (P<0.05). Similar to the results of viral DNA loads, WT virus 
infection exhibited approximately a 10-fold higher number of latently infected cells 
at day 14 p.i. compared to M4stop virus infection. This indicates the decrease in 
M4stop latency is not due to a reduced reactivation ability of this mutant virus. The 
increased viral latency during the M4stop infection at days 8 p.i. suggested that 
M4stop may stimulate a more aggressive anti-viral response than WT infection, 
which may control the M4stop virus during latency. 









Figure 4.5  Infectious centre in the spleen. 129SV mice were infected with 4 × 10
5
 PFU of 
M4Stop or WT virus intranasally. Spleens were removed at days 7, 10, 14 and 17 p.i. and 
virus load was determined by infectious center assay. The black bar shows the median of four 
mouse replicates, and D denotes day. Groups that have mean values that vary significantly 
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4.2.3.3 Viral induced splenomegaly 
The weight of the spleens was measured at days 7, 10, 14 and 17 p.i.. An expansion 
of lymphocyte numbers which causes the splenomegaly was observed in both viral 
infections after day 7 p.i., compared to the spleen weight of the negative control. 
Evans et al (2006) reported significantly less splenomegaly in animals infected with 
M4stop at day 16 p.i. as compared to WT. In this study, less splenomegaly was found 
in the mice infected with M4stop at days 14 p.i. and 17 p.i. compared to that of mice 
infected with WT virus, however, this was not significant (p=0.057 and 0.1 
respectively) (figure 4.6). The different results may be due to the different time 
points. Moreover, the virus titre used for my in vivo experiment was different from 
Evans’s et al (2006) published data. 
4.2.3.4  Percentages of lymphocyte subsets 





 T cells and B cells (Usherwood et al., 1996). The infection of mice with 
M4stop virus leads to a similar splenomegaly to WT, but it is still unknown whether 
the same cellular types lead to the splenomegaly during M4stop infection. In order to 




 T cells, and B cells were determined in 
all three experiments by flow cytometry, whereas the percentages of NK cells were 
measured in the first two experiments. The percentages of cellular subsets in the  
spleens were recorded by flow cytometry and are presented in figure 4.7. Compared 
to day 7 p.i., decreased percentages of CD4
+
 T cells and B cells were found after 








Figure 4.6 Viral induced splenomegaly. 129Sv mice infected with 4×10
5
 PFU of WT and 
M4stop virus were sacrificed at days 7, 10, 14 and 17 p.i., and the spleens weighed. 
Splenomegaly was found following infection with both viruses after day 7 p.i.. The black bar 
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viral infection (figure 4.7a and 4.7c), which may be because the proliferation rate of 
these cell types was not as high as the other cellular types during splenomegaly, 
therefore the percentages were reduced. In contrast, an expansion in the percentage 
of CD8
+





 T cells in the spleens of the WT-infected mice were 
higher than that of M4stop-infected mice (p<0.05) at day 14 p.i. when the difference 




 T cells may play an 
important role during MHV-68 infection.  
4.2.3.4 Percentages of macrophages and neutrophils  
Cxcl2 and Cxcl5 are potent neutrophil chemoattractants in mice (Lin et al., 2007; 
Walz et al., 1991). In Chapter 3, M4 protein was shown to bind Cxcl2 and Cxcl5, 
suggesting that the migration of neutrophils may be affected by M4 protein during 
infection. To investigate this assumption, the percentages of neutrophils were 
examined in the spleens after M4stop and WT virus infection. Because MHV-68 
establishes latency in macrophages (Flano et al., 2000), increased proliferation of 
macrophages could increase viral latency. Moreover, macrophages express Cxcr2, 
which is the receptor for Cxcl2 and Cxcl5. Therefore, it is important to know if there 
are any differences in the percentage of macrophages during viral infections. To 
examine the percentages of neutrophils and macrophages, 129Sv mice were infected 
and sacrificed at (1) days 10, 12 and 14 p.i.; (2) days 8, 10, 12 and 14 p.i.. The 





           
 
 
Figure 4.7  Percentages of cell types in the spleens. Samples of splenocytes from the mice 
which were infected with either M4stop or WT virus were stained by anti-CD4, CD8, CD19 
and CD49b antibodies and analysed by flow cytometry to determine the percentage of each 
population. (a) CD4
+
 T cells (b) CD8
+
 T cells (c) CD19
+
 B cells (d) CD49b
+
 NK cells. One 
mouse was used as a negative control. The black bar shows the median of four to twelve 
mice replicates, D denotes day. Groups that have mean values that vary significantly (p<0.05) 
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splenocytes were double-stained with anti-CD11b and anti-Ly6G antibodies. Then 









. The percentages 
of neutrophils and macrophages in the spleens are shown in figure 4.8. Comparison 
of the percentage of neutrophils indicated no differences between M4stop-infected 
and WT-infected mice (figure 4.8a).  
One chemotaxis study has found that the reduction of Cxcl2 and Cxcl5 did not 
completely inhibit the recruitment and migration of neutrophils, because other 
neutrophil chemoattractants, such as Cxcl1, also contributed to the recruitment of 
neutrophils (Lin et al., 2007). This may explain why M4 protein can bind Cxcl2 and 
Cxcl5, but the lack of M4 protein does not influence the recruitment of neutrophils. 
Interestingly, there was a significant decrease in the percentage of macrophages in 
the spleens of the mice infected with M4stop at day 14 p.i. in comparison to that of 
WT infection (p<0.05) (figure 4.9b). As splenic macrophages are reservoirs of latent 
MHV-68, the decrease in macrophages may be related to the decreased M4stop viral 
loads. 
In order to know the location of the macrophages in the spleen following M4stop and 
WT virus infection, MacGreen mice were infected and then sacrificed at days 10, 12 
and 14 p.i.. The spleens were manipulated as described in Materials and Methods and 
frozen sections were cut using a cryostat microtome. Fluorescent macrophages and 
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granulocytes in the spleens were observed using a confocal microscope. The results 
are shown in figure 4.9. The B follicles were enlarged and started to form GCs after 
infection. The GCs of the WT-infected mice exhibited more macrophages at days 10 
and 12 p.i. compared to M4stop virus infection. Unfortunately, the expansion of the 
GC macrophages was not clear on day 14 p.i., due to the green fluorescence being 
too faint. It would be better to stain the GC B cells to study the interaction of 
macrophages and B cells. M4 protein may influence the migration of macrophages. 
4.2.3.5  Cellular activation in the spleens 
The activation of T lymphocytes reflects the control of infection by the host immune 
system (Gredmark-Russ et al., 2008). CD8
+
 T cells play a key role in controlling 





 T cells control MHV-68 reactivation during persistent infection 
(Cardin et al., 1996; Ehtisham, Sunil-Chandra, and Nash, 1993). Increased NK cell 
percentage were found after MHV-68 infection, therefore, the activation status of NK 
cells was also compared between the two viral infections, although NK cells may not 
be associated with the virus clearance mechanism in the spleen (Thomson et al., 2008; 





) in the spleen (Moser et al., 2005; Stevenson and 
Doherty, 1999). Therefore, the detection of activated B cells reflects the infection of 
B cells. There were two hypotheses about how WT virus successfully escapes 
immune responses and establishes latency at day 14 p.i.. One hypothesis was that M4  




Figure 4.8  The percentages of neutrophils and macrophages. Mice were infected with 4 × 
10
5
 PFU of either M4stop or WT virus. Spleens were harvested at days 8, 10, 12 and 14 p.i. 













). One mouse was 
used as a negative control. The black bar shows the median of four to eight mice replicates, D 
represents day. Groups that have mean values that vary significantly (p<0.05) by 
Mann-Whitney test are indicated by *. 
 
 


























Figure 4.9   Macrophages and granulocytes in the spleens of MacGreen Mice following 
M4stop or WT virus infections. Mice were infected with 4 × 10
5
 PFU of either M4stop or WT 
virus. Spleens were harvested at days 10 and 12 p.i. and sections were cut using a cryostat 
microtome. Fluorescent macrophages and granulocytes in the spleens were observed using 
a confocal microscope. A mock-infected mouse was sacrificed and the spleen sections were 
prepared as for the viral infection groups. The confocal microscope was used at 20 x 
magnification. (a) WT virus infected spleen at day 10 p.i., (b) M4stop virus infected spleen at 
day 10 p.i., (c) WT virus infected spleen at day 12 p.i., (d) M4stop virus infected spleen at day 
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protein may reduce cellular activation during the establishment of latency in the 
spleen and therefore the WT virus would be cleared less rapidly. The other is that the 
higher M4stop viral load may induce more cellular activation in the spleens at day 7 
or 8 p.i., and that this controls M4stop virus. 
In order to test the two possibilities, cellular activation in the spleen was examined 
using the early activation marker CD69 (Caruso et al., 1997; Ziegler et al., 1993) in 




 T cells, B cells and NK cells markers. The 




 T cells and B cells were investigated at (1) 
days 10, 12 and 14 p.i. and (2) days 8, 10, 12 and 14 p.i., whereas the activation 
percentages of NK cells were determined at days 10, 12 and 14 p.i.. The infected 
spleens, as well as a spleen from a mock-infected mouse were examined and 
significantly higher activation percentages of CD4
+
 T cells (p<0.05), CD8+ T cells 
(p<0.001) and B cells (p<0.05) were detected in the spleens of WT-infected mice at 
day 14 p.i. (figure 4.10). The increased cellular activation in the WT-infected spleens 
correlated with the increased WT viral DNA loads in the spleen at day 14 p.i.. 
However, the percentage of activated NK cells in the spleens of the mice infected 
with WT virus was higher than M4stop virus infection, as shown in figure 4.10d, 
although this was not significant (p=0.2). As the percentage of NK cells was reduced 
suddenly at day 14 p.i., the detection of activated NK cells (CD69
+
) was limited by 
the number of cells present. 
It is known that NK cells respond to activation by producing IFN-. In order to 
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confirm the percentage of activated NK cells, the ability of NK cells to produce 
IFN-was analysed by double staining of splenocytes with anti-CD49b and 
anti-IFN- intracellular antibody at days 10, 12 and 14 p.i. The percentage of 
splenocytes expressing IFN- is shown in figure 4.11a. There was a significant 
increase in the IFN- expressing splenocytes in the WT virus infected mice at day 14 
p.i. compared to the M4stop infection (p<0.05). However, no difference was found 
between the percentages of IFN- expressing NK cells following infection with 
either M4stop or WT virus.  





 T cells, macrophages, etc. (Sandoval-Montes and Santos-Argumedo, 2005). In 




 T cells were also determined 
by an anti-CD38 antibody. To determine T cell activation in the spleen, splenocytes 
were double-stained with anti-CD38 and anti-CD4 antibodies or anti-CD38 and 
anti-CD8 antibodies at (1) days 7, 10, 14 and 17 p.i., and (2) days 10, 12 and 14 p.i.. 
The gating strategy is shown in figure 4.12 and results are plotted in figure 4.13. 




 (P<0.05) and CD8+CD38+ 
(P <0.001) T cells were found in the spleens of the mice infected with WT virus at 
day 14 p.i. compared to M4stop virus, supporting the increase in activating found by 
CD69 staining in figure 4.10 at day 14 p.i.. It also has been shown that CD38
+
 T cells 
have an ability to produce higher levels of cytokines, like IL-2 and IFN-, but 






Figure 4.10   Percentage of activated lymphocytes in the spleen. 129Sv mice were infected 
with 4 x10
5
 PFU of either M4stop or WT virus and the spleens were harvested at (1) days 8, 
10, 12 and 14 p.i., or (2) days 10, 12 and 14 p.i.. Lymphocytes were double stained with 




B-cell or CD49 
NK-cell antibody. The results were analysed by flow cytometry. (a) CD4, (b) CD8, (c) CD19, (d) 
CD49. Each symbol represents a mouse. D represents day. The black bar shows the median 
of four to eight mouse replicates. Groups that have mean values that vary significantly 
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undergo less proliferation (Sandoval-Montes and Santos-Argumedo, 2005; Spence 
and Green, 2008).  





T cells (CD38 and CD69) and B cells (CD69) of the spleens which were 
infected with WT virus at day 14 p.i., when the viral load of WT virus was 
significantly higher than M4stop virus. However, there was no difference in the 
percentages of activated cells at day 7 or 8 p.i., when a significantly higher viral load 
and cellular reactivation of M4stop were detected.  
T cell activation results in the up-regulation of inhibitory molecules, such as PD-1. 
The expression of PD-1 has been characterized as a negative regulator of T cells, 
which inhibits T-cell proliferation, cytokine production and autoimmunity (Francisco, 
Sage, and Sharpe, 2010; Latchman et al., 2001). The increase of PD-1 expression is 
related to cellular activation during a primary immune response, as well as during 
persistent immune activation (Keir, Francisco, and Sharpe, 2007; Sun et al., 1998). 
Therefore, fluorescent conjugated anti-PD-1 antibody was used to define the 





 over the total CD4
+
 T cells were calculated and compared 





 T cells was found in the spleen of the mice infected with WT at day 14 p.i. 
(p<0.05), which was comparable to the CD69 and CD38 results. Additionally, there 




 T cells in the spleens infected 




Figure 4.11  IFN- expression. 129Sv mice were infected with 4 x 10
5
 PFU of either M4stop 
or WT virus and the spleens were harvested at days 10, 12 and 14 p.i.. Lymphocytes were 
stained with anti-CD49, accompanied with intracellular staining of IFN-. (a) Percentage of 
splenocytes which expressed IFN-. (b) The percentage of the activated NK cells which have 
the ability to express IFN-. The black bar shows the median of four mouse replicates, D 
presents day. Each shape indicates one mouse. Groups that have mean values that vary 
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with M4stop virus at day 8 p.i. (p<0.05). It has been reported that herpesviruses, 
such as HCMV, MCMV and EBV, induce the PD-1-PD-L pathway that suppress T 
cell activation (Benedict et al., 2008; Green et al., 2012; Zhang et al., 2008). The 




 lymphocytes in the M4stop-infected spleen at 
day 7 or 8 p.i. may due to the immunosuppressive activity of PD-1. Although this 
experiment was only carried out once, it supported our hypothesis that the higher 
viral DNA load in the spleen following M4stop infection at day 7 and 8 p.i. 
stimulates earlier cellular activation. Interestingly, a higher percentage of total PD-1
+
 
cells were found in WT virus infected spleens compared to that of M4stop virus 
infected spleen at day 14 p.i. (14.5±2.5 versus 8.9±1.7). This indicates cellular 
activation had also occurred in other cells in the spleen at day 14 p.i.. In addition, it 
has been reported that PD-1 is involved in GC B cell formation and differentiation, 
as well as TFH cell development and function (Good-Jacobson et al., 2010). Therefore, 
the increase in PD-1 at day 8 p.i. in the spleens of M4stop-infected mice and day 14 
p.i. in the spleens of WT-infected mice may be related to the development of GC B 
cells. 
Cytokines secreted from activated T cells have an ability to induce macrophage 
activation. As the activation of macrophages is crucial for control of herpesvirus 
(Heise and Virgin, 1995), we were keen to know whether macrophages play a part in 
M4stop virus infection. To assess the activation of macrophages, splenocytes were 
triple stained with anti-CD11b, Ly6G, and CD69 antibodies. As described before, the  






Figure 4.12 Gating strategies for CD38 expressing CD4+ and CD8+ T cells. (a) The gate was 
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 T cells in the spleens 
following infection with M4stop or WT. 129Sv mice were infected with 4 × 10
5
 PFU of M4stop 
or WT virus and sacrificed at days 7, 10, 14 and 17 p.i., and days 10, 12 and 14 p.i.. 
Splenocytes which were double stained with CD38
+
 and (a) CD4
+
 or (b) CD8
+
 antibodies were 
determined the activated of T cells. D represents day. Each symbol indicates one mouse. The 
black bar shows the median of four to eight mouse replicates Groups that have mean values 
that vary significantly (p<0.05) by Mann-Whitney test are indicated by *. 
 
 












 T cells. 129Sv mice were infected with 4 × 10
5
 PFU 
of M4stop or WT virus and sacrificed at days 8, 10, 12 and 14 p.i. The splenocytes were 
double stained with anti-CD4 and anti-PD-1 antibodies. D represents day. Each symbol 
indicates one animal. The black bar shows the median of three to four mouse replicates, D 
denotes day. Groups that have mean values that vary significantly (p<0.05) by Mann-Whitney 

































) population was calculated. One mouse was mock-infected 
with the same amount of PBS and was used as a negative control. The black bar shows the 
median of three to four mouse replicates, D represents day. Groups that have mean values 












 cells were gated as the macrophage population, then the percentage of 
activated (CD69
+
) macrophages in the whole macrophage population was calculated 
(figure 4.15). Significantly higher (p<0.05) percentages of activated macrophages 
were found in M4stop-infected spleens at day 8 p.i. when compared to WT infection. 
The percentage of activated macrophages dropped sharply in the M4stop-infected 
spleen at day 14 p.i. compared to WT virus infection (p<0.05). The difference in 
macrophage activation between M4stop and WT virus infections may be associated 
with the production of proinflammatory cytokines (Sancho, Gómez, and 
Sánchez-Madrid, 2005). 
4.2.4 The transcription of immune molecules during infection 
Activated leukocytes can up-regulate the synthesis of chemokines, cytokines and 
chemokine/cytokine receptors. These immune molecules and receptors are involved 
in the regulation of immune responses, such as T cell activation, and the trafficking 
of immune cells. To gain insight into what mechanisms play a part in controlling 
M4stop infection, the expression of cytokines, chemokines and their receptors was 
analyzed and compared in the spleens of either M4stop or WT virus infected mice. 
RT² Profiler™ PCR arrays (PAMM-011) were performed using splenic cDNA which 
was reverse transcribed from splenic RNA that was isolated from mice culled at days 
10, 12 and 14 p.i.. The results were normalized using one house keeping gene that 
was simultaneously run with the samples. The names of the inflammatory genes, 
which are contained in PAMM-011, are listed in the Appendix II. Due to the limited 
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number of PCR array wheels, each of the eight spleen samples from day 12 p.i. was 
examined individually, whereas the samples of each infection group from day 10 or 
14 p.i. were pooled and examined as a single sample. The expression of genes in 
each sample was analysed on the manufacturer’s website (http://pcrdataanalysis. 
sabiosciences.com/pcr/arrayanalysis.php). The normalized 2
-Avg𝞓Ct values of these genes 
in the spleens of the mice following WT virus infection at day 10 p.i. were 
considered as controls. Then the other normalized 2
-Avg𝞓Ct values for M4stop virus 
infected samples and WT virus infected samples from days 10, 12 and 14 p.i. were 
compared to the WT virus infected sample at day 10 p.i.. Genes with fold changes in 
expression >2 or <0.5 at day 10, 12 or 14 p.i. were chosen and presented in figure 
4.16. Significant increases in IL-16, Ccr4, Cxcr2 and LT expression were detected 
in the spleens of mice infected with M4stop virus at day 12 p.i., compared to WT 
virus at the same time point (p<0.05). Several inflammatory chemokines, such as 
Ccl2 (figure 4.16b), Ccl7 (figure 4.16d), Ccl8 (figure 4.16d), Ccl11 (figure 4.16c) 
and Ccl12 (figure 4.16b), were apparently up-regulated in spleens which were 
infected with WT virus at day 14 p.i. based on the fold changes. These results were 
consistent with T cell activation (CD69
+
) results at day 14 p.i., since the activated T 
cells may generate more chemokines.  
As the RNA samples from days 10 and 14 p.i. were pooled, we did not know whether 
the differences in gene transcription between M4stop and WT virus infections were 
significant. Therefore, Ccl7, Ccl8, Ccl17 and Ccr4, whose transcripts were very 





Figure 4.16  Fold changes in gene expression. The mice, infected with 4 × 10
5
 PFU of 
M4stop or WT virus, were sacrificed at days 10, 12 and 14 p.i.. RNA was extracted from the 
spleens and transcribed into cDNAs. PCR arrays (PAMM-011) were carried out to examine 
gene expressions in the spleen. The samples from day 12 p.i. were examined individually, 
whereas the samples from days 10 and 14 p.i. were pooled. 23 genes, which have 
differences between M4stop and WT virus infections, are shown. The results of gene 
expression in the spleens infected with WT at day 10 p.i. were set as the controls (fold 
change=1), and up- or down-regulation of the other results are presented as fold changes. (a) 
IL-16, Ccr4, Ccr6, Ccr10, Cxcr2, CD40lg and LT. (b) IL-10, IL-11, Ccl12, Ccl2 and Ccr2. (c) 
IL-1r2, IL-4, Ccl1, Ccl11 and Spp1. (d) IL-13, IL-3, Ccl17, Ccl20, Ccl7 and Ccl8. Groups that 
have mean values that vary significantly (p<0.05) are indicated by *, which was calculated by 
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different between viral infections and involved in cellular activation, 
were selected and qPCR primers for these genes were purchased to examine the  
cDNA samples from days 10 and 14 p.i.. The results of the WT infected mice at day  
10 p.i. were set as the controls as in the earlier experiment showed. Then the 
normalized 2
-Avg𝞓Ct values of M4stop and WT infection from days 10, 12 and 14 p.i. 
were compared to the controls and the fold changes are presented in figure 4.17. Ccl7 
was significantly up-regulated (p<0.05) in the spleens of the mice infected with 
M4stop virus at day 10 p.i. in comparison to WT virus. The expression of Ccr4 was 
significantly increased (p<0.05) in the spleens following M4stop infection at days 12 
and 14 p.i. compared to WT virus infection. A great variability in the values of Ccl8 
was found at day 12 and 14 p.i.. 
4.3  Discussion 
In this chapter, several changes have been found during the course of the lytic 
infection in the lung and early latent infection in the spleen in the absence of M4 
compared to WT infection: (1) The viral load of the M4stop virus infection was 
lower in the lungs at day 8 p.i. which was consistent with the results of Evan et al 
(2006) at day 9 p.i.; (2) the number of latently infected was higher at 8 p.i. 




 T cells and activated 
macrophages were found in the spleens of the mice infected with the M4stop virus at 











 T cells and B cells were found in the spleens infected with M4stop virus 







Figure 4.17  Fold change in gene expression. Mice were infected with 4 × 10
5
 PFU of 
M4stop or WT virus and were sacrificed at days 10, 12 and 14 p.i.. The RNA was extracted 
from the spleen and transcribed to cDNAs. The qPCR was performed on selected genes. The 
results of gene expression in spleens infected with WT at day 10 p.i. were set as the controls 
(fold change=1), and up- or down-regulation of the other results are presented in the fold 
changes. The results were compared between M4stop and WT virus infections at each time 
point. The results of day 10 and 14 p.i. were got from qRT-PCR and the results of day 12 p.i. 
were from RT-PCR array. Groups that have mean values that vary significantly (p<0.05) are 
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at day 14 p.i.; (5) The transcription of IL-16, Ccr4, Cxcr2 and LT was shown to 
up-regulated in the spleens of M4stop infected mice at days 12 p.i., while the 
expression of Ccl7 was detected to be up-regulated in the spleens of M4stop infected 
mice at day 10 p.i.. In the Chapter 4, M4 was shown to be a chemokine binding 
protein. The faster clearance of M4stop viral loads in the lungs and spleen might be 
caused by M4 having the same function as Equine herpesvirus type 1 (EHV-1) gG 
which reduces the migration of neutrophils and macrophages to the lung (Vigne et al., 
2011). The transmission of the MHV-68 from lung to MLN requires the help of 
dendritic cells and macrophages. If M4 can slow down the trafficking of dendritic 
cells and/or macrophages, the virus may take longer to reach the MLN. Therefore, in 
the absence of M4 protein, there may possibly be more M4stop virus entering the 
MLN by day 8 p.i., accompanied by higher M4stop viral loads in the spleens at early 
latent infection. As the different viral loads in the lungs were found in the final 
experiment, it was a pity that there was no follow up studies looking at the 
chemokine levels, percentages of dendritic cells and/or macrophages in the lung, as 
well as the viral loads or latency in the MLNs at day 8 p.i.. The reduction in M4stop 
viral loads in the lung may also be caused by the increased inflammation in the lung 
during the M4stop virus infection. Therefore, the M4stop was cleared more quickly 
than WT in the lung at day 8 p.i.. However, this idea cannot explain the increase of 
M4stop viral load in the spleen at day 8 p.i..  
It has been shown for the first time that viral DNA loads and the number of 
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infectious centre in the spleens of mice infected with M4stop virus were higher than 
WT infection early after infection. This is associated with an increase of the 
percentages of activated CD4
+
 T cells (PD1
+
) and activated macrophages (CD69
+
) at 




 T cells and activated 
macrophages was seen in the M4stop-infected spleens at day 14 p.i.. PD-1 is 
essential for GC B cell development and the affinity of plasma cells antibody 
(Good-Jacobson et al., 2010). GC B cells are the reservoir of MHV-68 (Marques et 
al., 2003) and plasma cells are the main cells that induce MHV-68 reactivation 
(Liang et al., 2009). In addition, blockage of PD-1 and PD-L1 pathway influences the 
virus reactivation (Dias et al., 2010). Therefore, the down-regulation of PD-1 on 
CD4
+
 T cells at day 14 p.i. in the M4stop-infected spleens may impair the GC 
response, thereby, influence the M4stop latency and reactivation. In addition, as 
PD-1 is an immunoinhibitory receptor, it is beneficial for MHV-68 to exploit this 
inhibitory pathway. However, it is unclear whether the presence of M4 protein is 
essential for up-regulation of PD-1.  
The increase in the percentage of activated B cells (CD69
+
) in the WT infected 
spleens was consistent with the higher viral loads and latency. EBV infection drives 
B-cell differentiation that results in the accumulation of EBV (Calender et al., 1987). 
This can be measured by activation markers. This raises the possibility that M4 
protein may trigger the proliferation of B cells, leading to an increased WT viral load 
at day 14 p.i. compared to M4stop virus infection. However, the percentage of 





 B cells in the spleen showed no difference following the two viral infections.  
The results of PCR arrays and PCR showed that there was an increase in the 
transcription of Ccl7 at day 10 p.i., and IL-16, Cxcr2 and LT at day 12 p.i. in the 
spleens infected with M4stop virus. Ccl7 is secreted by macrophages and is able to 
attract a variety of leukocytes including monocytes, eosinophils, basophils, DC, NK 
cells and activated T cells (Fukuda et al., 1997). The increased expression of Ccl7 
suggests that the macrophages were highly activated in the spleens. It is known that 
IL-16 is a repressor for HIV replication (Maciaszek et al., 1997). The production of 
IL-16 is decreased after co-infection with HIV-1 and HHV-7, when HHV-7 
replication expands rapidly (Lisco et al., 2007). Therefore, HHV-7 infection may 
help to down-regulate the expression of IL-16 to help the virus evade the immune 
response. The up-regulation of IL-16 in M4stop virus infection may impair viral 
latency. Cxcr2 is expressed on endothelial cells, neutrophils and macrophages and is 
the receptor for Cxcl1, Cxcl2 and Cxcl5. Cxcr2 has a role in neutrophil and 
macrophage trafficking during several infections (Del Rio et al., 2001; Herbold et al., 
2010; Wareing et al., 2007). However, there was no difference in the percentage of 
neutrophils or macrophages at day 12 p.i.. MHV-68 and KSHV encoded ORF74 is a 
homologue of CXCR2 (Bais et al., 1998; Virgin et al., 1997). Meanwhile, M4 protein 
was shown to bind Cxcr2 ligands in Chapter 3. As the function of Cxcr2 is impaired 
by ORF74, it may explain why there was no difference in the percentage of 
neutrophils and macrophages in the spleens following M4stop and WT virus 
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infection, although the expression of Cxcr2 was increased in the M4stop virus 
infection. The up-regulation of LT was also found in the spleen of the mice infected 
with M4stop virus at day 12 p.i., with a 1.95 fold increase in expression compared to 
WT (p<0.05) (data not shown). LT and LT are members of the tumor necrosis 
factor (TNF) family and they are important factors for immune responses. For 
example, LT is required for the control of Mycobacterium tuberculosis infection 
(Roach et al., 2001) and LT can enhance immune responses of lymphocytes, boost 
antigen presentation by antigen-presenting cells, and inhibit the exhaustion or 
apoptosis of CD8
+
 T cells (Junt et al., 2006). Moreover, LT and LT are involved in 
the normal development of GC (Alimzhanov et al., 1997; Lee et al., 2000). 
Interestingly, we found more genes related to the development of GC were 
up-regulated when they were examined by qPCR. This result will be introduced in 
the next chapter. 
Compared to M4stop virus infected mice, more IFN-

 cells were found in the 
spleens at day 14 p.i., and may be responsible for the activation of the macrophages. 
Interestingly, IFN- may not be the only factor that induces the activation of 
macrophages. The up-regulation of IL-4 and IL-13 was found in the spleens infected 
with WT virus at day 14 p.i. (figure 4.16 c and d), which may drive alternative 
activation of macrophages at days 12 and 14 p.i.. Moreover, Ccr4 is the receptor for 
Ccl2, Ccl3, Ccl5 and Ccl17, and it expressed on activated T cells. CCr4 is important 
in proinflammatory macrophage differentiation, as the features of alternatively 
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activated macrophages were found in Ccr4 deficient mice (Ness et al., 2006). 
Therefore, decreased transcription of Ccr4 and the increased expression of IL-13 and 
IL-4 indicate that macrophages may be alternatively activated during WT virus 
infection. Therefore, both classical and alternative activation of macrophages may be 
stimulated simultaneously at day 14 p.i. It has been found that MHV-68 results in 
alternative activation of macrophages and fibrosis in IFN- unresponsive mice 
(IFN-R
-/-
 mice) (Gangadharan et al., 2008). This may be due to the blockage of  the 
IFN- pathway, leading to a dominant of Th2 immune response. In this case, the 
M4stop virus may induce less fibrosis in the IFN-R
-/-
 mice since M4stop infection 
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5 M4 may change the GC development 
5.1 Introduction 
GCs exist in secondary lymphoid organs and develop when naïve B cells are 
activated through stimulation of antigen receptors on their surface and receive 
stimulatory signals from immune helper cells, such as TFH cells. This procedure is 
dynamic, for example, newly activated B cells have an ability to enter existing GCs 
(Schwickert et al., 2009). During GC development, B cells transform into 
centroblasts that proliferate within the dark zone of the GC. Centroblasts revise their 
antigen receptors through somatic hypermutation of IgV region genes, a process that 
introduces mainly single nucleotide substitutions into the IgV gene to generate 
antibodies with a higher or lower affinity to the respective antigen. Centroblasts 
migrate to the light zone under the influence of chemoattractants, then develop to 
centrocytes, which express high-affinity antibody mutants and eventually 
differentiate into plasma cells or memory B cells. TFH cells provide help to B cells 
during GC development by secreting IL-21. IL-21 interacts with the IL-21R which is 
expressed on B cells, then B cells differentiate into plasma cells which have the 
ability to secrete antibodies (Bryant et al., 2007; Linterman et al., 2010). Moreover, 
IL-21 can modulate expression of CXCR5 and CCR7 on activated T cells (reviewed 
in King, Tangye, and Mackay, 2008). 
Homeostatic chemokines and some cytokines can promote lymphoid tissue 
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organization. For example, CCL19 and CCL21, the ligands of CCR7, can induce the 
expression of LT-LT complex, LT12, which precipitates secondary lymphoid 
organ formation (Luther et al., 2002). Moreover, IL-2, -4, -7, -15 are all able to 




 T cells (Luther et al., 
2002). On the other hand, CXCR5 is the receptor for CXCL13 and it is required for 
B cell homing to the spleen (Ansel et al., 2000). Therefore, the mice with deficiency 
of both Cxcr5 and Ccr7 exhibit severely disturbed architecture in the spleen (Ohl et 
al., 2003). CXCL12 mediates the trafficking of CXCR4-expressing B cells, dendritic 
cells and plasma cells (Hargreaves et al., 2001; Luther et al., 2002). Thus, the 
interaction of CXCR5-CXCL13 and CXCR4-CXCL12 is essential for the migration 
of centroblast and centrocytes (Allen et al., 2004).  
Aside from chemokines and cytokines, transcription factors also influence GC 
formation. For example, Bcl-6 is expressed highly in GC B cells and is selectively 
expressed in TFH cells. It has been reported that Bcl-6 knockout mice fail to develop 
GCs and do not produce high-affinity antibodies (Fukuda et al., 1997; Ye et al., 
1997). Bcl-6 is also required for programming of TFH cell generation. For example 
Bcl-6 represses the expression of several microRNAs that target several key TFH 
genes (Yu et al., 2009), therefore a deficiency in Bcl-6 results in impaired TFH cell 
development and GC development (Nurieva et al., 2009). 
Gammaherpesvirus infection is related to GC formation. For example, EBV infects 
naïve B cells and drives their activation and proliferation, which is regulated by 
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expression of viral growth transcription programmes, such as EBNA-2 (Sinclair et al., 
1994). EBV establishes latency in the GC when the GC reaction occurs (Roughan, 
Torgbor, and Thorley-Lawson, 2010). Most B cells die as a result of apoptosis during 
the GC reaction. However, LMP-1 and LMP-2A regulate NFB activation, which 
provides survival signals (reviewed in Spender and Inman, 2011). In the GC, virus 
has access to resting memory B cells, where persistent infection of EBV is found 
(Roughan and Thorley-Lawson, 2009). KSHV also infects B cells during infection. It 
may preferentially infect naïve B cells in the absence of EBV infection, but during 
co-infection with EBV, KSHV infects GC or post-GC B cells (Hamoudi et al., 2004). 
Moreover, KSHV-positive macrophages were detected only within GC (Valmary, 
Richard, and Brousset, 2005). MHV-68 establishes latency mainly in GC B cells, 
especially in the centroblasts (Collins and Speck, 2012; Flano et al., 2002). It has 
been found that plasma cells contain latent MHV-68 and the differentiation of 
plasma cells is important to maintain MHV-68 latency (Collins, Boss, and Speck, 
2009; Siegel et al., 2010). Moreover, the M2 protein encoded by MHV-68 drives 
plasma cell differentiation and this regulates viral reactivation (Liang et al., 2009). 
Therefore, the dysregulation of GC development during viral infection may affect 
MHV-68 latency.  
In Chapter 4, the analysis of PCR arrays demonstrated the up-regulation of 
inflammatory genes in the spleens of mice following M4stop virus infection 
compared to WT virus infection. Moreover, the arrays showed some transcripts 
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which are involved in the development of GC were up-regulated in the M4stop virus 
infection compared to WT virus infection. For example, LT and LTwere found to 
be significantly up-regulated in the M4stop-infected spleens at day 12 p.i. compared 
to WT virus infection (figure 4.16a and in the discussion of chapter 4). LT and LT 
are important in the development of stromal cells, which secrete T cell and B cell 
homing chemokines (Ngo et al., 1999). Without LT and/or LT, the spleen structure 
or the development of GC is abnormal. For instance, MHV-68 induced splenomegaly 
is absent in LT-deficient mice (Lee et al., 2000), probably because the mice fail to 
develop GC. In order to understand whether the development of GC were distinct in 
the spleen following M4stop and WT virus infections, the transcripts involved in the 
development of GC were analyzed. Furthermore, we analyzed key cell populations 
which are important in GC development and virus infection. 
5.2 Results 
5.2.1 M4stop infection increases gene expressions 
In Chapter 4, PAMM-11 PCR arrays were carried out to examine the expression of 
inflammatory genes in the spleen following M4stop and WT virus infections at days 
10, 12 and 14 p.i.. As described in Chapter 4, the samples from days 10 and 14 p.i. 
were pooled and examined, whereas the samples from day 12 p.i. were studied 
individually. In this chapter, the analysis was focused on the mRNA transcripts which 
are essential for GC development. As described in the Chapter 4, the results of the 
WT infection at day 10 p.i. were set as the control, while the other results from days 
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12 and 14 p.i. were compared with the control. PCR array results showed Cxcl12, 
Ccr7 and Bcl-6 were significantly up-regulated in the spleens of mice infected with 
M4stop virus (p<0.05, figure 5.1) at day 12 p.i. as compared to the WT virus 
infection. Moreover, the expression of Ccl19 and Cxcr5 was 2.1 and 2.3 fold 
up-regulated in the M4stop-infected spleen compared to WT virus infected at day 12 
p.i., but this was not significantly different (p=0.07 and 0.08 respectively). All five 
gene transcripts are known to be important in GC development. Since we could not 
perform statistical tests on the difference between the M4stop and WT virus 
infections at days 10 and 14 p.i. from the PCR arrays, RT-PCR analysis of the 
expression of Ccl19, Cxcl12, Cxcr5 and Bcl-6 mRNA was carried out to understand 
the change between viral infections at these two time points. Additionally, the 
transcription of Ccl19 was barely detected in the M4stop-infected spleens at day 14 
p.i. from the RT-PCR arrays and this may have been due to technical error. It was 
therefore necessary to confirm this result by qPCR. The results were analysed as in 
the Chapter 4, in which the gene transcription levels of WT virus infection at day 10 
p.i. were set as the control (fold change=1), then the other results were compared 
with the controls. Figure 5.2 shows transcript levels of Ccl19, Cxcl12, Cxcr5 and 
Bcl-6 in the spleens following M4stop and WT virus infections at days 10 and 14 p.i.. 
Additionally, the results of these four transcripts from RT-PCR arrays were also 
included in order to give a panorama of changes during infections (figure 5.2). 
Interestingly, all four genes were found to be up-regulated in the spleens of M4stop 
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virus infection when compared to WT virus infection at least at one time point. At 
days 10 and 14 p.i., the expression of Ccl19 in the spleens of M4stop infection was 
increased significantly (p<0.001 and <0.05 respectively). The transcription of 
Cxcl12 was increased significantly at day 12 and 14 p.i. (p<0.05 in both time points), 
accompanied by a significant increase in the levels of Bcl-6 and Cxcr5 mRNA at 
days 12 and 14 p.i. respectively (p<0.05 in both gene transcription). In contrast, the 
transcription of Ccl19, Cxcl12 and Cxcr5 in the spleens of mice following WT virus 
infection was significantly down-regulated at days 12 and 14 p.i., compared to the 
transcripts in the WT-infected spleens at day 10 p.i. (p<0.05 for Cxcr5 at day 14 p.i, 
and p<0.001 for Ccl19 and Cxcl12 at days 12 and 14 p.i.). Because of the 
importance of GC development during MHV-68 infection (Flano et al., 2002; Liang 
et al., 2009), the down-regulation of expression of Ccl19, Cxcl12, Cxcr5 and Bcl-6 
mRNA in the WT-infected spleens could be involved in the successful establishment 
of WT virus latency. 
The up-regulation of Cxcr5 and Cxcl12 mRNA in the spleen during M4stop virus 
infection may affect the differentiation of GC B cells, because the localization of GC 
B cells in the dark and light zone may be altered by Cxcr5 and Cxcl12 induced 
chemotaxis. Because Bcl-6 can trigger the differentiation of follicular B helper T 
(TFH) cells (Yu et al., 2009), the up-regulation of Bcl-6 may suggest an increase of 
TFH cells in the spleens following M4stop virus infection. Therefore, we proposed a 
hypothesis that there were differences in GC formation and B cell differentiation 






        
 
 
Figure 5.1  Fold change of gene transcription. 129Sv mice were intranasally infected with 5 × 
10
4 
PFU of M4stop or WT virus. The mice were sacrificed at days 10, 12 and 14 p.i., and the 
spleen RNA of each sample was reverse-transcribed to cDNA. The samples from day 12 p.i. 
were examined individually on PCR arrays, while the others were pooled and assessed. The 
results of the WT infection at day 10 p.i. were set as the control (fold change=1), then the 
levels of other results were compared to the control. Groups that have mean values that vary 
significantly (p<0.05) by student T test are indicated by *, which was calculated by the 


















Figure 5.2  Fold changes of gene expression. 129Sv mice were intranasally infected with 5 × 
10
4 
PFU of M4stop or WT virus. The mice were sacrificed at days 10, 12 and 14 p.i., and the 
spleen RNA of each sample was reverse-transcribed to cDNA. The gene transcription of 
Ccl19, Cxcl12, Cxcr5 and Bcl-6 were examined by RT-PCR. The results of the WT infection at 
day 10 p.i. were set as the control (fold change=1), then the levels of the other results were 
compared to the control. The results of day 10 and 14 p.i. were got from qRT-PCR and the 
results of day 12 p.i. were from RT-PCR array. Groups that have mean values that vary 
significantly (p<0.05) by student T test are indicated by *, which was calculated by the 
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between M4stop and WT virus infections which led to a decrease in M4stop latency. 
5.2.2 The percentage of GC B cells  
The up-regulation of Bcl-6, Ccl19 and LT in the spleens of the mice which were 
infected with M4stop virus suggested M4stop virus infection caused different 
development of GC. Because B cells are the main cellular types in the GC and GC B 
cells are essential for MHV-68 latency (Flano et al., 2002), the percentage of GC B 
cells was determined during M4stop and WT infections. Furthermore, the increase in 
PD-1 may help to maintain the number of GC B cells (Good-Jacobson et al., 2010). 
To examine GC B cells in the spleen, the splenocytes of M4stop or WT infected 
129Sv mice were double-stained with fluorescent conjugated anti-CD38 and 
anti-CD19 antibodies. The expression of CD38 is down-regulated (CD38
dim
) on GC 
B cells and mature plasma cells in the mice (Oliver, Martin, and Kearney, 1997). 





 represents GC B cells. The gating strategy is shown in figure 5.3. A 
number of resting B cells and memory cells (CD38
high
) were found at day 7 p.i.. Then 
GC B cells were shown to be generated from day 10 p.i. (figure 5.3). 
The determination of GC B cells proportions following viral infections was carried 
out three times, where the mice were sacrificed at (1) days 7, 10, 14 and 17 p.i.; (2) 
days 10, 12 and 14 p.i.; (3) days 8, 10, 12 and 14 p.i.. The percentages of GC B cells 
are presented in figure 5.4. A significant increase (p<0.05) in the percentage of GC 
Chapter 5                                        M4 may change the GC development                               
172 
 
B cells occurred in the spleens infected with M4stop virus at day 10 p.i. (figure 5.4), 
compared to WT virus infection at the same time point. This result may be associated 
with the rise of PD-1 positive CD4
+
 T cells in the M4stop-infected spleen (figure 
4.13). Or the increased M4stop viral latency (figure 4.4) induced naïve B cells to 
migrate to GC. After day 10 p.i., the levels of GC B cells are increased in both 
infections, but there was no difference between the two viral infection groups at any 
later time points, even at day 14 p.i. when PD-1 positive CD4
+
 T cells and viral 
latency were found to be decreased in M4stop infected spleens (figure 4.14 and 4.4). 
The increase in the percentage of GC B cells during M4stop infection at day 10 p.i. 
may be because the increased M4stop viral latency at earlier time points (figure 4.4) 
induced the development of naïve B cells and formation of GC.  
Down-regulation of Cxcl12 and Cxcr5 was found in spleens following WT virus 
infection at days 12 and 14 p.i., which could have influenced the development of 
centroblasts (Allen et al., 2004). Furthermore, latent MHV-68 is mainly found in 
centroblasts (Collins and Speck, 2012) which are reported to have a high 
proliferation rate. In this case, we would like to examine whether the reducion in 
M4stop latency was due to a low proliferation rate of B cell. The expression of Ki-67 
antigen occurs preferentially during late G1, S, G2 and M phases of the cell cycle, 
while it cannot be detected in G0 phase. Therefore, to investigate the 
proliferation of B cells, splenocytes were double-stained with florescent conjugated 
 









 B cells. (a) Histogram of the infected CD19
+
 B cells stained 




















Figure 5.4  The percentage of GC B cells after infection. 129Sv mice were intranasally 
infected with 5×10
4
 PFU of M4stop or WT virus. The mice were sacrificed at days (1) 7, 10, 





 B cells, and the percentage was calculated by the ration of percentage of GC 
B cells and percentage of CD19
+
 B cells. Each symbol represents an animal, and D presents 
day. The black bar shows the median of four to twelve mice replicates. Groups that have 
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anti-CD19 and anti-intracellular antigen Ki-67 antibodies and examined by flow 
cytometry. The proliferation of B cells in WT-infected spleen was slightly higher at 
day 10 p.i., compared to M4stop infection, but not significantly (p=0.052) (figure 
5.5). This result confirmed that the M4 protein does not have an ability to induce the 
proliferation of B cells during infection. This result was consistent with previous 
results showing that the percentage of B cells was the same during M4stop and WT 
virus infections (figure 4.7c).  
The percentage of GC B cells and proliferation of B cells were the same at days 12 
and 14 p.i. between M4stop and WT virus infections, indicating that the decrease in 
the level of M4stop viral latency did not appear to be related to the number of GC B 
cells or proliferating B cells. 
5.2.3 Levels of TFH cells during M4stop and WT infections 
Increased levels of transcripts of Bcl-6 and Cxcr5 in M4stop-infected spleens at days 
12 or 14 p.i. (figure 5.2) suggests M4stop virus infection might induce a higher level 
of TFH cells, because Bcl-6 is required for the development of TFH cells and Cxcr5 is 
expressed on TFH cells (reviewed in Fazilleau et al., 2009). To determine the 




 TFH cells were gated on CD4
+
 live 
lymphocytes from the spleens following M4stop and WT virus infections by flow 
cytometry. The proportion of TFH cells was calculated by the ratio of the percentage 
of TFH cells and the percentage of CD4
+
 T cells (figure 5.6). 










Figure 5.5  The percentage of proliferating B cells after infection. 129Sv mice were 
intranasally infected with 5×10
4
 PFU of M4stop or WT virus. The mice were sacrificed at 
days 8, 10, 12 and 14 p.i.. The splenocytes were double stained with anti-CD19 and 
anti-intracellular proliferation marker Ki-67 antibodies. The percentage of proliferating B cells 
was calculated from the total CD19
+
 B cell population. Each symbol represents an animal, 












Figure 5.6  The percentages of TFH cells in the spleen. 129Sv mice were intranasally infected 
with 5×10
4
 PFU of M4stop or WT virus. The mice were sacrificed at days 8, 10, 12 and 14 
p.i., and splenocytes were triple-stained with anti-CD4, anti-Cxcr5 and anti-PD-1 antibodies, 
then selected by FACS. The percentage of TFH was calculated from percentage of CD4
+
 T 
cells. Each symbol represents an animal, and D presents day. The black bar shows the 
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No difference in percentage of TFH cells was found in the spleens between M4stop 
and WT virus infections. Therefore, the increase in Bcl-6 and Cxcr5 in the spleens of 
M4stop infection did not result in increased proportions of TFH cells at days 12 and 
14 p.i.. 
5.2.4 The percentages of plasma cells during M4stop and WT 
infections 
Increased levels of Cxcr5 in the M4stop-infected spleens did not result in an 
increased percentage of TFH cells at least at days 12 or 14 p.i.. However, it has been 
shown that Cxcr5 and Ccr7 are down-regulated in mouse plasma cells (Hargreaves et 
al., 2001). The increase in Ccr7 at day 12 p.i. (figure 5.1) and Cxcr5 at day 14 p.i. 
(figure 5.2) in the M4stop-infected spleens suggests less plasma cell may have 
developed in the spleens compared to WT virus infection. Moreover, Bcl-6 is a 
repressor of plasma cells differentiation as it represses the expression of Blimp-1, 
which has a role in promoting plasma cell formation and immunoglobulin secretion 
(Shapiro-Shelef et al., 2003). Plasma cells are vital for MHV-68 latency (Collins, 
Boss, and Speck, 2009; Liang et al., 2009), therefore, the decrease in the number of 
plasma cells can lead to reduced viral latency and reactivation. Additionally, M2 
protein has been shown to play an important role in the differentiation of plasma cells 
(Liang et al., 2009). The absence of PD-1-PD-L interaction impairs plasma cell 
development. As we found an increase in PD-1 expression at day 8 p.i. and a 
decrease in PD-1 at day 14 p.i. in the spleen of M4stop virus infection when 
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compared to WT virus infection, we hypothesized that plasma cell development was 
different between M4stop and WT virus infections, thus the reduction in M4stop 
latency and M4stop viral reactivation may be due to impaired differentiation of 
plasma cells in the absence of M4 protein. In order to test this hypothesis, the 
percentage of plasma cells at days 8, 10, 12 and 14 p.i. following M4stop and WT 
virus infection was determined by double-staining splenocytes with anti-CD19 and 
anti-CD138 antibodies and examined by flow cytometry. No difference in percentage 
of plasma cells was found between M4stop and WT infection at these indicated time 
points (figure 5.7). However, there was non-significant (p=0.2) increase in the 
percentage of plasma cells in the M4stop-infected spleen at day 10 p.i. compared to 
WT infection. This experiment should be repeated to confirm whether the difference 
observed is real using a larger group number.  
Similar to the TFH cells result, the up-regulation of mRNA expression of Bcl-6, Cxcr5 
and Ccr7 in the M4stop virus infection did not result in the development of plasma 
cells at days 12 and 14 p.i.. It might be because other cells that are involved in the 
GC reaction. For example, a subset of Treg cells can highly express Bcl-6 and Cxcr5. 
And they can inhibit the development of GC (Chung et al., 2011). However, due to 
the time limitation, we have not examined the population of Treg cells. 
5.2.5 Histological examination of spleens 
The difference in the expression of Bcl-6 and Ccl19 between M4stop and WT virus 








Figure 5.7  The percentage of plasma cells after infection. 129Sv mice were intranasally 
infected with 5×10
4
 PFU of M4stop or WT virus. The mice were sacrificed at days 8, 10, 12 
and 14 p.i.. The splenocytes were double stained with anti-CD19 and anti-138 antibodies. 




 cells. Each symbol represents an animal, and D presents 
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infections may induce distinct GC formation (Luther et al., 2002; Nurieva et al., 
2009). The spleens following M4stop and WT virus infections were examined by 
histology. The mice were sacrificed at days (1) 10, 12 and 14 p.i., and (2) 8, 10, 12 
and 14 p.i., and the spleens were harvested and stained with H&E. Sections were 
examined, but no clear difference in the GC structure was detected by light 
microscopy, when comparing the two viral infection groups (data not shown). Since 
the H&E staining only showed the shape of GCs, we are not clear about what cell 
populations contained in the GC and what the distribution of these cells. It would be 
more useful to determine the GC structure further. 
5.3 Discussion 
Levels of viral latency of M4stop were decreased in the spleen at day 14 p.i. 
compared to WT infection (figure 4.4) (Geere et al., 2006). In this chapter, we 
examined the transcript levels of Cxcl12, Cxcr5, Ccr7, Ccl19 and Bcl-6, which have 
been shown to be involved in development of GC, and were up-regulated in the 
spleens of mice infected with M4stop virus when compared to that of WT virus 
infection. Moreover, these genes were down-regulated in the WT-infected spleens at 
days 12 and 14 p.i. compared to that of WT infection day 10 p.i. (figure 5.1 and 
figure 5.2). Because these genes are involved in GC B cell formation and B cell 
proliferation, the up-regulation of these genes in the M4stop-infected spleens may 
interfere with the development of GC B cells, which are known to be related to viral 
latency. The examination of percentage of GC B cells showed a difference at day 10 
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p.i. during M4stop and WT viral infections, but levels were similar at days 12 and 14 
p.i., indicating GC B cells and the proliferative ability of B cells were not related to 
the decrease in M4stop viral latency in the spleen at day 14 p.i..  
As Cxcr5, Ccr7 and Bcl-6 are indicators of the development of TFH cells and plasma 
cells, which are two important factors for GC development, the percentages of these 
two cellular types were investigated between the two viral infections. However, no 
difference was observed. Therefore, the levels of TFH cells and plasma cells appear 
not to be related to the failure of M4stop latency at day 14 p.i.. These experiments 
have only been carried out once; therefore the results require confirmation. It seems 
like the increase in the PD-1 and decrease in these gene transcripts work in opposite 
ways, which may maintain the levels of TFH cells and plasma cells during WT virus 
infection. Furthermore, although the percentage of TFH cells and plasma cells was the 
same during infection, we do not know whether the functions of these cells are the 
same between the two viral infections. It would be interesting to examine the level of 
cytokines, such as IL-4 and IL-21, expressed by TFH cells and the antibodies that 
secreted from plasma cells to assess the functions of these cells. 
The up-regulation of Ccl19, Cxcl12, Cxcr5 and Bcl-6 during M4stop virus infection 
was not due to changes in the percentages of GC B cells, proliferating B cells, TFH 
cells or plasma cells. Some other possibilities that may be related to the up-regulation 
of these transcripts, such as (1) other cellular types in the spleen may be involved in 
controlling M4stop virus infection. For example, FDC can also express Cxcr5. The 
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latency of MHV-68 in FDC is unknown, but other herpesvirus infections have been 
found in FDC (El-Daly, Bower, and Naresh, 2010). Moreover, FDC interact with B 
cells in the GC light zone; therefore, the disruption of FDC can affect the 
development of B cells. Treg cells might also be involved in the up-regulation of 
Bcl-6 and Cxcr5 during the M4stop infection (Chung et al., 2011). Therefore, the 
down-regulation of CD69 on splenic lymphocytes might be due to the increase in 
Treg following M4stop virus infection. (2) Other mechanisms may induce transcripts 
in the M4stop infection. For example, Bcl-6 can repress the microRNAs that 
modulate several genes of TFH cells and Cxcr5 (Yu et al., 2009). Therefore, the 
decrease in Bcl-6 may result in the down-regulation of expression of other genes. 
Antigen-specific B cells go through somatic hypermutation in the dark zone during 
the GC response.  Plasma cells producing high affinity antibodies are important for 
the control of viral infections. Although the percentages of plasma cells were the 
same between the two viral infections, antibody affinity for antigen remains unclear. 
Moreover, it has been found that immune sera cannot block MHV-68 infection of 
macrophages and dendritic cells, instead the virus exploits the IgG Fc receptor to 
increase their infection (Rosa et al., 2007). Therefore, it would be interesting to 
compare the levels of antibodies, such as IgG, in the peripheral blood during M4stop 
and WT infections.  
It is worth noticing that the changes in gene expression during viral infections are 
involved in Th1/Th2 polarization. LT has been characterized as a Th1 cytokine. 
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LT12 is absent on Th2 cells (Gramaglia et al., 1999). Moreover, the expression of 
Bcl-6 represses GATA-1 and STAT-6, thus Bcl-6 down-regulates expression of IL-4 
and IL-13 (Dent et al., 1997; Harris et al., 1999; Kusam et al., 2003). Bcl-6 deficient 
mice develop a Th2-mediated inflammatory response, as the expression of Th2 
cytokines was increased (Dent et al., 1997; Ye et al., 1997). Moreover, Bcl-6 is an 
antagonist of Blimp-1, which can repress Th1 genes and reinforce Th2 differentiation 
(Cimmino et al., 2008). Therefore, Th2 differentiation may be more likely to occur in 
an environment which contains lower level of Bcl-6, such as in the spleens of mice 
infected with WT virus. IL-4 and IL-13 signals are required for the differentiation of 
Th2 cells (Mora et al., 2006). Higher levels of Bcl-6 in the spleens of 
M4stop-infected mice may impair Th2 differentiation. In addition, it would be 
interested to examine the transcription of IL-4 and IL-13 in the spleens at day 14 p.i.. 
Moreover, it has been reported that Bcl-6 can repress the proliferation of 
macrophages (Yu et al., 2005). Thus, the lower levels of macrophages in 
M4stop-infected spleens compared to WT infection may due to negative regulation 
of Bcl-6.  
The development of GC might be different between M4stop and WT virus infections, 
but does not appear to be related to the proportions of GC B cells, TFH cells and 
plasma cells. Therefore, more experiments are required to determine whether cell 
populations are changed during the two viral infections. 
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6 Role of M4 in MHV-68 pathogenesis in IFN-R-/- Mice 
6.1 introduction 
IFN-γ, which is produced predominantly by NK, NKT cells, CD4
+
 (Th1) and CD8
+
 T 
cells, is critical for innate and adaptive immunity during many viral infections. It has 
been reported to be involved in protective immune responses to several herpesviruses 
(Bodaghi et al., 1999; Christensen et al., 1999; Orange et al., 1995; Smith et al., 
1994). During the acute phase of MHV-68 infection, IFN- is produced at high levels 
in the MLN, cervical lymph node and spleen. Nevertheless, this cytokine is not 
essential for control of this viral infection in the lungs using MHV-68-infected 
IFN-R
-/-
 mice (Dutia et al., 1997; Nash et al., 2001; Sarawar et al., 1997; Sarawar et 
al., 1996) and IFN-
-/- 
mice (Sarawar et al., 1997). However, an expansion of latent 





 mice (Dutia et al., 1997; Weck et al., 1997). In Chapter 4, we 
showed that the M4 protein of MHV-68 played an important role in the establishment 
of latent infection in the spleen of immunocompetent 129Sv mice. The study of the 
role of IFN- in MHV-68 infection shows that it can inhibit reactivation from latency 
and control viral gene expression during latency (Steed et al., 2006). The 
transcription of M4 can be found in the spleen during the early latency stage 
following infection (Marques et al., 2003; Townsley, Dutia, and Nash, 2004). 
Therefore, I investigated whether the M4 protein has a role in the pathogenesis that 
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occurs in the absence of IFN- 
Multi-organ, including mediastinal lymph node, lung and liver, fibrosis has been 
found in IFN-R
-/-
 mice following intranasal infection with MHV-68 (Dutia et al., 
1997; Ebrahimi et al., 2001; Lee et al., 2009). The most obvious changes of 
lymphoid pathology in IFN-R
-/-
 mice are the decrease in the number of splenocytes, 
which lead to an increase in leukocytes, lymphocytes and neutrophils in venous 
blood, and splenic atrophy after day 14 p.i., coupled with the generation of collagen 
and fibrosis by day 23 p.i. (Ebrahimi et al., 2001). It has also been considered that the 
change of splenic structure was related to the left-end gene of MHV-68 since 
MHV-76 fails to induce atrophy (Dutia et al., 2004). A further study reported that the 




 T cells after day 18 p.i., which are 
activated by the M1 protein (Evans et al., 2008). Therefore, this is why the loss of the 
splenic structure did not occur in CD8
+
 T cell depleted mice (Dutia et al., 1997) or 





cells, alternatively activated macrophages, which are driven by the Th2 response, are 
involved in the generation of fibrosis during MHV-68 infection (Gangadharan et al., 
2008). The histology of M4stop-infected spleens in IFN-R
-/- 
mice has not been 
studied yet, therefore the differences of the histology were studied and comparisons 
were made following M4stop and WT virus infections in this chapter. 
In order to determine whether the M4 gene product plays a role in the development 




 mice were infected with the WT 
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and M4stop viruses. Comparisons were made between the spleen weights, 
percentages of splenocyte subsets, viral DNA loads, viral reactivations, and the 
percentages of activated of lymphocytes between two viral infections. 
6.2 Results 
To study whether M4stop influences the development of fibrosis in the absence of 
IFN- during MHV-68 infection, IFN-R
-/-
 mice were intranasally infected with 4 x 
10
5
 pfu of M4stop or WT virus. The experiments were performed during the early 
latency stage of MHV-68 infection when M4 transcripts can be detected. In four 
separate experiments, the mice were sacrified at (1) days 7, 10, 14 and 18 p.i.; (2) 
days 10, 14, 18 and 25 p.i.; (3) days 18 and 25 p.i.; and (4) days 18 and 25 p.i.. There 
were four mice in each group. A mock-infected mouse which was intranasally 
infected with the same amount of SPBS was sacrificed to get a better understanding 
of the pathological changes during both virus infections.  
6.2.1 Viral DNA loads and viral reactivation in the spleen 
Previous studies of MHV-68 infection of IFN-R
-/-
 mice showed that MHV-68 
infection resulted in significantly higher viral latent loads in IFN-R
-/-
 mice than in 
immunocompetent mice (Dutia et al., 1997; Dutia et al., 2004). In order to assess 
whether there is any difference in the viral DNA loads and viral reactivation during 
M4stop and WT virus infections, qPCR and infectious centre assays were carried out 
as described in Materials and Methods, and the results are presented in figure 6.1 and 
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6.2 respectively. The number of the infectious centres reflects the reactivation of the 
virus from infected cells. The viral DNA loads of WT virus in the spleens were 
higher than M4stop virus at days 7, 18 and 25 p.i. (p<0.05). The number of 
infectious centres caused by WT virus infection was significantly higher at day 18 p.i. 
(p<0.05) than that of M4stop-infected spleen of IFN-R-/- mice. Compared to levels 
of viral latency and reactivation in the spleens of 129Sv mice (figure 4.4 and 4.5), 
viral DNA loads and the number of infectious centres were higher. The delay in the 
viral clearance from the spleen reflects the importance of IFN- in the control of 
MHV-68 latency in the spleen. However, the decrease in viral DNA loads and the 
ability of the virus to reactivate from latency in the spleens of IFN-R
-/- 
mice 
following M4stop virus infection was similar to the decrease in that of 
M4stop-infected 129Sv mice, therefore the lack of response to IFN- did not stop the 
decrease in M4stop virus latency.  
6.2.2 Viral induced changes of splenic morphology 
MHV-68 infection leads to splenic fibrosis in IFN-R
-/-
 mice; however, the splenic 
morphology in M4stop-infected IFN-R
-/-
 mice was unknown. Therefore, the weight 
of spleens from three different experiments is presented in figure 6.3. Splenomegaly 
with an increase in the number of splenocytes was found at the initial stage of spleen 
infection at days 7 and 10 p.i. in both viral infections. Then spleens from  WT 
virus infected IFN-R
-/-
 mice became pale, shrunken and fibrous from day 14 p.i. 
onwards, and decreased in weight at day 18 p.i. when compared to the spleens 







Figure 6.1   Viral DNA loads in spleens. IFN-R
-/-
 mice were infected with 4 × 10
5
 PFU of 
M4Stop or WT virus by the intranasal route. Viral DNA loads of WT and M4stop obtained from 
latently infected splenocytes were analysed by qPCR at days (1) 7, 10, 14 and 18 p.i. and (2) 
18 and 25 p.i., all normalized to GAPDH. Each symbol represents an animal and D 
represents day. The black bars denote the median of each group. Groups that have mean 
























Figure 6.2  Latent virus in spleen. IFN-R
-/-
 mice were infected with 4 × 10
5 
PFU of M4Stop 
or WT virus by the intranasal route. Spleens were removed at (1) days 7, 10, 14 and 18 p.i. 
and (2) days 10, 14, 18 and 25 p.i.. The levels of latent virus were quantified by an infectious 
center assay. Each symbol represents an animal and D represents day. The black bars 
denote the median of each group. Groups that have mean values that vary significantly 
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infected with M4stop virus (p<0.05). Fibrosis was found in the M4stop-infected 
spleens at day 25 p.i., and the texture of the spleens was similar to the WT-infected 
spleens at day 18 p.i.. Therefore, the generation of fibrosis may be delayed in the 
absence of M4 protein. 
To determine fibrosis and architectural changes in the spleens after viral infection, 
the spleens were harvested at days 18 and 25 p.i. and examined by H&E staining and 
Masson’s trichrome staining (figure 6.4). A mock-infected mouse was sacrificed and 
the spleen was stained as a negative control. Compared to the negative control H&E 
staining (figure 6.4a), the white pulps were enlarged, merged with each other and 
GCs were generated by day 18 p.i. during M4stop and WT virus infections (figure 
6.4c and e). However, the GC structure was not clear at day 25 p.i. (figure 6.4g and i). 
The staining clearly showed that collagen fibers, seen in blue, were starting to be 
generated in the WT-infected spleens at day 18 p.i. (figure 6.4f), but were absent 
from the M4stop-infected spleens (figure 6.4d). The fibrosis level was defined by 
measuring the area of blue staining using imageJ. The area of fibrosis in the spleen 
which infected with WT virus was 10 times larger than M4stop virus infection at day 
18 p.i.. At day 25 p.i., more fibrosis was seen in the spleens of mice infected with 
WT compared to day 18 p.i. (figure 6.4j). As we expected, fibrosis was found in the 
M4stop-infected spleen at day 25 p.i., but to a lesser degree when compared to WT 
virus infection. The area of fibrosis in WT virus infected spleen was about 2 times 
larger than M4stop virus infection at day 25 p.i.. Therefore, M4stop virus infection 







Figure 6.3   Splenomegaly and atrophy occurred in IFN-R
-/-
 mice infected with WT or 
M4stop virus. IFN-R
-/-
 mice were intranasally infected with 4 × 10
5
 PFU of either WT or 
M4stop virus. Then the mice were sacrificed at (1) days 7, 10, 14 and 18 p.i.; (2) days 10, 14, 
18 and 25 p.i.; and (3) days 18 and 25 p.i.. The spleens were weighed and recorded. Each 
symbol represents an individual animal, D represents day. The black bars denote the median 
of each group. Groups that have mean values that vary significantly (p<0.05) by 













Figure 6.4  Detection of splenic structure and fibrosis by H&E and Masson’s trichrome 
staining. The spleens were harvested at days 18 and 25 p.i. after being infected with M4stop 
and WT virus. One mock-infected mouse was sacrificed and the spleen was stained. (a), (c), 
(e), (g) and (i) are H&E staining. (b), (d), (f), (h)and (j) are Masson’s trichrome staining.  
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can also cause fibrosis in the spleen, but the fibrosis is delayed. 
6.2.3 Proportion of different cell populations in spleens 
In order to determine whether the splenomegaly in the IFN-R
-/-
 mice following 





 T cells, B cells and NK cells in the spleens of IFN-R
-/-
 





T cells are essential for the structural change and fibrosis in IFN-R
-/-
 spleens caused 
by MHV-68 as depletion of these two subsets reduces the pathology (Dutia et al., 
1997) and they are essential in controlling virus infection in the acute and latent 
stages. MHV-68 establishes a latent infection in B lymphocytes of the spleen in mice 
(Sunil-Chandra, Efstathiou, and Nash, 1992). Therefore, a change in the number of B 
cells could influence levels of virus latency. During infection, a large amount of 
IFN- is produced by NK cells. It has been found that IFN- is elevated in a MHV-68 
infection in IFN-R
-/-
 mice; therefore, it would be interesting to monitor the 
percentage and numbers of NK cells. Macrophages are associated with the 
generation of fibrosis induced by MHV-68 infections in IFN-R
-/-
 mice through their 
alternative activation pathway (Gangadharan et al., 2008), thus they were considered 
as another main target to study. At the beginning of a latent infection in the spleen, 
an increase in neutrophils in IFN-R
-/-
 mice was found (Ebrahimi et al., 2001). 
Therefore, the percentages of neutrophils in the spleen following WT virus infection 
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were compared to that of M4stop virus infection.  




 T cells, B cells and NK cells. 
Among these subsets the percentages of CD19
+
 B cells remained at the same level 
during infections between M4stop and WT infections except at day 14 p.i. (p<0.05) 
(figure 6.5c). The percentages of CD4
+
 T cells were increased in the WT-infected 
IFN-R
-/-
 mice at day 18 and 25 p.i. as compared to the M4stop virus infection 
(figure 6.5a) (p<0.05). The proportions of CD8+ T cells were decreased in 
WT-infected spleens as compared to M4stop infections at day 10 and 18 p.i. (figure 
6.5b) (p<0.05). The percentages of NK cells were also decreased at day 18 p.i. in the 
WT-infected spleens compared to M4stop infection (figure 6.5d) (p<0.05). An 
increase in the percentage of CD4
+
 T cells was also found in the 129Sv mice 
following infection with WT virus compared to M4stop virus at day 14 p.i. (figure 
4.5). Therefore, CD4
+
 T cells may be important for MHV-68 latency. IFN-R
-/-
 mice 
have a bias toward Th2-type responses with impaired Th1 responses. It is possible 
that the CD4
+
 T cells in the WT virus infection are Th2 cells. Furthermore, MHV-68 
infection in Th2-biased mice causes splenic fibrosis (Ebrahimi et al., 2001; 
Gangadharan et al., 2008). Therefore, the increased percentage of CD4
+
 T cells in the 
spleen may be related to the higher level of fibrosis in the WT-infected mice as 
compared to M4stop virus infection.  
To determine the changes in proportion of macrophages and neutrophils, anti-CD11b 




 cell  







Figure 6.5   Changes in percentages of lymphocytes in the spleen. IFN-R
-/-
 mice were 
infected with 4 × 10
5
 PFU of either M4stop or WT virus and the splenocytes were stained 
with fluorescent conjugated anti-CD4, -CD8, -CD19 and -CD49b antibodies and analysed by 
flow cytometry to determine the percentage of each population in the spleen. (a) CD4
+
 T cells. 
(b) CD8
+
 T cells. (c) B cells. (d) NK cells. Each symbol represents an animal, and D 
represents day. The black bars denote the median of each group. Groups that have mean 
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 was determined as 
macrophages. The percentages of neutrophils and macrophages are presented in 
figure 6.6. There was non-significant increase (p=0.057) in the percentages of 
macrophages in the WT-infected spleens at day 10 and 14 p.i. (figure 6.6b). In 
contrast, there was a significantly (P<0.05) increased percentage of neutrophils in 
the spleens of the mice infected with WT at day 25 p.i. as compared to M4stop virus 
infection (figure 6.6a). 
6.2.4 The percentage of V4+CD8+ T cells in the spleens 




 cells is related to IM-like syndrome and fibrosis in 
MHV-68-infected IFN-R
-/-
 mice by day 21 p.i., and is induced by the M1 protein 
(Evans et al., 2008; Tripp et al., 1997). Although M4 protein was shown not to 




T cells from day 28 p.i. (Evans et al., 2008), the 
ability of the M4 protein to induce this cellular type during earlier time points has not 
been examined. Because M4 protein can be detected during acute latency and the 
fibrosis pathogenesis was delayed in M4stop virus infection, it is possible that the 




cells in the spleen of IFN-R
-/-
 mice  




 T cells was calculated by comparing to total CD8
+
 T cells in the 
spleens during M4stop and WT infections at days 18 and 25 p.i.. The percentage of 
V4 expressing CD8
+
 T cells among the total CD8
+
 T cell population was the same 
at day 18 p.i., suggesting the development of fibrosis in the WT-infected spleens at 





Figure 6.6   Changes in the percentage of neutrophils and macrophages in the spleens after 
infection. IFN-R
-/-
 mice were infected with 4 × 10
5
 PFU of M4stop or WT virus and the 








respectively by fluorescent-conjugated antibodies in the FACS. (a) The percentages of 
neutrophils. (b) The percentages of macrophages. Each symbol represents one mouse and D 
represents day. The black bars denote the median of each group. Groups that have mean 
values that vary significantly (p<0.05) by Mann-Whitney test are indicated by *. 
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 T cells. Moreover, the 
development of fibrosis in the WT-infected spleens of IFN-R
-/- 
mice at day 18 p.i. 
may be due to some other reasons, such as the Th2 response. However, at day 25 p.i., 




T cells was lower (p<0.05) in the M4stop-infected 
spleens when compared to WT virus infection (figure 6.7), which may be due to 
decreased expression of M1 protein in spleens which harbored less M4stop latent 
virus than WT virus infection.  
6.2.5 Cellular activation 
It has been found in Chapter 4 that a high level of latency in the spleen of 
WT-infected 129Sv mice correlated with a higher percentage of activated 
lymphocytes at day 14 p.i.. To examine whether there was a difference between the 
cellular activation observed in IFN-R
-/-
 mice from that found in WT mice, the 




 T cells, B cells and NK cells was monitored by 
flow cytometry. Because the changes of splenic pathology were mainly found 
between day 10 and day 25 p.i., days 10, 14, 18 and 25 p.i. were chosen. The results 
are shown in figure 6.8. Non-significant (p=0.057) increase in activated lymphocytes 
was found in all four lymphocyte subsets in the spleens of WT-infected mice at day 
18 p.i., when the notable increase in the latency was found in the WT-infected spleen. 
It would be interesting to repeat this experiment to determine whether a higher WT 
viral latency induces a higher level of cellular activation in IFN-R
-/-
 mice. 







Figure 6.7  The change in V4 expressing CD8 T cells. IFN-R
-/- 
mice were infected with 4 × 
10
5
 PFU M4stop or WT virus and the splenocytes were stained with anti-V4 and CD8 




 T cells 
was calculated by comparing with the percentage of CD8
+
 T cells. The black bars denote the 
median of each group; each symbol represents one mouse and D represents day. Groups 
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6.2.6 Changes in GC B cells 
MHV-68 is mainly latent in the GC B cells; therefore, a change in level of the GC B 
cells could influence viral latency. The expression of CD38 on B cells is an indicator 
of B-cell differentiation in the spleen (Oliver, Martin, and Kearney, 1997). Hence, to 
determine the percentage of GC B cells, splenocytes were double-stained with 
anti-CD38 and anti-CD19 antibodies. The histogram and density plots in figure 6.9a 












 B cells was increased after M4stop and WT infection, but this 
population disappeared in the spleens of IFN-R
-/-
 mice infected with WT virus at 
day 25 p.i.. The percentage of GC B cells in the WT-infected spleens was 
significantly higher than for M4stop (p<0.05) at day 18 p.i. , then the GC B cell 
population which was found in M4stop virus infection was not seen in the spleens of 
WT-infected mice at day 25 p.i. (p=0.05) (figure 6.10). This result is consistent with 
the previous results, which showed the GC structure was disturbed during a MHV-68 
infection around day 23 p.i. (Ebrahimi et al., 2001). The disruption of the GC 
structure may influence the population of plasma cells in which the reactivation of 
MHV-68 occurs.  
It has been shown in Chapter 5 that the difference in viral latency between WT and 
M4stop virus infections at days 14 and 17 p.i. was not related to the percentage of 






Figure 6.8  Percentages of activated lymphocytes in the spleens following infection with 
M4stop or WT virus. IFNR
-/-
 mice were infected with 4 × 10
5
 PFU of either M4stop or WT 
virus. Spleens were harvested at days 10, 14, 18 and 25 p.i.. Lymphocytes were double 
stained with anti-CD69 and CD4, CD8, CD19 or CD49b
 
antibodies, followed by analysis using 
flow cytometry. The black bars denote the median of each group. Each symbol represents 
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splenic GC B cells during the 129Sv mice infection, because the percentage of GC B 
cells was the same between the two viral infections at day 12, 14 and 17 p.i.. 
Interestingly, the percentages of B cells that were GC B cells in the WT-infected 
IFN-R
-/-
 mice spleens was higher than that seen in M4stop virus infection at day 18 
p.i.. However, the increase in splenic GC B cells is possibly related, but not the only 
reason for the higher level of WT viral latency at day 18 p.i., because the sudden 
disappearance of GC B cells at day 25 p.i. did not reduce the latency difference 
between M4stop and WT, indicating the decrease in M4stop latency at day 18 p.i. is 
not due to the lower GC B.  
6.3 Discussion 
In this chapter, pathological changes were compared between the immune response 
and kinetics of virus replication that occur in IFN-R
-/-
 mice following infection with 
WT and M4-mutant viruses. As described in the results part of this chapter, there was 
a notable pathological change in the WT-infected IFN-R
-/-
 mice, whereas a delay in 
the loss of splenocytes and the formation of fibrosis were found to occur in M4stop 
virus infection. Compared to 129Sv mice infection, the peak of WT latency was 
postponed to day 18 p.i.. M4stop virus infection showed a reduced ability to establish 
latency in both mouse strains. It is indicated that although IFN- is essential for the 
control of viral latency in the spleen, it does not appear to be modulated by the M4 
protein.  




Figure 6.9  Gating strategies of GC B cells. IFN-R
-/-
 mice were infected with 4 × 10
5
 PFU 
of either M4stop or WT virus and sacrificed at days 10, 14, 18 and 25 p.i.. Splenocytes were 







. The red peak indicates the unstained cells, the 
middle peak represents the CD38
dim
, and the right peak represents the CD38
high
 cells. (b) The 
change in proportion of CD38
dim
 cells during M4stop and WT virus infections. The cells in the 




 B cells. 










Figure 6.10  The percentages of GC B cells. IFN-R
-/-
 mice were infected with 4 × 10
5
 PFU 
of either M4stop or WT virus and sacrificed at days 10, 14, 18 and 25 p.i.. Splenocytes were 





 B cells. The median from each group of animals are shown. Each symbol 
represents one mouse and D represents day. Groups that have mean values that vary 
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 T cells, which are induced by the M1 protein, are 
involved in the generation of fibrosis in the IFN-R
-/-
 mice during MHV-68 infection 





T cells from day 28 p.i., there was no evidence to show that 




 T cells at earlier time points. Therefore, 




 T cells were monitored during infection. A slight but 
significant (p<0.05) increase in the percentage of V4+CD8+ T cells was found in 
WT-infected spleens at day 25 p.i. as compared to that found during M4stop virus 
infection. However, the results of M4stop virus infection are unlike those seen in a 




 T cells is decreased 
dramatically in the IFN-R
-/-
 mice at day 28 p.i. compared to that seen in a WT 
infection (Evans et al., 2008). The number of splenocytes in M1-deficient virus 
infected IFN-R
-/-
 mice is maintained at a similar level during infection, whereas the 
number decreased in WT virus infection (Dutia et al., 2004). Moreover, no fibrosis is 
found in M1-mutant virus infected IFN-R
-/-
 mice (Evans et al., 2008), whereas 
M4stop virus infection induced a delayed fibrosis in the spleens at day 25 p.i.. These 




 T cells in WT virus infection is not the only 
reason for inducing the splenic fibrosis. 
IFN-R
-/-
 mice develop a Th2 biased response after MHV-68 infection (Gangadharan 
et al., 2008). Transcription of chemokines and cytokines in IFN-R
-/-
 mice following 
MHV-68 infection is different from that seen in WT mice (Ebrahimi et al., 2001; 
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Gangadharan et al., 2008). For example, the transcription of Cxcl9 were significantly 
reduced during infection (Ebrahimi et al., 2001). The M4 protein has been shown be 
a Cxcl9 binding protein, therefore, the M4 protein may reduce these Th1 chemokines 
and enlarge the Th2 response. In this case, it would be interesting to assess and 
compare the levels of Th1 chemokines in the spleens of M4stop-infected IFN-R
-/-
 
mice with WT virus infection.  
An increased percentage of macrophages was found in WT infected IFN-R
-/-
 mice at 
day 10 and 14 p.i.. It has been reported that MHV-68 infection of IFN-R
-/-
 mice 
leads to the activation of F4/80
+
 macrophages via the alternative pathway, and the 
alternatively activated macrophages migrate to the GC at day 12 p.i. (Gangadharan et 
al., 2008), which is related to the development of fibrosis in the spleen. We do not 
know what the kinetics of the macrophage migration in the M4stop virus infection of 
IFN-R
-/-
 mice are, but it would be interesting to compare it to that of a WT infection. 
The splenic transcripts of Th2 cytokines and chemokine receptor, such as IL-4, IL-5, 
IL-13, IL-21 and CCR4, were significantly higher in IFN-R
-/-
 mice as compared to 
WT mice around day 20 p.i. (Gangadharan et al., 2008). These Th2 biased cytokines 
and chemokine receptor are involved in the alternative activation of macrophages 
(Gordon, 2003), which induce fibrosis in the spleen in IFN-R
-/-
 mice (Gangadharan 
et al., 2008). Transcripts of IL-13, IL-4 and Ccr4 were found to be expanded in the 
spleens of the 129Sv mice infected with WT virus as compared to M4stop virus 
infection at day 14 p.i., whereas the levels of transcripts of these chemokines in the 





 were unknown. IFN- is an anti-fibrogenic cytokine, and it 
may control the fibrosis formation mechanism in 129Sv mice. Therefore, in the 
non-responsive IFN- mice, the over-expansion of the Th2 chemokines and 
cytokines may induce fibrosis. Therefore, to understand the generation of spleen 
fibrosis through the chemokines, cytokines and their receptors, it would be 




The loss of the splenocytes and the change of spleen structure during WT virus 
infection in the IFN-R
-/-
 mice did not impact on viral latency at day 18 p.i.. 




B cells) at day 25 p.i. only 
reduced viral reactivation in comparison to M4stop virus infection. However, WT 
viral DNA loads were higher than that seen in M4stop virus infection, indicating GC 
B cells are not the only main site of MHV-68 latency in the IFN-R
-/-
 mice at day 25 
p.i.. The mechanism of GC B cell loss is still unknown, but it is probably one way to 
defend the host from viral infection, or latent virus could trigger the differentiation of 
B cells into memory B cells or plasma cells. However, the percentage of memory B 
cells has been shown to be reduced at the same time (S Li’s personal 
communication). Due to the decrease in the number of infectious centres in the 
WT-infected spleen at day 18 p.i.. The number of infectious centres in WT-infected 
spleens decreased at day 25 p.i., but the viral DNA loads of WT virus were higher 
than M4stop suggesting that it is unlikely that the decrease in the M4stop viral 
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latency was because of the disruption of plasma cells differentiation (which are the 




























The left end of the MHV-68 genome, which encodes M1-M4, vtRNAs and 
microRNAs, plays an important role during viral lytic and latent infections. The M4 
gene encodes a secreted glycoprotein which is predicted to have modulatory 
functions, because the viral DNA load and reactivation of virus are decreased after 
infection with a virus lacking a functional M4 gene compared to WT virus infection. 
In this study, we investigated the function of M4 protein of MHV-68 by examining 
the chemokine binding ability of the recombinant M4 protein in vitro and by 
comparing the host responses following M4stop virus and WT virus infections.  
The recombinant M4 protein was shown to bind to Cc- and Cxc-chemokines. 
Moreover, the binding of M4 protein and chemokine inhibited the chemokine-GAGs 
interaction. Interestingly, the binding ability of M4 protein to Cxcl2 and Cxcl5 was 
higher than M3 protein. In contrast, M4 protein showed lower binding activity to 
CXCL8, which has been shown to bind to M3 protein with a high activity (Parry et 
al., 2000). Therefore, it could be possible that MHV-68 secretes two chemokine 
binding proteins, which bind to different chemokines. It would be interesting to 
examine the binding activity of M4 with more chemokines which M3 protein does 
not bind or binds with a low affinity. 
M3 protein modulates the immune response in the lungs of wood mice (Hughes et al., 
2011), but there is no change in the lung inflammation in the laboratory mice 
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following M3 mutant virus (Sarawar et al., 2002). Similarly, there was no difference 
in the lung inflammation during M4stop infection as compared with WT infection. 
This might be due to a difference between the natural host environment and the 
laboratory mouse. Alternatively, the timing post infection might be very important 
for MHV-68 infection. 
We noticed that the M4stop viral titres in the lung were lower at day 8 p.i.. 
Furthermore, M4stop virus had a higher viral load in the spleens at the same time 
point compared to WT viral infection, suggesting the spread of M4stop virus is faster. 
It has been found that MHV-68 is passed to macrophages through the infected 
epithelial cells, then the B cells are infected only after the infection of macrophages 
(Frederico et al., 2012). Although, the kinetics of viral transportation are not clear 
during M4stop viral infection, it is possible that the infected macrophages in the lung 
are able to migrate faster to the MLN in the absence of M4 protein. Hence, more B 
cells might be infected in the MLN and transported to the spleen. However, more 
experiments, such as investigating the viral DNA loads of M4stop and WT virus and 
the number of macrophages in the MLN, are required to confirm our hypothesis. 
The absence of M4 protein led to a decrease in viral DNA load and reactivation of 
viral latency at day 14 p.i., accompanied by less activation of T cells, B cells and 
macrophages compared to WT infection. The activation of B cells depends on the 
assistance of CD4
+
 T cells (Stevenson and Doherty, 1999). Then the activated B cells 
migrate to the GC and develop to centroblasts (reviewed in Nutt and Tarlinton, 2011; 
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Schwickert et al., 2009). However, there was no difference in the percentage of 
proliferating B cells or the percentage of GC B cells in the spleens of 129Sv mice 
infected with M4stop and WT viral infections. Interestingly, more GC B cells were 
found in the spleens of WT-infected IFN-R
-/-
 mice at day 18 p.i., accompanied by a 
higher WT viral load. However, at day 25 p.i., the disappearance of GC B cells 
during WT virus infection did not influence the fact that WT virus latency was still 
higher than M4stop virus. This evidence suggests GC B cells are not responsible for 
the decreased M4stop virus latency. 
The expression of Ccl19, Cxcl12, Cxcr5 and Bcl-6 mRNA, which are related to the 
development of GC, was found to be decreased in the WT-infected spleen when 
compared to M4stop viral infection at various time points. Moreover, these 
transcripts were down-regulated at day 12 or 14 p.i. in the spleens of WT-infected 
129Sv mice compared to WT viral infection at day 10 p.i.. Therefore, we believed 
the development of GC was different between M4stop and WT infection. However, 
the percentages of GC B cells, TFH cell and plasma cells in the spleens of two viral 
infections did not support our hypothesis. Although we noticed that there was no 
difference in the percentage of macrophages in the spleen following M4stop and WT 
virus infection at days 10 and 12 p.i., the distribution of macrophages in the GC were 
distinct. Therefore, it would be interesting to examine the distribution of TFH cells 
and plasma cells, as M4 protein may affect the trafficking of these cells. 
An increase in the transcripts of IL-4 and IL-13 and a decrease in the transcripts of 
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LT, LT, Bcl-6 and Ccr7 in the spleen indicate there was a strong Th2 response 
during WT infection. Th2 cytokines, such IL-4 and IL-13, can downregulate the Th1 
response, which suggests WT virus infection induced a reduced Th1 immune 
reaction. Several viruses modulate the immune system by inhibition of the biological 
activity of Th1 cytokines, thus the immune response shifts from Th1 response to Th2 
response and the viruses increase their chance to survive. For example, EBV encodes 
an IL-10 homolog(Swaminathan et al., 1993) and Myxoma virus encodes a homolog 
of IFN- receptor (Upton, Mossman, and McFadden, 1992), which both inhibit the 
Th1 response. Additionally, KSHV encodes a vCCL2 homolog, which drives a 
Th2-type immune response in vivo and avoids a Th1 response (Weber et al., 2001). 
On the contrary, immune responses in M4stop viral infection seem to be less Th2 
skewed than in WT viral infection. M4 protein has an ability to bind to Cxcl2 and 
Cxcl9, which are Th1 chemokines. Therefore, the chemokine binding ability of M4 
protein might be involved in the Th1/Th2 equilibrium by binding the Th1 
chemokines. We also found that M4 protein can bind to Cxcl4 and prevent the 
Cxcl4-GAGs interaction. However, Cxcl4 inhibits the production of IFN- and 
promotes the development of Th2 cytokines (Fleischer et al., 2002; Romagnani et al., 
2005). However, it has been found that chemokine binding protein can enhance the 
function of chemokines (Coscoy et al., 2012). Therefore, it is necessary to examine 
the ability of these chemokines to mediate chemotaxis after binding with M4 protein. 
The development of fibrosis was delayed in the M4stop-infected spleen compared to 
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WT viral infection in the IFN-R
-/-
 mice. It is believed that fibrosis is related to the 
alternative activation of macrophages, involving Th2 cells secreting IL-4 and IL-13 
(Gangadharan et al., 2008; Gordon, 2003; Stein et al., 1992). Therefore, the earlier 
generation of fibrosis in the WT-infected IFN-R
-/-
 mice might be due to the severe 
imbalance of Th1/Th2 response. Moreover, we found the difference in the levels of 
viral load in the absence of M4 protein is not related to the IFN-response
Although we know M4 protein has an ability to bind chemokines, the mechanism of 
successful latency establishment of WT virus in the spleens of immunocompetent 
mice at day 14 p.i. is still unsure. Our study helps to shed some light on the 
possibilities of what roles M4 protein might be involved in. However, to fully 
understand the function of M4 protein, we still have some goals to achieve. Firstly, as 
we know M4 protein interrupts the chemokine-GAGs interaction, we further want to 
investigate whether M4 protein modulates chemotaxis. Supposing M4 protein can 
affect chemotaxis, whether it inhibits or enhances cell migration or the function of 
chemokines is another question. Secondly, we know that GC regulatory factors and 
PD-1 expression are different between the two viral infections. We would like to 
study GC development further to find out whether the distribution of cells is distinct 
after infection by histological methods. Thirdly, Th1 and Th2 responses will be 
studied during M4stop and WT viral infections to confirm that WT virus induces a 
Th2 response which is absent from M4stop infection. Lastly, the laboratory mouse 
strain we selected has distinct immune responses during MHV-68 infection from its 
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natural host. Therefore, the influence of M4 protein in the wood mice will be 





















Antibody Dilution Technique 
Mouse anti His-tag 1:500 ELISA, Western Blot 
Rabbit anti mouse biotin 1:1000 Western Blot 
Rat anti Cxcl4 1:500 Western Blot 
Rat anti Cxcl4 1:1000 ELISA 
Streptavidin-AP 1:500 Western Blot 
Goat anti rat HRP 1:1000 ELISA 
Goat anti mouse HRP 1:500 ELISA 
CD4-PE 1:666 Flow cytometry 
CD8-PE 1:130 Flow cytometry 
CD19-PE 1:230 Flow cytometry 
CD19-APC/Cy7 1:160 Flow cytometry 
CD38-APC 1:666 Flow cytometry 
CD49b-PE 1:100 Flow cytometry 
CD49b-FITC 1:20 Flow cytometry 
CD138-PE 1:1000 Flow cytometry 
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Cxcr-5-APC 1:68 Flow cytometry 
PD-1-FITC 1:68 Flow cytometry 
CD11b-APC 1:34 Flow cytometry 
Ly6G-PE 1:42 Flow cytometry 
Ki-67 1:200 Flow cytometry 
IFN--PE 1:1000 Flow cytometry 
Goat anti rabbit biotin 1:300 Flow cytometry 
Alexa Fluor
®
 647 1:500 Flow cytometry 
Alexa Fluor
®
 568 1:1000 Immunostaining 
















Position Symbol Position Symbol Position Symbol 
A01 Abcf1 C05 Ccr7 E09 Il1b 
A02 Bcl6 C06 Ccr8 E10 Il1f6 
A03 Cxcr5 C07 Ccr9 E11 Il1f8 
A04 C3 C08 Crp E12 Il1r1 
A05 Casp1 C09 Cx3cl1 F01 Il1r2 
A06 Ccl1 C10 Cxcl1 F02 Il20 
A07 Ccl11 C11 Cxcl10 F03 Il2rb 
A08 Ccl12 C12 Cxcl11 F04 Il2rg 
A09 Ccl17 D01 Cxcl12 F05 Il3 
A10 Ccl19 D02 Cxcl13 F06 Il4 
A11 Ccl2 D03 Cxcl15 F07 Il5ra 
A12 Ccl20 D04 Pf4 F08 Il6ra 
B01 Ccl22 D05 Cxcl5 F09 Il6st 
B02 Ccl24 D06 Cxcl9 F10 Cxcr2 
B03 Ccl25 D07 Cxcr3 F11 Itgam 
B04 Ccl3 D08 Ccr10 F12 Itgb2 
B05 Ccl4 D09 Ifng G01 Lta 
B06 Ccl5 D10 Il10 G02 Ltb 
B07 Ccl6 D11 Il10ra G03 Mif 
B08 Ccl7 D12 Il10rb G04 Aimp1 
B09 Ccl8 E01 Il11 G05 Spp1 
B10 Ccl9 E02 Il13 G06 Tgfb1 
B11 Ccr1 E03 Il13ra1 G07 Tnf 
B12 Ccr2 E04 Il15 G08 Tnfrsf1a 
C01 Ccr3 E05 Il16 G09 Tnfrsf1b 
C02 Ccr4 E06 Il17b G10 Cd40lg 
C03 Ccr5 E07 Il18 G11 Tollip 
C04 Ccr6 E08 Il1a G12 Xcr1 
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